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Research conducted in the past couple of decades has showcased the importance
of the gut microbiota in human health and well-being. While many studies have reported
on the differences in community membership between a disease state and a healthy state,
few have investigated the mechanisms through which an aberrant microbiota contributes
to a disease phenotype. One of the primary reasons for this are the many technical and
ethical barriers to conducting the necessary studies directly in human individuals. Human
microbiota-associated (HMA) porcine models have the potential to become important
research tools which can enable the testing of hypotheses regarding host-microbiota
interactions in human health and disease without directly involving humans. However,
relatively few microbiome studies have utilized porcine models in this capacity. Through
multiple studies, we evaluated HMA porcine models in terms of their suitability for use
in gut microbiota studies. Results demonstrated that (1) compared to an HMA C3H/HeN
mouse model, a higher percentage of donor taxa from donors of different age groups
were able to persistently colonize HMA piglets, (2) while a majority of donor taxa in
infant donors were able to colonize HMA piglets, rare/low-abundance taxa found in the
infant donors enriched once engrafted into the piglets, and (3) the potential for using

HMA piglets for studying host-microbiota interactions related to obesity. We believe that
further improvements to address some of the shortcoming and challenges associated with
HMA piglets will facilitate more wide-spread use of this animal model in the field of gut
microbiome research.
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CHAPTER 1
MODEL SYSTEMS TO STUDY THE HUMAN
GASTROINTESTINAL MICROBIOTA AND THE USE OF HUMAN
MICROBIOTA-ASSOCIATED (HMA) PORCINE MODELS

1.1 The gut microbiota in health and disease
A growing number of studies have suggested that the intestinal microbiota may
contribute to the metabolic health of the human host. While a ‘healthy’ gut microbiota
has been difficult to define mainly due to the high interindividual variation in gut
microbiota composition, characteristics such as high taxonomic diversity, high microbial
gene richness, and stable core microbial functions are thought to define a healthy gut
microbial community [1, 2]. Consequently, aberrations of the microbiota from this
healthy state are thought to contribute to the pathogenesis of various metabolic disorders
such as obesity, type 2 diabetes, non-alcoholic fatty liver disease, cardiometabolic
diseases and malnutrition [2].

1.2 Model systems for microbiome research
While the studies referred to above have greatly contributed to our increasing
appreciation of the important role played by the gut microbiota in overall human health
and well-being, many such findings have been associations, and mechanistic insights into
the causality of the microbiota in human health/disease conditions have been difficult to
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establish. One of the primary reasons for this are the inherent limitations of directly
interrogating the gut microbiota of human subjects. These limitations include 1) variation
in human genotypes, 2) large interindividual variation in gut microbiota composition, and
3) current and past environmental exposures [3]. Another confounding factor may be the
difficulty in establishing adherence of human subjects to experimental treatments (e. g.,
adherence to a given dietary regime). Therefore, there is a need for in vitro and in vivo
experimental model systems which allow the systematic manipulation of variables and
thus allow the setting up of experiments aimed at validating results derived from
microbiome data [4].
In vitro models typically aim to mimic gut microbial processes using bioreactors
which may be setup to simulate specific parts of the human gastrointestinal (GI) tract [4].
Compared to in vivo models, they are typically cheaper and offer greatly improved
throughput, flexibility and scalability for hypothesis testing [4]. Examples of such
systems include the Simulator of the Human Intestinal Microbial Ecosystem (SHIME)
[5], which was later improved to include a mucus layer and named M-SHIME [6]. Other
such systems include the automated in vitro GI tract system [7, 8], a three-stage
continuous culture system [9], and the more recent SIMulator Gastro-intestinal (SIMGI)
automated system [10]. Despite their advantages, one of the major drawbacks of these
systems is the lack of long-term interactions between the host and co-cultures of human
and microbial cells [4] and the lack of an immune system, which are particularly
important contributors of microbial community structuring within the host.
The most common in vivo models used in gut microbiome research are germ-free
(GF) animals which are subsequently colonized with specific microorganisms (from
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single species/strains to entire microbial consortia). Since the microbial composition of
such animal models is known to and ‘controlled’ by the investigator, they are referred to
as gnotobiotic (from the Greek words ‘gnostos’ (known) and ‘biota’ (living flora and
fauna) [11]) animal models. The advantage of using gnotobiotic animals in research is the
ability to investigate the systemic impact of specific microorganisms on the host animal
[4]. Gnotobiotic animal models have proved essential to the study of host-microbiota
interactions, in particular in the context of immune system-microbiota feedbacks [4].

1.3 Human microbiota-associated (HMA) animal models
Of particular relevance to the study of the human microbiota are the so-called
‘humanized’ or human microbiota-associated (HMA) animal models. These animal
models are derived by colonizing GF animals with microbial consortia from human
donors. HMA animal models are attractive to researchers due to their potential to enable
in vivo study of a human microbiome under controlled conditions [3]. In concept, this
translates to a higher probability that findings from HMA animal studies can be more
readily applied to humans.
To date, HMA mouse and rat models have been the most widely used HMA
animal models. The availability of numerous disease-specific and genetically altered
mouse models from multiple vendors, quick reproduction rate, and relatively small size
(which facilitates maintenance and performing long-term studies in isolators as well as
the possibility of having large numbers of ‘observational units’ – in studies with HMA
animals, the human donor is the experimental unit [83]) are some of the major advantages
of HMA rodent models [4]. Some of the disadvantages of HMA rodents include
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important metabolic and physiological differences from humans, differences in immune
system dynamics, and the inability of many rodent models to dependably replicate
clinical manifestations observed in humans [4, 12]. Despite these limitations, HMA
rodents have been successfully used to transfer human phenotypes, as well as to provide
insights into the potential mechanisms through which the microbiome affects host
disease/health conditions [13, 14, 15, 16, 17].
Domestic pigs have also been used as HMA animal models [18, 19]. While not
nearly as widely employed as the aforementioned HMA rodent models, several
characteristics of these animals make them very attractive as HMA animal models. The
domestic pig is omnivorous and has close similarities to humans in terms of anatomy,
physiology, and genetics, and is considered the preferred non-primate model for humans.
Increased cost, expensive housing, long lifespans, and ethical concerns have limited the
use of non-human primates for microbiome studies [20, 21]. In addition, both pigs and
humans are colon fermenters (rodents are cecum fermenters) [22]. Immunologically, pigs
are more similar to humans than commonly used rodent models [12, 23, 24]. Therefore,
the domestic pig can be considered a clinically relevant model to study the human
microbiota.

1.4 The domestic pig (Sus scrofa domesticus)
The origins of the domestic pig (Sus scrofa domesticus) are believed to be traced
back to the Eurasian wild boar (Sus scrofa), and domestication is thought to have
occurred about 9,000 years ago in multiple areas, including near the Tigris Basin and the
Far East [25, 26]. Introduction of the domestic pig to the New World was initiated during
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the explorations of Columbus and other Spanish explorers and then later on by colonists
from England [27]. Pigs can vary in size from small miniature breeds to large breeds
which can reach weights of around 350 lbs. [28]. The pork industry is concentrated
around 6 major outbred breeds: Large White (Yorkshire), Landrace, Duroc, Hampshire,
Berkshire, and Piétrain [28]. As a protein source for humans, the domestic pig is of great
global importance as pork is considered to be the most consumed terrestrial animal meat
in the world, with China and the United States being the major contributors to worldwide pork production [29].

1.5 The gastrointestinal system of the domestic pig
While the porcine cardiovascular, urinary, and integumentary systems have
commonly been cited as suitable model systems to study in a human context [30], of
particular interest to the field of gut microbiome research is the porcine gastrointestinal
system.
The digestive physiology of the porcine gastrointestinal tract is considered
remarkably similar to humans; however, the anatomy of the gastrointestinal tract (GIT)
shows some important differences [30]. Pigs have the stomach of a typical monogastric
animal with the exception of the presence of a prominent muscular outpouching known
as the ‘torus pyloricus’, as well as the presence of a more prominent cardia. The small
intestine consists of approximately 10% duodenum, 80% jejunum, and 10% ileum, and
roughly 30-40 times the length of the pig’s body [30]. In contrast to other mammals, the
mesenteric vessels of the small intestine form vascular arcades in the muscularis mucosa
and not in the friable mesentery [30, 31]. Another characteristic which differentiates the
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porcine GI tract from that of other domestic animals is the occurrence of Peyer’s patches
as a continuous band along much of the length of the small and large intestines. The
cecum, ascending and transverse colon, and the proximal portion of the descending colon
are arranged in a series of centrifugal and centripetal coils in the left upper quadrant of
the abdomen, collectively forming the spiral colon [30]. The cecum consists of three
longitudinal muscular bands known as ‘tenia’, while the proximal part of the spiral colon
has two such bands. The presence of these bands results in a series of sacculations known
as ‘haustra’ [30].

1.6 The porcine gut microbiota
The porcine gut microbiota consists of a large and diverse microbial population
which is believed to play an important role in the health and well-being of these animals
[32]. The advent and widespread availability of high-throughput sequencing technologies
have provided unprecedented insight related to the composition and function of the
microbiota of various animal species, including pigs. Sequencing of the 16S rRNA genes
of the microbial community is the most commonly used culture-independent technique to
characterize the microbial composition of a given environment, and this technique has
been widely employed in studies related to the porcine microbiota as well. Similar to
other mammals, the gastrointestinal microbiota of pigs is dominated by the phyla
Firmicutes and Bacteroidetes which account for ~85% of the 16S rRNA gene sequences
of the porcine GIT, regardless of sampling location [33]. Many physiological and
environmental factors such as weaning [34], different dietary substrates [35, 36], and
exposure to antibiotics [37, 38] appear to play a role in structuring the porcine
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microbiota. Despite the variation in the gut microbiota composition reported in different
studies as a result of the different diets, sampling methods, age of animals, and other
factors, there appears to be a core set of genera which includes members of the genera
Clostridium, Prevotella, Ruminococcus, Lactobacillus, and Roseburia that inhabit the
porcine gastrointestinal microbiome [33].

1.6.1 Microbial colonization of the porcine gastrointestinal tract in early life
Colonization of the neonatal piglet gut commences immediately following birth
[39]. These initial colonizers are mostly aerobic or facultatively anaerobic bacteria such
as Escherichia coli, Shigella flexnerii, and Streptococcus spp. [39, 40]. These organisms
consume available oxygen, thus creating an anaerobic environment conducive to the
growth of anaerobes such as Bacteroides, Clostridium, Bifidobacterium, and
Lactobacillus spp. [39, 40, 41].
Several longitudinal studies have investigated the temporal patterns associated
with the establishment of the gut microbiota in pigs. Using full length 16S rRNA gene
libraries, Petri et al. (2010) studied the microbial succession patterns in digesta collected
from the stomach, small intestine, and the colon of neonatal pigs. Members belonging to
the families Clostridiaceae and Enterobacteriaceae were the major early colonizers (up
to about 0.5 days), but were quickly displaced by members of the family
Streptococcaceae. Streptococcaceae remained the dominant family between days 1 and 3
before being displaced by members of the family Lactobacillaceae, which remained the
dominant bacterial group for the remainder of the study (day 20). The authors observed

8
that the bacterial succession pattern was similar across all the gastrointestinal locations
sampled in the study (stomach, small intestine, and colon) [41].
Hinkle et al. studied the development of the gut microbiota of pigs from birth to
the end of the nursery period by assessing the fecal microbiome using high-throughput
amplicon-based DNA sequencing [42]. The sampling scheme covered the lactation
period (d7 and d14), weaning period (d26), and the end of the nursery period (d61).
Changes were observed with age in the phylum Firmicutes. However, this phylum
remained as the predominant phylum at all ages investigated. Previous research [43] has
also shown that Firmicutes, along with Bacteroidetes, were the two major bacterial phyla
found in the porcine gut regardless of the age of the animals. The abundance of
Firmicutes was lowest during the lactation period (71.2% and 62.3% on d7 and d14,
respectively) and their abundances increased following weaning (87.0% and 87.3% on
d26 and d61, respectively). An opposite trend was observed for members of the phylum
Bacteroidetes, where the highest abundances were observed in pre-weaned piglets (16.9%
and 26.4% on d7 and d14, respectively), while post-weaning, relative abundances of
these bacteria decreased (3.6% and 7.8% on d26 and d61, respectively). At the genus
level, Bacteroides was dominant during the lactation period (d7 and d14) while genus
Prevotella increased towards the end of the nursery period (d61). This post-weaning
increase in Prevotella abundance is consistent with previous research [43]. The authors
observed a large shift in the bacterial community due to the dietary changes associated
with the transition from sow’s milk to solid feed during weaning. On d26, the
predominant family was Lactobacillaceae (31.4%) with Lactobacillus amylovorus
identified as the predominant species within this group. Previous studies had also
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observed an increase in L. amylovorus following weaning [44, 45]. Other bacterial
families with high representation were Lachnospiraceae (13.4%), Ruminococcaceae
(13.2%), and Enterococcaceae (2.7%). A high prevalence of members of the genus
Blautia was observed within the Lachnospiraceae family. At the end of the nursery
period (d61), the diet had changed as the animal protein fraction in the diets were
decreased and replaced with plant proteins. This resulted in the family Streptococcaceae
(28.8%) being the dominant family, with lower abundances of Lactobacillaceae (9.8%),
Lachnospiraceae (8.8%), Ruminococcaceae (8.6%), Clostridiaceae (5.6%),
Veillonellaceae (4.9%), and Erysipelotrichaceae (3.5%). Among Streptococcaceae
members, the most significant increase was noted in the genus Streptococcus, particularly
in the species Streptococcus alactolyticus which is consistent with previous research [46].
There was an increase in the amount of Bifidobacterium observed in the fecal samples
collected on d26; however, this increase was not observed on d61. The authors
hypothesized that this short-term increase in Bifidobacteria might have been due to the
presence of lactose resulting from the incorporation of whey proteins in diets used early
in the weaning period [42].
The succession of the microbiota that develops in the pig depends on
environmental factors as well as management practices such as the early-life use of
antibiotics. Schmidt et al. (2011) studied the impact of excessive hygiene on the
development of the pig microbiota by rearing pigs in high-hygiene isolators after they
had initially been allowed to colonize naturally in outdoor and indoor rearing systems.
Rearing animals in high-hygiene isolators resulted in the disruption of the microbial
succession and stabilization events that are known to occur in conventionally-reared
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animals. The authors concluded that the early establishment and development of a normal
pig microbiota required continuous microbial exposure and that conditions of excessive
hygiene interfered with this natural process [47]. Schokker et al. [48] looked at the impact
of early-life exposure to antibiotics as well as stressful management practices on the gut
microbial community and on genome-wide intestinal transcriptome profiles. The authors
observed that the use of antibiotics early in life altered the composition and diversity of
the gut microbiota and reduced the expression of genes related to a number of immunerelated processes [48]. Studies have also examined the impact of early-life pig microbiota
on health outcomes later in life. A recent publication by Dou et al. [49] investigated the
impact of the early-life gut microbiota on the susceptibility of pigs to post-weaning
diarrhea using a combination of culture-dependent and culture-independent techniques.
The results revealed that as early as postnatal day 7 (PND7), the diversity and
composition of the fecal microbiota discriminated pigs that remained healthy and pigs
that developed post-weaning diarrhea. On PND7, pigs which remained healthy had
higher abundances of Lachnospiraceae, Ruminococcaceae, and Prevotellaceae members
and lower abundances of the families Fusobacteriaceae and Corynebacteriaceae,
compared to the pigs which developed diarrhea [49].

1.6.2 Changes in porcine intestinal microbiota across growth stages
Several studies have performed longitudinal investigations monitoring the
dynamics of the porcine gut microbiota at different growth stages of the production
system. Han et al. [50] monitored the intestinal microbiota of healthy pigs from birth to
harvest across 5 growth stages (according to feeding system). Fecal samples were
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collected at d10 (pre-weaning on sow milk), d21 (preparation for weaning on feed and
milk replacer), d63, d93, and d147 (weaned pigs, growing pigs, finishing pigs,
respectively) of age. They observed that intestinal microbial communities clustered into 3
distinct groups which were categorized as early (d10 and d21), mid (d63), and late stage
(d93 and d147). In addition, the microbial diversity tended to decrease with increasing
age with the finishing pigs having a significantly lower diversity than at other growth
stages. The age of the pigs and dietary composition as well as other factors were
identified as drivers affecting the observed clustering pattern [50]. Regardless of growth
stage, the two dominant phyla observed were Bacteroidetes and Firmicutes. In addition to
these two phyla, Proteobacteria were prominent in samples from d10, 21, and 63, and
Spirochaetes were at high abundance in samples collected at d93 of age. The authors also
observed rapid changes in the structure and function of the intestinal microbiota as a
result of weaning. Additionally, innate factors (maternal effects and gender) affected the
intestinal microbiota in earlier growth stages but this effect was not observed for later
stages of growth [50].
A more recently published longitudinal study by Wang et al. [51] also
investigated the succession of the swine gut microbiome from birth to market. These
investigators collected rectal swabs from the same piglets at 4 different growth stages:
lactation (d0, 11, 20), nursery (d27, 33, 41, 50, 61), growing (d76, 90, 104, 116), and
finishing (d130, 146, 159, and 174) stages. Similar to the previous study by Han et al.
[50], the two most dominant phyla regardless of growth stage were Bacteroidetes and
Firmicutes. However, contrary to what was observed in the previous study, Wang et al.
observed a general increase in community richness and diversity from birth to harvest.
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Distinct shifts in microbiota composition were observed at different growth stages with
diet once again being identified as a major factor driving swine gut microbiota
composition. Of the different diet constituents, crude fiber from corn appeared to have
the strongest effect in shaping the swine gut microbiota.

1.7 The domestic pig as an animal model for humans
Other than its principal use as a food source, the domestic pig has also been of
utility as an animal model for human research. The pig is considered similar to humans in
terms of dental characteristics, renal morphology and physiology, cardiovascular
anatomy, as well as digestive anatomy and physiology, among others [52]. The pig has
been used as a research model in diverse areas such as cardiovascular physiology,
obesity, dermatology, experimental surgery, diabetes, and nutrition [27].

1.7.1 Comparison of the gastrointestinal tracts between pigs and humans
At the level of physiology and development (growth and maturation) of the
gastrointestinal tract (GIT), pigs are considered close to humans in many aspects during
fetal and post-natal development [52]. In both humans and pigs, prenatal development of
the GIT occurs mainly during the third trimester [53, 54]. At the fetal stage, evolution of
gut regulatory peptide production is described to be similar between humans and pigs
[52, 55]. Although piglets are less mature than human neonates at birth in aspects such as
the digestive system and body composition, the development of GIT enzymes is more
similar between humans and pigs than it is between humans and rodents [52]. In addition,
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the principal enzymes involved in the digestion of milk proteins and other milk
components have comparable activities between human infants and piglets [52]. Digesta
transit time is also considered to be comparable between humans and pigs, and is altered
in a similar manner in response to dietary fiber content [56].
Anatomically, the small intestine of both humans and pigs have plica circularis
(Kerckring’s folds) resulting in a larger surface area for absorption [56]. In addition, the
small intestines of both species are macroscopically comparable, characterized by a linear
continuous tube anchored to the peritoneum by intricately-vascularized mesentery [57].
However, length-wise, the small intestine of the pig (approx. 16-21m) is much longer
than that of the adult human (4 - 7m) [56]. Both pigs and humans are predominantly
colon fermenters. However, compared to humans, pigs have larger colons. As a
percentage of the GIT, the human colon is only about 20% whereas the porcine colon is >
45% [27, 56]. Additionally, the cecum, ascending and transverse colon, and proximal
portion of the descending colon of pigs have centrifugal and centripetal coils which are
structurally different from those of the human colon [28, 56]. In both species, the cecum
and varying lengths of the colon are haustrated, although the cecum is poorly defined in
humans compared to pigs [56]. It has also been proposed that sacculations and tenia
within the human and pig colons would provide similar anatomic and physiologic niches
which can facilitate the development of similar microbial populations [57]. Despite the
differences that exist between humans and pigs at the level of the GIT (gut closure,
materno-fetal transfer of immunity), the pig is still considered a relevant model to study
aspects related to the human digestive system [52].
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1.7.2 Immunological comparison between pigs and humans
Similar to other mammals, pigs possess a full set of innate and adaptive immune
effectors [28]. The porcine immune system is considered to be very similar to its human
counterpart in terms of its anatomy, organization and response [58]. The porcine model
also enables a clear distinction between maternal and fetal contributions to immune
responses due to the presence of an epitheliochorial placenta which prevents the transfer
of maternal cells and immunoglobulins to the fetus [58, 59]. Anatomically, the lymphoid
tissues associated with the oral cavity and the upper respiratory tract are similar between
pigs and humans [58]. The spleen of pigs is also considered to be comparable to the
human spleen and the pig model has been used to assess the impacts of splenectomy [60].
Although differences exist between the human and porcine immune systems (such
as the absence of alpha-defensins in pigs, the inversion of lymph nodes, and the presence
of two types of Peyer’s patches), most proteins of the porcine immune system share
structural and functional similarities with their human counterparts [28]. In fact, a
comparative assessment revealed that the porcine immune system more closely
resembled humans for >80% of analyzed parameters, while mice were only similar to
humans in <10% of the parameters analyzed [23]. In general, all the immune cell
populations identified in humans and mice are also present in pigs. Similar to humans
(and in contrast to rodents) pigs have a high percentage of neutrophils (50-70%) in the
peripheral blood [61]. Globally functional orthologs for all cytokines involved in
differentiation of T cells (known as the Th1/Th2/Th17/Treg paradigm) have been
described in pigs [28]. The neutrophil chemoattractant IL-8 has a direct homolog in pigs,
whereas there is no such direct homolog in mice [61]. Also, similar to observations in
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human macrophages, there is no evidence of nitric oxide (NO) production by porcine
macrophages after lipopolysaccharide (LPS) stimulation [62]. With respect to Toll-like
receptor (TLR) and dendritic cell (DC) biology (which play important roles in microbial
recognition and induction of immune responses to pathogens), the porcine immune
system is considered to be functionally similar to humans [28]. Thus, the similarities
between the porcine and human immune systems makes the porcine model a very
relevant system for translational research related to immunity and microbiome research.

1.8 Derivation and maintenance of germ-free and gnotobiotic pigs

The first reported studies of successfully deriving germ-free pigs originated in
1960 from work done by Dr. Jaroslav Sterzl and colleagues at the Czech Academy’s
Institute of Microbiology in Prague, Czechoslovakia [63]. Shortly afterwards, several
research groups in the United States [64, 65, 66] also reported on methods to deliver
germ-free pigs and their use in biomedical research [67, 68]. Since the development of
gnotobiotic pig facilities, the gnotobiotic pig has been established as a valuable animal
model in the study of enteric bacterial pathogenesis (Mainly through pioneering research
conducted at The Ohio State University), and the study of infectious diseases [28, 63].
Notwithstanding the utility of these animal models, the high costs and complexity
associated with establishing and maintaining gnotobiotic pig facilities has limited the
widespread use and development of gnotobiotic pig models [63].
The facilities required for the derivation and maintenance of gnotobiotic pigs are
very different in design from those used for germ-free rodents [63]. Facilities should have
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wall finishes of an epoxy paint that tolerates chemical exposure, mainly disinfectants.
Similarly, ceiling finishes should be impervious to moisture and resistant to disinfectants.
Lighting should be adjustable in the 10-80 foot-candles (Fc) range. Air change rates are
to be maintained at 15 air changes per hour. To ensure animal comfort at all stages of pig
development, the rooms should be capable of maintaining temperatures in the 72 - 950F
range. Essential equipment in the facility should be backed up by an electric generator
that is preferably powered by natural gas [63].
Germ-free piglets can be derived from sows (at or near the term of the normal
gestation period of 114 days) either through hysterectomy or hysterotomy (Caesarian
section). Hysterectomies involve removal of the intact uterus (with the piglets) and
transfer to a sterile surgical unit to perform surgeries to derive the piglets [63]. The
hysterotomy procedure consists of attaching (by means of a surgical spray, for example) a
plastic surgical isolator to the skin and flank of an anesthetized sow [67], following
which an incision is made using a sterile scalpel (or similar instrument) through the floor
of the isolator and integument of the sow [67, 69]. The uterus is exposed and opened and
the piglets are passed directly into an attached transfer isolator where they are washed,
dried, and their umbilical cords ligated and cut. Unlike in hysterectomies, a surgical
repair of the sow is possible following hysterotomies if desired [67]. The piglets thus
derived can subsequently be transferred to their main housing area via pre-sterilized lightweight, flexible-film isolators or stainless-steel transfer boxes. The light-weight, flexiblefilm isolators have been employed to transport piglets over distances in excess of 100
miles [67].
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The isolators used for housing the germ-free piglets consists of leak-proof,
stainless-steel (or other suitable corrosion-resistant material) rectangular tubs, fitted with
a flexible plastic canopy, a 12-inch port (for transfer of piglets and other materials such as
food and water), and typically 2-4 pairs of rubber gloves. The dimensions of these
isolators can vary, but some examples reported in the literature are 24 in. deep, 24 in.
wide, and 42 in. long [63] and 22 in. by 28 in. by 24 in. [67]. The isolator can be divided
into compartments using dividers so that individual animals can be separated if
necessary. The dividers rest on top of a perforated raised flooring system which provides
for the separation of animals from excrement and wasted diet. Each unit is provided with
round bowl-type feeders to provide food and water to the animals [63]. A clear plastic (or
a polyvinyl chloride) canopy which is custom-fitted with the required number of rubber
gloves is fastened to the top of the isolator [63, 67]. Shelving, which allows for the
storage of food, syringes, and other materials such as those required for sampling, can be
placed on top of the enclosure dividers in a perpendicular arrangement [63]. The 12-inch
port fitted to one side of the isolator allows for the transfer of material (in a sterile
manner) into and out of the isolator [63]. The outside and inside of the port has plastic
caps attached (secured by tape and a rubber band). In some designs, the inside of the port
may be sealed by an air-tight door instead of a plastic cap. Materials to be moved into the
isolator unit in a sterile manner can be placed in the port between the two port covers and
fogged using a sterilizing chemical (such as an appropriately diluted Clidox-S solution or
Spor-Klenz ready-to-use solution). The fogging is achieved by aerosolization of the
sterilizing solution using an air compressor and a spray-bottle. To ensure the circulation
of sterile air within the isolator, high efficiency particulate air (HEPA) filters that have
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been sterilized are attached to the end of the unit through open ‘nipples’ within the
isolator. It is important that each isolator has two HEPA filters that are used to supply
sterile air to the animals and to also filter out exhaust air, thus protecting workers from
pathogen exposure [63].
Once the GF piglets have been housed in their isolators, these animals can be
inoculated with the microorganism(s) of interest thus rendering the piglets gnotobiotic.
Typically, oral inoculations are administered with one person holding the piglet vertically
while restraining its front limbs and the back/shoulder of the pig. A second person can
then administer the inoculum via a syringe (a 10 cc syringe, for example) in small doses,
while allowing the pig to swallow. It’s important to perform these procedures with two
people to ensure the safe handling of the piglets [63]. The timing of inoculation can vary
from within 24 hours of birth to several weeks after birth depending on the study
requirements.

1.9 Studies conducted using HMA porcine models

The first study reported in the literature using HMA pigs as an animal model was
published by Pang et al. in 2007 [18]. In this pioneering study, the investigators orally
inoculated germ-free piglets delivered through cesarean section with a whole fecal
suspension obtained from a 10-year-old boy. The study objective was to determine how
successfully this donor microbiota established in the ex-germfree piglets. The microbiota
composition of the donor inocula and the fecal samples collected from the HMA piglets
was determined using a combination of molecular techniques which included
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Enterobacterial repetitive intergenic consensus sequence-PCR (ERIC-PCR), denaturing
gradient gel electrophoresis (DGGE) analysis, 16S rRNA gene clone library profiling,
and real-time PCR [18].
ERIC-PCR fingerprinting revealed that a stable human microbiota had established
in the piglets by 12 days of age and all littermates exhibited similar DNA fingerprint
patterns of gut microbiota. By inoculating three litters of piglets (n = 28) with the same
donor fecal suspension, the authors were able to demonstrate the reproducibility of these
results. ERIC-PCR fingerprinting-based DNA hybridization was used to compare the
fecal microbial communities of the HMA piglets with the human donor community as
well as the fecal microbial communities of unrelated humans and conventional pigs.
Cluster analysis based on the DNA fingerprint patterns showed that the human donor,
HMA piglets and other human samples clustered together whereas the conventional
piglet fecal samples clustered separately [18]. In addition, the authors also employed
group-specific primers in combination with temperature gradient gel electrophoresis
(TGGE) to monitor the establishment of Bifidobacteria and Bacteroides spp. in the HMA
piglets, as these two groups of bacteria are considered important members of the human
gut microbiota. Comparison of bifidobacterial TGGE patterns between the human donor
and the HMA piglets indicated that most of the donor’s bifidobacterial species had
established in the piglets at comparable levels. Similar TGGE patterns for Bacteroides
spp. were also observed between the human donor and the HMA piglets, although the
patterns were not identical. Specifically, two Bacteroides bands which produced very
weak signals in the donor fingerprint showed stronger signals in the HMA piglets. In
addition, several bands which were not detected in the donor appeared in the TGGE
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pattern of the HMA piglets. This publication by Pang et al. was the first study to
demonstrate the feasibility of establishing human-like gut bacterial communities in ex-GF
piglets.
Zhang et al. (2013) utilized deep sequencing of the V6 region of the bacterial 16S
rRNA gene to monitor the establishment of human fecal microbiotas from adult and
infant donors in GF pigs maintained on solid or milk diets, respectively [19]. A total of 3
experiments were conducted: Two of these experiments utilized fecal extracts from
human adults (a composite fecal extract from fecal samples collected from 10 adults aged
50-70 years) and the remaining experiment was carried out with a fecal extract from a 3month-old breast-fed infant. In the first experiment, 2 piglets were inoculated at 8d of age
with the adult donor fecal extract and subsequently maintained on a Similac milk replacer
diet for the remainder of the study (20d). In the 2nd experiment, 2 GF piglets were
inoculated at 5d of age and another two piglets were inoculated at 30d of age with fecal
extract from the infant donor and maintained on Similac. The last experiment involved
two piglets which were inoculated with the adult fecal extract at 23d of age (3 days postweaning) and provided with a solid diet. Based on phylogeny, comparisons of diversity,
and UniFrac distances for the fecal samples collected from the HMA piglets, the authors
concluded that there was a loss of diversity in the pigs transplanted with the adult donor
microbiota (compared to the donor inoculum), while the fecal microbiota of piglets
transplanted with the infant donor microbiota tended to converge towards the donor
microbiota based on weighted UniFrac distances, indicating more similarity. A
comparison of the microbiota composition of fecal and colonic samples collected at or
just prior to euthanization of selected pigs revealed a close resemblance of the colonic
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microbiota with the fecal microbiota [19]. The three experiments had relatively short
durations (28-41d) and a low number of animals (total of 8 across 3 experiments) and the
lack of replication of experiments makes it difficult to assess the significance and
reproducibility of these findings.
Several studies have used the HMA piglet model to investigate various aspects of
infection with Human Rotavirus, especially in the context of human infants. The reason
for the popularity of this model in this research area seems to be because GF pigs infected
with HRV exhibit similar clinical signs and intestinal lesions to those seen in human
infants [70]. The effect of a probiotic (Lactobacillus rhamnosus GG) on the microbiota
composition following human rotavirus (HRV) vaccination and challenge was
investigated by Zhang et al (2014) using an HMA neonatal piglet model [71]. The donor
was a cesarean-section delivered, exclusively breast-fed infant. Stool samples collected at
17-23 days of age from this infant were pooled to prepare the inocula which were
subsequently used to inoculate GF piglets. The piglets (maintained in sterile isolators)
were inoculated daily, starting from 12h after birth and until 3d of age. All piglets
involved in the study received two doses of an oral attenuated HRV vaccine at 5d and
15d of age. Subsequently, the piglets were divided among 4 treatment groups: (1) no
Lactobacillus rhamnosus GG (LGG) feeding, no virulent HRV challenge (-LGG- HRV,
n=4), (2) no LGG feeding with virulent HRV challenge (-LGG +HRV, n=4), (3) with
LGG feeding but no virulent HRV challenge (+LGG -HRV, n=4), and (4) with both LGG
and virulent HRV challenge (+LGG +HRV, n=3). All piglets were provided with ultrahigh-temperature sterilized milk throughout the study. The piglets in treatment groups (2)
and (4) were challenged with virulent HRV at post-attenuated HRV inoculation day
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(PID) 28. Piglets in treatment groups (1) and (3) were euthanized at PID 28, while those
in groups (2) and (4) were euthanized 7 days after challenge with virulent HRV.
Rotavirus diarrhea and fecal virus shedding were monitored for the piglets challenged
with virulent rotavirus. Colonic contents from all piglets were collected at euthanization
and used for microbiota profiling. Microbiota characterization was performed by high
throughput sequencing targeting the V4 hypervariable region of the bacterial 16S rRNA
gene. Firmicutes and Proteobacteria were the major phyla encountered in both the infant
donor stool inoculum and in the HMA piglet colonic contents. No significant differences
in alpha diversity was observed between the 4 treatment groups. Weighted UniFrac-based
comparisons between the microbial communities corresponding to the different
treatments was also performed. Based on this analysis, the authors reported that the
microbiota structures were significantly different between piglets which received LGG
and those that did not. Using UniFrac distances between virulent HRV challenged and
unchallenged piglet samples, the authors also suggested that the LGG treatment could
resist changes in microbiota community structure resulting from challenge with virulent
HRV. However, LGG feeding in this study did not significantly improve the protective
effect of the rotavirus vaccine [71]. Although the authors concluded that the piglets
harbored microbiotas similar to that of the infant donor, they did not evaluate this claim
statistically. Also, since all the HMA piglets underwent treatments which had the
potential to alter microbiota composition following transplantation, it is likely that the
HMA piglet microbiota deviated from that of the human infant donor.
The same research group also carried out a study to verify the dose-effects of
probiotics on HRV vaccine-induced immune responses using an HMA neonatal piglet
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model [72]. In this study GF pigs and HMA pigs inoculated with an infant microbiota
were treated with different doses of the probiotic Lactobacillus rhamnosus GG (LGG)
with and without vaccination with an attenuated HRV vaccine (AttHRV). The authors
observed that vaccination with AttHRV conferred similar levels of protection against
diarrhea and associated clinical signs in both the GF pigs and the HMA pigs when
challenged with a virulent HRV strain. This was despite the fact that the HMA pigs had
significantly higher Th1 type effector T cell responses and lower Treg cell responses
relative to the GF pigs. In addition, although the feeding of higher doses of LGG resulted
in increased fecal and intestinal LGG counts and increased HRV-specific IFN-gamma
producing T cell responses, it did not significantly enhance the protective efficacy of the
AttHRV vaccine. The authors concluded that both the GF and HMA piglet models were
applicable in the evaluation of rotavirus vaccines and therapeutics, although each model
had its pros and cons [72]. Interestingly, there was no data shown which compared the
human infant donor microbiota to the transplanted microbiota of the HMA piglets.
Fischer and colleagues [73] investigated the relationship between protein
malnutrition and rotavirus infection using an HMA piglet model inoculated with fecal
microbiota from a 2-month-old infant. Piglets were derived through C-section and
maintained in sterile isolators. The isolators were assigned to four treatment groups: (i)
protein-sufficient diet (n = 10), (ii) protein-deficient diet (n=18), (iii) protein-sufficient
diet with 0.4g/day tryptophan supplementation (n=3), and (iv) protein-deficient diet with
tryptophan supplementation (n=3). The researchers then compared adaptive immune
responses (antibody production and T cell frequencies), concentrations of angiotensin Iconverting enzyme 2 (ACE2) and levels of tryptophan among the different treatment
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groups. At 4d of age piglets were orally inoculated with human infant fecal matter.
Subsequently, at day 9- or 10-days post inoculation the piglets were inoculated with
virulent HRV. Following HRV challenge, all piglets were euthanized on 14d post viral
challenge. The results demonstrated that the pigs in the protein-deficient diets had
decreased HRV antibody titers and total IgA concentrations, lower systemic T helper and
cytotoxic T lymphocyte frequencies, serum tryptophan and ACE2 levels. The authors
concluded that protein deficiency negatively affected the adaptive immune response to
HRV and disrupted tryptophan homeostasis and catabolism in their HMA neonatal piglet
model [73]. Similar to studies described above, this study also failed to determine the
composition of the transplanted microbiota of the HMA pigs and compare it to the infant
donor microbiota. Several studies from the same group investigated the impact of
protein-deficiency on innate immunity and gene expression by intestinal epithelial cells
as related to HRV infection using an HMA neonatal piglet model [74] but failed to
investigate how well the transplanted microbiota established in the HMA piglets.
Kumar et al. [70] used an HMA piglet model of human infants to investigate the
relationship between diversity of the microbiota, diet and HRV infection using a 2month-old, breastfed, full-term male infant. Multiple fecal samples collected from this
infant were homogenized to prepare the inoculum which was subsequently used to
inoculate the GF piglets. Six treatment groups depending on whether the piglets were
GF/HMA and whether they were provided a protein-sufficient or protein-deficient diet
was used in this study. A total of 24 piglets with 3-5 piglets/treatment group was used in
this study. The piglets that were inoculated with infant fecal matter were inoculated at 4d
of age and those that were challenged with virulent HRV were exposed to the virus at 14
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days of age. Fecal samples for microbial profiling were collected at multiple time points.
At euthanization (14d after HRV challenge), small intestinal and colonic samples as well
as systemic tissue (spleen, liver, mesenteric lymph nodes) samples were collected for
analysis.
The authors of this study were specifically interested in evaluating how the
transplanted microbiota of the HMA piglets compared to the infant donor microbiota.
The results demonstrated that a majority of operational taxonomic units (OTUs) were
shared between the donor and the HMA piglets although they were at different relative
abundances. At the phylum level, the major components of the infant donor were
members of the phyla Actinobacteria, Proteobacteria, and Firmicutes which represented
40, 35, and 24% of the bacterial community, respectively. In the HMA piglet fecal
samples, however, the most abundant phylum was Firmicutes (61%) followed by
Proteobacteria (37%). The authors also noted that >99% of genus level OTUs were
shared between the HMA piglets and the original donor samples. Based on these results,
the authors concluded that by day 7 post-inoculation the HMA piglets harbored a stable
microbiota which was representative of the infant donor microbiota. Interestingly, in both
the protein-sufficient and protein-deficient groups, the HMA piglets had less severe
diarrhea with a shorter duration compared to the GF piglets. The authors also observed
that the systemic tissues of HRV challenged HMA piglets had a higher microbial
diversity compared to non-HRV challenged HMA piglets irrespective of diet. It was also
observed that the HMA piglets on the protein-deficient diet had the highest diversity in
their systemic tissues. These observations suggested that HRV infection decreased gut
barrier function and that this was exacerbated under conditions of malnutrition. Since the
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HMA piglets had less severe disease symptoms compared to the GF piglets, the authors
also suggested that the presence of a microbiota alone may have a moderating effect
against HRV infection [70].
In addition to the above-mentioned studies which have used the HMA piglet
model to study HRV infections in humans, the HMA pig model has also been used in
other contexts. Shen and colleagues [75] used an HMA piglet model to study the effects
of short-chain fructo-oligosaccharides (scFOS) on gut bacterial populations. Germ-free
piglets delivered through cesarean section were inoculated with fecal suspensions from a
healthy 27-year-old male subject. The piglets were initially orally-gavaged 12h after birth
and subsequently inoculated with 1mL of inoculum/piglet/day on days 1-3 followed by 1
mL inoculations/pig every other day until day 10 after birth. The study involved 10
piglets which were divided into a control group and a treatment group, with 5
piglets/group. The control group received a basal diet (a mixture of milk and commercial
infant cereal) while the treatment group received a basal diet supplemented with scFOS at
a dose of 0.5g/kg of body weight throughout the 37-day trial. Changes in microbiota
composition was monitored in HMA piglets using fecal samples collected on day 12 (preweaning), day 17 (during weaning), and days 25 and 37 (post-weaning). Denaturing
gradient gel electrophoresis (DGGE) targeting the V3 hypervariable region was used to
determine fecal microbiota composition. In addition, group-specific primers targeting the
16S rRNA gene were used to determine the compositions of the genera Bacteroides and
Bifidobacterium, as well as members belonging to the Clostridium leptum subgroup. The
beta diversity and alpha diversity results did not indicate any significant global
community-level changes between the treatment and control groups of piglets. However,
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differences were observed between the two groups of piglets when specific bacterial
groups were considered. Members of the genus Bifidobacterium increased in the scFOSfed piglets compared to the control piglets at both the formula-fed and post-weaning
stages; at weaning, no significant differences were observed. Bacteroides spp. were
significantly lower in scFOS-fed piglets compared to the controls at day 37, which the
authors suspected was due to the lower pH and/or bacteriocins produced by bifidobacteria
as a result of scFOS fermentation. The C. leptum subgroup showed variation in
abundance depending on time point. At 12 days after birth, C. leptum were decreased in
the scFOS-fed piglets compared to the controls while C. leptum levels were elevated in
the scFOS-fed piglets relative to the controls at day 25. In conclusion, the authors noted
the consistent bifidogenic effect of scFOS feeding (except during weaning) in the HMA
piglet model as well as the variability of the effect of scFOS on selected nonbifidobacterial components of the microbiota depending on the developmental stage of
the animals [75]. Similar to some of the other studies noted previously, no attempt
appears to have been made to evaluate how successfully the human donor microbiota had
engrafted in the HMA piglets.
Che et al. (2009) used the HMA pig model with the objective of evaluating the
impact of human microbiota on intestinal health and development in ex-GF piglets, with
a special emphasis on mucosal immune development [76]. This was done by comparing
HMA piglets to piglets inoculated with a porcine microbiota (PMA). The HMA piglets
were inoculated with fecal matter from a 28-year-old male subject whereas the PMA
piglets were inoculated with a fecal sample from a 4 month-old-pig. A total of 14 piglets
were involved in the study: 7 in the HMA group and 7 in the PMA group. The piglets
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were initially provided with a sterile artificial milk formula tailored for neonatal piglets
before weaning at 4 weeks of age, after which they were provided with a commercial
infant cereal for the remainder of the study. The study was terminated when the piglets
were 6 weeks of age, at which point they were humanely euthanized. Tissue samples
were collected from the duodenum, jejunum, ileum, and colon of each pig at
euthanization. Histochemical analyses were performed to examine changes in
intraepithelial lymphocytes (IEL), goblet cells (GC), and mast cells (MC) in the two
groups of piglets. Immunohistochemical analyses were also performed to determine
levels of IgA- and IgG-producing cells as well as CD4+ T lymphocytes and MHC class II
expressing cells. In addition, real-time PCR was performed using specific primers to
determine the fecal levels of lactic acid bacteria (LAB), Bifidobacterium members,
Clostridium leptum subgroup and members of the genus Bacteroides in the two groups of
piglets. The authors reported that the jejunal villus height and crypt depth were
significantly higher in the HMA piglets compared to the PMA piglets. Similarly, the
number of goblet cells with neutral mucins was significantly increased in the HMA pigs
whereas the number of intraepithelial lymphocytes in jejunum was lower in these animals
compared to the PMA piglets. The HMA piglets also had significantly higher areas of
IgA- and IgG-producing cells in the duodenum and jejunum compared to the PMA pigs,
while there were no significant differences in the areas of these cells between the two
groups in the colon. Similarly, no significant difference in mast cell numbers was
detected. The duodenum, ileum, and colon had similar areas of CD4+ T cells between the
two groups, while they were higher in the jejunum of HMA piglets compared to the PMA
piglets. Areas of MHC class II-producing cells in the duodenum and colon were also
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significantly higher in the HMA piglets compared to the PMA piglets. Bifidobacterium
was the only bacterial group that differed significantly among the two groups, and was
detected at higher levels in the HMA piglets. The authors concluded that the microbiota
composition differentially affected host intestinal development and mucosal immunity in
the piglet model [76].
Dhakal et al. [77] performed a study which compared the microbiological and
mucosal immune maturation characteristics of HMA piglets transplanted with the fecal
microbiotas of either Amish (rural) or non-Amish (urban) infants. Fecal samples from
five Amish and five non-Amish infants were used for this study. For inoculating the GF
piglets, two inocula were prepared – one contained a mixture of the fecal samples from
the Amish infants, while the other contained a mixture of the non-Amish infant fecal
samples. Piglets were randomly grouped into two groups (male/female balanced, n=4 per
group) and one group was inoculated with the inocula from the Amish infants while the
other group was inoculated with inocula from the non-Amish infants. The authors
reported marked differences in between the microbiotas of the Amish infants and the
non-Amish infants, with Actinobacteria and Bacteroidetes predominating the non-Amish
infant microbiota and Firmicutes dominating that of the Amish infants. Comparison of
the transplanted microbiotas in the piglets with that of the infant donors revealed that,
while the human infants and the HMA piglets harbored similar bacteria at the phylum
level, they differed at the genus level with Proteobacteria becoming enriched in the HMA
piglets. Some of the transplanted bacterial genera were also correlated with the frequency
of important lymphoid and myeloid immune cells in the ileal submucosa and mesenteric

30
lymph nodes, which led the authors to propose the utility of the HMA piglet model in
studying the impact of the infant microbiota on mucosal immune development [77].
An important consideration in studies involving HMA pigs appears to be the
microbiological safety of the human fecal inoculum used to inoculate the GF piglets. Wei
et al. (2008) reported of a scenario where 17 out of 24 GF piglets died following oral
inoculation with the fecal content of an apparently healthy human donor [78]. At two
weeks following oral inoculation, the HMA piglets had begun to show signs of infection.
All the infected animals showed signs typical of the onset of septicemia. Eventually, all
the infected piglets succumbed and 4 of these were randomly selected for necropsy and
bacterial isolation. Hemorrhaging was observed on the surface of the liver, lung, and
kidney along with mildly enlarged mesenteric lymph nodes in the dissected piglets.
Bacteriological examinations resulted in the isolation of large mucoidal non-hemolytic
colonies which further tests identified as belonging to Klebsiella pneumoniae.
Sequencing of the 16S rRNA gene of these isolates was performed to further confirm
their identity. Molecular analysis using amplified ribosomal DNA restriction analysis
(ARDRA) and ERIC-PCR revealed that all the strains isolated most likely had the same
clonal origin. Subsequently, the researchers were able to isolate K. pneumoniae with the
same ARDRA and ERIC-PCR profiles from the fecal matter of the human donor,
suggesting that the source of these opportunistic pathogens was the human donor feces.
This was further confirmed by infecting 5 naturally-born piglets with K. pneumoniae
isolated from the donor feces which resulted in the piglets developing continued serious
diarrhea and the death of two out of the five piglets. It is likely that the immune naivety
of cesarean section-derived GF piglets as a consequence of the epitheliochorial placenta
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(which prevents the transfer of maternal immunoglobulins to the fetus) and the lack of
exposure to colostrum, plays a role in the increased risk of these animals to opportunistic
infections. In conclusion, the authors recommended screening of human donor feces for
potential pathogens as well as testing donor inocula on conventional neonatal piglets for
signs of infection prior to their use in inoculating GF piglets [78].
The summary of the studies conducted using HMA piglets presented above
demonstrate the utility of this animal model in gut microbiota studies. However, as has
been noted in a review by Wang and Donovan [12], studies have not yet exploited the
capacity of HMA piglet models to study the causality of microbiotas associated with
specific diseases in contributing to particular disease outcomes, as has been done using
HMA rodent models [79]. Furthermore, many of these studies have focused on HMA
piglets as a model for human infants and there is a lack of information as to the
usefulness of this animal model to study the more complex gut microbiota of mature
human subjects. Advantages of using HMA pigs in this context may be the relatively
well-developed nature of the HMA piglet immune system [12, 76] as well as the ability
of pigs to recapitulate the physiology and symptoms of human diseases, the inability of
which is a major limitation in rodent models [80, 81].
As alluded to above, several knowledge gaps exist in the current literature relating
to the use of HMA pigs in gut microbiome research. Prominent among these is the lack of
information regarding the transplantation efficacy of human donor fecal bacterial
communities in GF piglets. Thus, future studies need to perform more in-depth analysis
of the efficacy of transplant of the human microbiota in HMA pigs, preferably at finer
taxonomic levels such as genus and species levels. Another area where more information
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is needed relates to the diversity of human donors used for transplanting GF piglets. As
was noted previously, many studies in the current literature have focused on colonizing
GF piglets with fecal microbiota from human infants and children. It would be interesting
to expand the donor ‘pool’ to include adult and elderly donors as well, since differences
in microbiota structure related to age/maturity might influence the colonization success of
human microbiotas in GF piglets. Another opportunity to further establish the utility of
HMA pigs as animal models is to compare them with other commonly used HMA animal
models such as HMA mice. While it has been speculated that HMA piglets may have
advantages over HMA rodents [82, 83], no study in the current literature appears to have
directly compared the two animal models in this regard. There is also a lack of studies in
the current literature which have investigated the possibility of transferring human donor
phenotypes (such as obesity) to HMA pigs using fecal microbiota transplants.
The research presented in this dissertation aims to address some of the knowledge
gaps mentioned above. The first study compares HMA piglets and HMA mice in terms of
the success with which fecal bacterial communities from human donors from different
age groups can colonize these two animal models. The second study evaluates the HMA
piglet as a model for human infants at both the taxonomic (16S rRNA gene-based
analysis) and functional level (metagenomics) of the transplanted bacterial communities.
The final study investigates the possibility of studying host-microbiome interactions
related to obesity, using both bacterial community analysis and RNA-seq data, utilizing
HMA piglets transplanted with fecal microbiota from obese or normal weight donors.
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CHAPTER 2

DIFFERENTIAL LONGITUDINAL ESTABLISHMENT OF HUMAN
FECAL BACTERIAL COMMUNITIES IN GERM-FREE PORCINE
AND MURINE MODELS

This chapter is published: Aluthge ND, Tom WA, Bartenslager AC, Burkey TE, Miller PS,
Heath KD, Kreikemeier-Bower C, Kittana H, Schmaltz RJ, Ramer-Tait AE,
Fernando SC (2020). Differential longitudinal establishment of human fecal
bacterial communities in germ-free porcine and murine models. Communications
Biology 3, 760. Modifications have been made to the original work.

Abstract
The majority of microbiome studies focused on understanding mechanistic
relationships between the host and the microbiota have used mice and other rodents as the
model of choice. However, the domestic pig is a relevant model that is currently
underutilized for human microbiome investigations. In this study, we performed a direct
comparison of the engraftment of fecal bacterial communities from human donors
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between human microbiota-associated (HMA) piglet and mouse models under identical
dietary and similar environmental conditions.
Analysis of 16S rRNA genes using amplicon sequence variants (ASVs) revealed
that with the exception of early microbiota from infants, the more mature microbiotas
tested established better in the HMA piglets compared to HMA mice. Of interest was the
greater transplantation success of members belonging to phylum Firmicutes in the HMA
piglets compared to the HMA mice.
Together, these results provide evidence for the HMA piglet model potentially
being more broadly applicable for donors with more mature microbiotas while the HMA
mouse model might be more relevant for developing microbiotas such as those of infants.
This study also emphasizes the necessity to exercise caution in extrapolating findings
from HMA animals to humans, since up to 28% of taxa from some donors failed to
colonize either animal model.

Key Words: Human microbiota-associated, piglets, mice, microbiota, animal models

Introduction
The human gut microbiota has been intensively studied during the past couple of
decades, and much light has been shed on the importance of this microbial community in
influencing the health and well-being of humans and animals [1]. A broad range of
human disease conditions ranging from immune and metabolic pathologies to behavioral
and psychological conditions [2, 3, 4] have been linked to aberrations in gut microbiota
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composition. However, most of the apparent links made so far between the gut
microbiota and human health conditions have been limited to correlations. Consequently,
the role of the microbiota as a driver of pathologies has been difficult to establish[5].
To move beyond correlations and identify the causality and mechanistic role of
the microbiota in influencing human health, researchers have turned to human
microbiota-associated (HMA) animal models as surrogates for human subjects. To date,
rodents are the most widely-used HMA animal model, but HMA pigs (Sus scrofa
domesticus) also represent a highly-relevant model system for studying host-microbiota
interactions [6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16]. The ‘humanization’ process involves
the inoculation of germ-free (GF) animals with human fecal matter to establish human
gut microbial communities in these animal models while controlling for many
confounding factors such as environment, diet, and host genetics. A number of human-toanimal fecal transplantation studies using recipient GF mice appear to have been
successful in recapitulating human donor phenotypes such as development of obesity
[17], amelioration of asthma symptoms [18], and manifestation of autistic behaviors [19],
although a recent systematic review questioned the ability to transfer human pathologies
to HMA rodent models [20]. However, interspecies gut microbiota transplantations are
known to cause shifts in the original donor microbiota composition as it establishes and
adapts to the new gut environment of the recipient species [21]. Unfortunately, the extent
to which the composition of a human microbiota represents that of the donor following
transplant into a recipient animal is not always assessed in studies using HMA animal
models [22, 23]. If microbial establishment is evaluated in the recipient mouse or pig,
then such comparisons are often limited to only describing higher taxonomic levels such
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as phylum, class, or genus [8, 24] or measures of global microbiota structure such as
alpha and beta diversity [22]. Additionally, many reports using HMA animals do not
evaluate whether the transplanted microbiota is stably maintained over time within the
new host [22]. This lack of reporting on the fine-scale differences of microbiotas before
and after transplant highlights an important caveat of working with HMA animal models
- the ability of animal models to establish and maintain a human gut microbiota that
closely resembles the donor over time is currently not well-characterized.
The objective of this study was to evaluate the establishment of human fecal
bacterial communities derived from multiple human donors with varying levels of
microbiota diversity in porcine and murine models. By transplanting fecal microbiotas
from the same human donors into GF piglets and mice and maintaining both species
under identical dietary and similar environmental conditions, we were also able to
directly compare the ability of HMA porcine and murine models to harbor and maintain
‘human-like’ gut bacterial communities over time. The results from the current study
suggest that human fecal bacterial communities from donors with more mature
microbiotas establish more successfully in the HMA porcine model while the simpler
infant microbial communities favor the HMA murine model. Specifically, members of
the phylum Firmicutes had greater success in colonizing the HMA piglets compared to
the HMA mice. These findings point to the usefulness of both of these animal models for
human microbiome studies with the HMA porcine model potentially having a broader
scope.

Results
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Identifying core microbiotas in the human donors
To compare the establishment of human fecal bacterial communities in HMA
mice and piglets, we inoculated GF mice and piglets maintained in gnotobiotic isolators
with fecal matter from four separate human donors. The donors selected had diverse
microbial communities (Fig. 1) and represented different stages of human development
(see ‘Methods’ for donor information). All animals in a given isolator (for both mice and
piglets) were inoculated with the inocula obtained from a single donor. Both recipient
species of animals were inoculated twice during the study – the initial round of
inoculations were performed after weaning and the second round of inoculations occurred
two weeks after the first round of inoculations. All inocula were prepared at the same
time under the same conditions and both mice and piglets were fed the exact same sterile
solid diet.
To compare the engraftment of donor microbiota in the two HMA animal models,
the establishment of amplicon sequence variants (ASVs) identified in the donor inocula
was evaluated. To reduce variation in composition due to sequencing depth, a ‘core’
bacterial community was defined for each donor by identifying ASVs that were found in
all aliquots of the pooled donor inoculum used to inoculate the corresponding HMA
animals (see ‘Methods’ for details on donor inoculum preparation). There was a total of 4
inoculum aliquots per donor – two used for inoculating the GF mice and two used for
inoculating the GF piglets. All 4 inoculum aliquots were sequenced separately. For
Donor_1, one of the inoculum aliquots used to inoculate the corresponding GF piglets did
not have sufficient material for DNA extraction, which resulted in only three inoculum
aliquots from this donor for subsequent analysis. Twenty-six, 76, 140 and 134 core ASVs
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that fit the above criteria were identified from Donor_1, Donor_2, Donor_3, and Donor_4
respectively. As a percentage of the total number of reads, the core ASVs identified
accounted for 99%, 96%, 98%, and 96% of the total reads in the 4 donor inocula used in
the study. The taxonomy and relative abundance information of the core ASVs identified
for each donor across the animal models is provided in Supplementary Data 1. Since core
ASVs identified are found in all inoculum aliquots of a given donor and represent the
major portion of the reads generated (96% - 99%), we reasoned that these taxa can be
considered as the major taxa within the human donors having the highest probability of
colonizing each animal model. With the exception of alpha diversity analysis, the
remainder of the results presented are focused on the core ASVs identified.

Global diversity patterns in the HMA animal models
To evaluate global bacterial community differences, we compared the
establishment of the core microbiotas of the corresponding human donors in the two
HMA animal models using Principal coordinate analysis (PCoA) plots based on
unweighted UniFrac and Bray-Curtis distances (Fig. 2). For Donor_1, the Bray-Curtis
distance-based analysis revealed the donor inoculum aliquots to cluster more closely to
the HMA mouse fecal samples than the HMA piglet fecal samples (Fig. 2a). However,
for Donor_2, Donor_3, and Donor_4, the donor inoculum aliquots were more similar to
the HMA piglet fecal samples than the HMA mouse fecal samples (Fig. 2b-d). As
previously reported [25], we also compared microbial community engraftment using
UniFrac distances and Bray-Curtis distances (Fig. 3), which further corroborated the
results from the beta diversity analysis.
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To evaluate the weekly variation in alpha diversity of recipient microbiotas, we
compared the alpha diversity of the HMA animals with that of their respective human
donors at each time point (Fig. 4). Since alpha diversity analyses are sensitive to the
presence/absence of low prevalence taxa, we considered all ASVs (not only core ASVs)
of a given donor for this analysis. Donor_1-HMA mice maintained a stable alpha
diversity over time, with only the fecal samples from week 4 showing a Shannon index
significantly different (p = 0.018) from that of Donor_1 which represents an infant
microbiota. However, greater variation in alpha diversity was observed in Donor_1-HMA
piglet fecal samples with days 2, 7, 14, 21, and 40 post-inoculation yielding significantly
different Shannon indexes compared to the Donor_1 inoculum aliquots (Fig. 4a).
Diversity estimates for Donor_2- and Donor_3-HMA piglet fecal samples were
maintained similar to that of the estimates for the human donors throughout the study
(Fig. 4b and 4c). However, significantly lower Shannon index values for Donor_2- and
Donor_3-HMA mouse fecal samples were observed compared to the donor inoculum
aliquots. Donor_4-HMA piglet fecal microbiota displayed notable variations in alpha
diversity throughout the study period (Fig. 4d). The Donor_4-HMA mouse fecal samples
did not show much variation in alpha diversity between sampling time points although
the Shannon indexes were significantly lower relative to the donor inoculum aliquots.

Establishment of core donor ASVs in the two HMA animal models
Heatmaps (Supplementary Figs. 1 - 4) and chord diagrams (Fig. 5) were generated
to visualize the establishment of the core donor ASVs in HMA mice and piglets, which
revealed notable differences in their success of engraftment in the two species. Notably,
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certain ASVs only established in one of the two animal models, while some others did
not establish in either. With the exception of Donor_1, more core ASVs found in the
human donors were identified in the HMA piglets compared to the HMA mice.
To determine how successfully the core ASVs found in human donors established
and persisted in the corresponding HMA animal models, we defined ‘colonization
criteria’, which were established based on the number of animals and sampling time
points in which a donor ASV was detected. If a core donor ASV was detected in at least
one fecal sample of a given HMA animal model, then this ASV was considered as a
‘colonizer.’ However, if a donor ASV was detected in the fecal samples of >50% of the
animals in a given time point, and found in at least 4 of the 7 sampling time points, then
this ASV was considered as a ‘persistent colonizer’ for that animal model (Table 2.1 and
Supplementary Data 2). Relative abundance and taxonomic information related to
persistent colonizers identified following these criteria for each donor group and animal
model are provided in Supplementary Data 3.
For Donor_1, a single ASV out of the five core ASVs that were not detected in
the HMA mice was detected in the HMA piglets. Similarly, 2 ASVs of the 6 core
Donor_1 ASVs that were not detected in the HMA-piglets were detected in the HMA
mice. Four ASVs (15%) failed to colonize either animal model.
For Donor_2 and Donor_3, a higher proportion of core donor ASVs established in
the piglets compared to the mice (Table 2.1). Twenty-eight of the 39 Donor_2 core ASVs
that failed to colonize the mice colonized the piglets. The 11 ASVs that were not detected
in the piglets were also absent in the mice. Only 3 out of the 34 Donor_3 core ASVs that
failed to colonize the HMA piglets colonized the HMA mice. However, 43 out of the 74
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core donor ASVs that failed to colonize the HMA mice colonized the HMA piglets.
Eleven (14%) and 31 (22%) core ASVs failed to colonize either animal model for
Donor_2 and Donor_3, respectively.
For Donor_4, Forty-one out of the 79 core ASVs that did not colonize the HMA
mice colonized the HMA piglets. Only 4 out of the 42 ASVs that failed to colonize the
HMA piglets colonized the HMA mice. Thirty-eight (28%) core Donor_4 ASVs failed to
establish in either animal model. The taxonomic classifications of the core ASVs in each
donor that failed to colonize both HMA animal models are provided in Supplementary
Data 4.

Establishment of common ASVs found among donors in the two HMA animal
models
With the assumption that ASVs common to all donors may represent part of the
autochthonous microbes in the human gut, we evaluated the establishment of such ASVs
in the two HMA models. However, Donor_1 was not considered for this analysis as the
Donor_1 microbiome is from an infant, and infants are known to have unstable and
highly dynamic gut microbiota compositions[26, 27, 28]. We identified 27 core donor
ASVs (Supplementary Data 5) that were shared by all 12 inoculum aliquots originating
from Donor_2, Donor_3, and Donor_4 (4 aliquots for each donor). Twenty-four of these
shared ASVs were classified as members of the phylum Firmicutes and 2 were classified
as members of phylum Bacteroidetes. The remaining ASV belonged to the phylum
Desulfobacterota (Supplementary Data 5). The 27 common ASVs identified were
compared between the two HMA models in terms of how many ‘colonizers’ and

48
‘persistent colonizers’ were present. The results of this analysis (Supplementary Data 6)
revealed that, for all three donors, the 27 shared core ASVs established more efficiently
in the HMA piglets compared to the HMA mice. Specifically, 24 of these 27 ASVs
(89%) had established in the Donor_2-HMA piglets, while 25 (93%) and 19 (70%) had
colonized the HMA piglets inoculated with Donor_3 and Donor_4, respectively. In
contrast, only 9 (33%), 15 (55%), and 10 (37%) of these ASVs had colonized the HMA
mice for Donor_2, Donor_3, and Donor_4, respectively. In terms of persistent colonizers,
16 (59%), 20 (74%), and 6 (22%) of the 27 common ASVs were identified as persistent
colonizers of the piglets inoculated with Donor_2, Donor_3, and Donor_4, respectively.
For the same donors, 5 (18%), 6 (22%) and 5 (18%) ASVs were persistent colonizers of
the mice (Supplementary Data 6).

Members of the phylum Firmicutes establish in the HMA piglets with greater
success compared to the HMA mice while Bacteroidetes successfully colonize both
animal models
We compared core donor taxa establishment at phylum, family, and genus levels
between the two HMA animal models for each donor (Supplementary Data 7). At the
phylum level, the most notable differences between the two animal models were
observed for the phylum Firmicutes. Donor_2 had 58 core ASVs belonging to Firmicutes,
and only 21 (36%) of these ASVs established in the HMA mice; however, 48 (83%)
colonized the HMA piglets. Out of the 48 core Firmicutes ASVs that established in the
HMA piglets, 31 (65%) were persistent colonizers, while 10 of the 21 (48%) Firmicutes
ASVs persistently colonized the HMA mice (Supplementary Data 2). The Donor_3
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inocula contained 97 core Firmicutes ASVs, 71 (73%) of which established in HMA
piglets and 31 (32%) established in the HMA mice. Only 6 out of the 31 (19%) core
Firmicutes ASVs colonizing the HMA mice were persistent colonizers, whereas 44 of the
71 (62%) Firmicutes ASVs persistently colonized the HMA piglets. Similarly, out of the
95 core Firmicutes ASVs found in the Donor_4 inocula, 21 (22%) colonized the HMA
mice and 57 (60%) colonized the HMA piglets. Eight of the 21 (38%) Firmicutes core
ASVs that established in the HMA mice were persistent colonizers, while 15 of the 57
(26%) Firmicutes ASVs persistently colonized the HMA piglets. Phylum Firmicutes was
represented in 18 ASVs and was the predominant phylum in the Donor_1 core with a
mean abundance of 62.77% (SD = 5.18%). Fourteen and thirteen of these Firmicutes
ASVs colonized the HMA mice and HMA piglets, respectively, with mean relative
abundances of 40.5% (SD = 11.15%) and 10.72% (SD = 7.6%), respectively
(Supplementary Data 7).
The differential establishment of Firmicutes in the two HMA animal models was
observed at the family level by members of Lachnospiraceae and Ruminococcaceae
(Supplementary Data 7). Of the 34 Donor_2 core Lachnospiraceae ASVs, only 11 (32%)
were detected in the HMA mice while 28 (82%) were detected in the HMA piglets.
Sixteen of the 28 (57%) Lachnospiraceae ASVs detected in the piglets were persistent
colonizers, while 6 of the 11 (54%) Lachnospiraceae ASVs that established in the mice
were persistent colonizers (Supplementary Data 2). Similarly, the Donor_3 core consisted
of 40 Lachnospiraceae ASVs, 15 (37%) of which colonized the HMA mice and 31 (77%)
which colonized the HMA piglets. Only 3 out of the 15 (20%) Lachnospiraceae ASVs
colonizing the HMA mice were persistent colonizers. In contrast, 20 out of the 31

50
Lachnospiraceae ASVs (64%) were persistent colonizers in HMA piglets. The Donor_4
core contained 40 Lachnospiraceae ASVs; only 7 of these ASVs (17%) established in the
HMA mice, whereas 22 (55%) established in the HMA piglets. Two core
Lachnospiraceae ASVs (29%) persistently colonized the HMA mice, while 4 out of the
22 (18%) core Lachnospiraceae ASVs colonizing the HMA piglets were persistent
colonizers (Supplementary Data 2). Similar to Lachnospiraceae, core donor ASVs
belonging to the family Ruminococcaceae were poorly established in the HMA mice
relative to the HMA piglets (Supplementary Data 7). Donor_2 contained 6 core ASVs
belonging to Ruminococcaceae. All 6 of these ASVs (100%) successfully colonized the
HMA piglets, while only 1 (17%) colonized the HMA mice. Four of the 6 (67%) core
Ruminococcaceae ASVs that successfully colonized the HMA piglets were identified as
persistent colonizers (Supplementary Data 2). Out of the 17 core ASVs belonging to
Ruminococcaceae found in Donor_3, 12 (71%) colonized the HMA piglets, while only 6
(35%) colonized the HMA mice. One of these 6 core Ruminococcaceae ASVs (17%)
persistently colonized the mice. However, 9 out of the 12 (75%) Donor_3 core
Ruminococcaceae ASVs that established in the piglets were persistent colonizers.
Donor_4 consisted of 14 core Ruminococcaceae ASVs but only 4 (29%) colonized the
HMA mice. In contrast, 12 (86%) core Ruminococcaceae ASVs colonized the piglets.
Three of the 4 (75%) core Ruminococcaceae ASVs persistently colonized the mice,
whereas 5 out of the 12 (42%) core Ruminococcaceae ASVs persistently colonized the
piglets (Supplementary Data 2).
The Firmicutes family Christensenellaceae, which has recently been identified as
the most heritable bacterial family in the human microbiota and also related to health
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benefits[29, 30], successfully colonized the HMA piglets but was not detected in the
HMA mice (Supplementary Data 7). Specifically, Christensenellaceae ASVs were
identified as core members only in Donor_3 and Donor_4 inocula, with 6 core ASVs in
Donor_3 and 7 core ASVs in Donor_4. Out of the 6 core Christensenellaceae ASVs in
Donor_3, 4 established in the HMA piglets – 3 of these were persistent colonizers.
Additionally, 4 out of the 7 core Christensenellaceae ASVs in Donor_4 established in the
HMA piglets. A single core Christensenellaceae ASV persisted in these HMA piglets
(Supplementary Data 2).
In contrast to the notable differences in colonization efficiency of members of the
phylum Firmicutes between the HMA mice and the piglets, ASVs belonging to
Bacteroidetes successfully colonized both animal models (Supplementary Data 7). All 3
of the core Bacteroidetes ASVs identified in Donor_1 persistently colonized both animal
models (Supplementary Data 2), although their abundances were much higher in the
HMA mice (mean = 35.56%, SD = 14.42%) compared to the HMA piglets (mean =
9.74%, SD = 6.98%). Similarly, all 8 core Bacteroidetes ASVs of Donor_2 persistently
colonized both HMA animals (Supplementary Data 2) and at higher relative abundances
compared to the donor (Supplementary Data 7). Twenty-one of the 25 core Bacteroidetes
ASVs of Donor_3 established in both animal models, with 18 (85.7%) and 16 (76.2%) of
these ASVs persistently colonizing the HMA mice and HMA piglets, respectively.
Higher relative abundances for these Bacteroidetes ASVs were observed in the HMA
mice compared to both the donor and the HMA piglets (Supplementary Data 7). Finally,
of the 25 core Bacteroidetes ASVs detected in Donor_4, 21 (84%) and 23 (92%)
colonized the HMA mice and piglets, respectively, although their relative abundances
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were much lower compared to the donor (Supplementary Data 7). Fourteen of the 21
(67%) Bacteroidetes ASVs colonizing the mice were persistent colonizers, while 13 of
the 23 (56%) Bacteroidetes ASVs persistently colonized the piglets (Supplementary Data
2).
Together, our results demonstrate that a greater number of ASVs belonging to the
phylum Firmicutes (especially those of the families Lachnospiraceae, Ruminococcaceae,
and Christensenellaceae) from the human donors established and persisted in the HMA
piglets compared to the HMA mice. Our results also indicate that members of the phylum
Bacteroidetes successfully colonized both animal models, although their relative
abundances were higher in the HMA mice compared to the HMA piglets.

Bacteroides and Bifidobacterium members successfully colonize both animal models
The genera Bacteroides and Bifidobacterium are key members of the human gut
microbiota and were identified as part of the core microbiotas of all four donors in this
study (Supplementary Data 1). The Donor_1 core included a single Bifidobacterium ASV
classified as Bifidobacterium bifidum (mean abundance = 4.5%, SD = 3.47%), which
colonized both animal models at much lower relative abundances compared to the donor
with means of 0.81% (SD = 0.71%) and 0.84% (SD = 1.17%) for the HMA mice and
HMA piglets, respectively. This Bifidobacterium bifidum ASV also persistently
colonized both HMA animal models (Supplementary Data 3). The Donor_2 core
contained 3 Bifidobacterium ASVs, with all 3 ASVs colonizing the HMA piglets and 2
out of the 3 ASVs colonizing the HMA mice. The Donor_3 and Donor_4 cores contained
1 and 3 Bifidobacterium ASVs, respectively, all of which established in both HMA
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animal models. The single core Bifidobacterium ASV identified for Donor_3 did not
persist in either animal model. Only 1 of the 3 core Bifidobacterium ASVs of Donor_4
persistently colonized the mice while all 3 ASVs persistently colonized the piglets
(Supplementary Data 2).
All core Bacteroides ASVs found in the donors successfully colonized both
animal models (Supplementary Data 3). Donor_1 core contained 3 Bacteroides ASVs at a
mean abundance of 18.05% (SD = 0.34%). Two of these Bacteroides ASVs were
assigned to the species B. vulgatus while the remaining ASV was classified as B.
uniformis (Supplementary Data 1). These Bacteroides ASVs bloomed in the HMA mice
with a mean abundance of 35.56% (SD = 14.42%). In contrast, these same ASVs reached
a mean relative abundance of only 9.74% (SD = 6.98%) in the HMA piglets. All 3 of
these Bacteroides ASVs persistently colonized both animal models (Supplementary Data
2). Donor_2 contained 6 core Bacteroides ASVs (mean abundance = 11.37%, SD =
1.42%), which established at higher abundances in both HMA animal models - 26.86%
(SD = 7.23%) and 22.80% (SD = 6.09%) for the HMA mice and piglets, respectively
(Supplementary Data 7). In addition, all 6 of these ASVs persisted in both groups of
animals (Supplementary Data 2). The 7 core Bacteroides ASVs in Donor_3 (mean
abundance = 6.51%, SD = 0.67%) established in the HMA piglets at similar levels but
with greater variation (mean abundance = 7.01%, SD = 8.67%). However, in the HMA
mice, the abundances were much greater (mean abundance= 18.9%, SD = 6.34%)
compared to both the donor and the HMA piglets. All 7 ASVs persistently colonized the
HMA mice, while 6 out of the 7 persisted in the HMA piglets. The Donor_4 core
contained 7 Bacteroides ASVs (mean abundance = 7.13%, SD = 0.62%) and these ASVs
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colonized the HMA mice at comparable relative abundances (mean = 9.52%, SD =
4.53%). The relative abundances for the same Bacteroides ASVs were much lower in the
HMA piglets (mean = 3.01%, SD = 4.16%). Six and 4 of these 7 core Bacteroides ASVs
persistently colonized the HMA mice and piglets, respectively (Supplementary Data 2).

Establishment of ASVs classified as Faecalibacterium prausnitzii, Roseburia and
Ruminococcus bromii in the HMA animal models
Previous studies have demonstrated Faecalibacterium prausnitzii and Roseburia
species to be functionally important members of the human gut microbiota and potential
biomarkers of gut health [31, 32]. We therefore evaluated the establishment and
persistence of these ASVs in the two HMA animal models. Donor_2, Donor_3 and
Donor_4 had core ASVs which were classified as Faecalibacterium prausnitzii
(Supplementary Data 1). The Faecalibacterium prausnitzii (ASV_3233) of the Donor_2
core was detected only in the HMA piglets but at a lower relative abundance. Two ASVs
classified as Faecalibacterium prausnitzii (ASV_3233 and ASV_3238) were part of the
Donor_3 core. While ASV_3238 had colonized both HMA animal models, ASV_3233
only colonized the HMA piglets (Supplementary Data 1). Donor_4 contained three ASVs
classified as Faecalibacterium prausnitzii (ASV_3233, ASV_3238, and ASV_3239). All
three ASVs were detected in the HMA piglets, while none were detected in the HMA
mice (Supplementary Data 1). Thus, all the core Faecalibacterium prausnitzii ASVs from
the different donors colonized the HMA piglets, albeit at lower relative abundances.
However, only ASV_3233 found in the Donor_3-HMA piglets was a persistent colonizer
(Supplementary Data 3).
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The butyrate-producing human gut commensal genus Roseburia was represented
among the core ASVs of Donor_2, Donor_3, and Donor_4 inocula (Supplementary Data
1). All core Roseburia ASVs found in each donor (2, 3, and 2 ASVs for Donor_2,
Donor_3, and Donor_4, respectively) colonized the corresponding HMA piglets. The
relative abundances of these ASVs were comparable or higher to that of the donor, with
the exception of ASV_6057 found in the Donor_2- and Donor_4-HMA piglets
(Supplementary Data 1). Furthermore, apart from the 2 core Roseburia ASVs of
Donor_4, the remaining core Roseburia ASVs that established in the HMA piglets were
persistent colonizers (Supplementary Data 2). In contrast, the only core Roseburia ASVs
that established in the HMA mice were 2 core Roseburia ASVs found in Donor_3. These
ASVs colonized at very low abundances (mean abundance = < 0.01%, SD = 0.01%) in
the HMA mice. Across donors, the main species of Roseburia identified in the core
microbiotas were R. inulinivorans and R. intestinalis (Supplementary Data 1).
The prominent resistant starch degrading gut symbiont Ruminococcus bromii has
also been proposed as a keystone species within the human gut microbiota[33]. R. bromii
(ASV_3350) was identified in the core microbiotas of Donor_2 and Donor_4
(Supplementary Data 1). R. bromii had only engrafted successfully in the corresponding
HMA piglets and at higher relative abundances than in the human donors (Supplementary
Data 1). Moreover, this ASV had persistently colonized both Donor_2- and Donor_4HMA piglets (Supplementary Data 3).

The ability of persistent colonizers to maintain donor-like abundances in the HMA
animal models over time
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To determine if the persistent colonizers identified in the HMA animals were
capable of maintaining abundances similar to the human donors over time, we compared
the relative abundances of the persistent colonizer ASVs established in the two HMA
animal models to their abundances in the respective human donors at each sampling time
point. For persistent colonizer ASVs colonizing each HMA animal model, we determined
the number of time points in which the relative abundance of each of the ASVs were
significantly different from the corresponding human donor inocula. We considered a
persistent colonizer ASV as having maintained a ‘donor-like’ relative abundance if that
ASV’s relative abundance in a given animal model was not significantly different from
the corresponding human donor in at least 4 out of the 7 sampling time points.
Supplementary Data 8 and 9 provide the relative abundance and taxonomic information
for all persistent colonizer ASVs with donor-like relative abundances with respect to each
HMA animal model.
Based on the above criterion, we observed 7 out of 16 (44%) and 8 out of 15
(53%) of the persistent colonizer ASVs to maintain donor-like relative abundances for
Donor_1 in the HMA mice and HMA piglets, respectively. Bifidobacterium bifidum
(ASV_3778) was able to maintain a donor-like relative abundance in the HMA mice but
not in the HMA piglets (Supplementary Data 9). For Donor_2, the HMA mice contained
only 2 out of the 21(9%) persistent colonizer ASVs with donor-like abundances. The
HMA piglets contained 15 out of 43 (35%) persistent colonizer ASVs with donor-like
relative abundances. For Donor_2, members of the genera Bacteroides, Blautia, and
Roseburia were among the ASVs with donor-like abundances in the HMA piglets
(Supplementary Data 9). For Donor_3, 40 out of the 69 (58%) persistent colonizers
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maintained donor-like abundances in the HMA piglets while only 6 out of 31 (19%)
persistent colonizer ASVs identified in the HMA mice were able to do so. Five out of the
6 persistent colonizers with donor-like abundances identified for Donor_3 in HMA mice
were Bacteroidetes members. Bacteroidetes and Firmicutes were widely represented
among the persistent colonizers with donor-like abundances for Donor_3 in HMA piglets
(Supplementary Data 9). For Donor_4, 7 out of 28 (25%) and 16 out of 38 (42%)
persistent colonizers were maintained at donor-like relative abundances in the HMA mice
and HMA piglets, respectively.
Altogether, these findings suggest that only a small proportion of persistent
colonizers are able to consistently maintain relative abundances similar to those of the
respective donors within the two HMA animal models. The HMA piglets, however, had
higher proportions of persistent colonizers with donor-like relative abundances compared
to the HMA mice.

Phylogenetic analysis of Firmicutes colonizing the two HMA animal models
As noted previously, ASVs of the phylum Firmicutes were the most conspicuous
in terms of their differential establishment between the two HMA animal models. To
further identify phylogenetic lineages that may affect colonization of core ASVs of the
phylum Firmicutes among the two animal models, we analyzed the phylogenetic
relationships among the core Firmicutes ASVs identified in the 4 donors (Fig. 6).
In total, we identified 178 core ASVs across the 4 donors which belonged to the
phylum Firmicutes. Out of these 178 ASVs, 131 (74%) were identified as colonizers of
the HMA piglets while only 69 (39%) colonized the HMA mice. Twenty-four of the 69
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(39%) Firmicutes ASVs colonizing the mice were persistent colonizers while 74 out of
the 131 (56%) were persistent colonizers of the piglets. As shown in Fig. 6, we identified
3 clades as preferentially colonizing the HMA pigs. This included a clade consisting of
members of the family Christensenellaceae and two other clades consisting of members
of the order Oscillospirales. We also observed five closely related Lachnospiraceae
ASVs which persistently colonized both animal models. Additionally, we identified a
clade consisting of Clostridia UCG-014 that failed to colonize either animal model, with
the exception of a single ASV which colonized the HMA piglets (Fig. 6).

Core microbiota establishment in HMA animals using a different set of donors
As described in Table 2.1, markedly low percentages of colonizers as well as
persistent colonizers were identified for HMA mice compared to HMA piglets for
Donor_2, Donor_3, and Donor_4. In order to further verify these observations and
investigate the potential donor-to-donor variation in colonization efficiency, we
performed a second study where we inoculated mice with fecal inocula from a different
set of donors (Donor_5, Donor_6, and Donor_7; see ‘Methods’ for donor information)
and provided the same solid diet. Core ASVs (i. e., present in all inoculum aliquots),
“colonizers” and “persistent colonizers” were identified using the same approach. These
donors were also selected to represent the variation in the human microbiome
(Supplementary Fig. 5) and belonged to similar age groups as our first set of donors. In
addition, since Donor_1, an infant donor, was the only donor from our first set of donors
which had a bacterial community that established more successfully in HMA mice
compared to HMA piglets, we investigated the repeatability of this observation by
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performing another inter-species transplantation experiment using fecal matter from a
different infant donor (Donor_8) to GF mice (C3H/HeN) and GF piglets (Sus scrofa
domesticus), similar to our first study.
The results of this subsequent study (Table 2.2) demonstrated that the Donor_7HMA mice had comparable percentages of colonizers and persistent colonizers relative to
Donor_4 HMA mice (Both Donor_4 and Donor_7 were seniors; see ‘Methods’ for
details). A similar comparison of core ASV establishment among the child donors
(Donor_2 and Donor_5) revealed that these two groups of mice had very similar levels of
persistent colonizers while Donor_5-HMA mice had a greater percentage of colonizers
(Table 2.1 and Table 2.2). Donor_6-HMA mice had notably higher percentages of
colonizers as well as persistent colonizers compared to the similarly-aged donor
(Donor_3) of the first study (Table 2.2). These results demonstrate the possibility of
having considerable donor-to-donor variation in colonization efficiency when
transplanting human fecal bacterial communities into GF mice. The taxonomic
distribution of the colonizing core ASVs in the HMA mice (Supplementary Data 10) was
consistent with our previous observations – Bacteroidetes members colonized with high
efficiency while Firmicutes ASVs established poorly (Supplementary Data 10). In
agreement with our previous results, ASVs belonging to the phyla Lachnospiraceae and
Ruminococcaceae showed low colonization success, with the exception of the mice
inoculated with Donor_6, which were efficiently colonized by Lachnospiraceae members
(Supplementary Data 10). Additionally, the mice inoculated with Donor_6 as well as the
mice inoculated with Donor_7 were poorly colonized by members of the family
Oscillospiraceae. In contrast to the observation with the previous set of donors, some
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Christensenellaceae ASVs from Donor_6 (1 out of 1) and Donor_7 (1 out of 6) colonized
the GF mice of this second study.
Similar to the results for our first infant donor (Donor_1), the core bacterial
community of the donor inocula of our second infant donor (Donor_8) was more similar
to the donor in the HMA mice than HMA piglets (Supplementary Fig. 6). Once again, the
major taxonomic groups were established at much lower relative abundances in the
Donor_8 HMA piglets compared to both the donor and the HMA mice (Supplementary
Data 10).

Comparison of predicted function between the human donors and the HMA animals
To determine the potential functional consequences of the differential
establishment of fecal bacterial communities between the two HMA animal models, we
used PICRUSt [34] to predict the functional capacity of the human donors and the
corresponding HMA animal models. Using the PICRUSt-predicted functional
annotations, we identified the KEGG Orthology (KO) features that were detected in all
the inoculum aliquots of a given donor and defined them as ‘core predicted KO features’
for each donor microbiome. Subsequently, this information was used to compare
potential functions of the microbiomes established in the HMA models against the
donors. The results, represented as PCoA plots (Supplementary Fig. 7), showed a similar
clustering pattern to what we observed with the core ASVs (Fig. 2) where the Donor_1
inocula clustered closer to the HMA mouse samples while for the remaining donors, the
donor inocula clustered closer to the HMA piglet samples. Thus, these results indicate
that the differences in establishment of human donor microbiotas between the two animal
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models also results in potential differences in their functional capacities. As such,
function may have favored the established taxa. Therefore, our belief is if similar taxa to
the donor are established, similar function would also be present in the corresponding
animal model.

Discussion
To the best of our knowledge, this is the first study that directly compares HMA
mice and HMA piglets to evaluate the establishment of fecal bacterial communities
originating from the same human donors under similar dietary and environmental
conditions. Using amplicon sequence variants, we compared the establishment of taxa
from a total of five separate human donors in GF mouse and piglet models and an
additional 3 donors in only the GF mouse model. We observed that the piglet model
established a microbiota more similar to that of the human donors, with the exception of
the two infant donors (i. e., Donor_1 and Donor_8), in which case the HMA mice
established a more donor-like microbiota than the HMA piglets (Fig.2 and
Supplementary Fig. 6). Compared to the HMA mice, not only did the HMA piglets
establish a considerably higher number of core donor ASVs but also harbored higher
percentages of ASVs identified as persistent colonizers (Table 2.1). Notably, ASVs
belonging to the phylum Firmicutes established more successfully in the HMA piglets
compared to the mice (Fig 6 and Supplementary Data 7). The phylogenetic analysis
demonstrated certain groups of related Firmicutes ASVs to preferentially colonize the pig
compared to the mouse. Additionally, certain ASVs present in the donor did not colonize
either model. Since the HMA mice were inoculated with smaller volumes of inocula
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compared to the inocula volumes used for the HMA piglets (see ‘Methods’ section) it
was possible that some of the lower abundance taxa in the donor inocula may not have
transferred to the mice during gavaging. If this was indeed the case, then one would
expect a pattern where the ASVs which did not colonize the mice would be low
abundance members in the donor inocula, while the ASVs which were successful in
colonizing the mice would be highly abundant members. However, the data in
Supplementary Data 1 show no evidence of such a pattern (i. e., there were both high
abundance and low abundance core ASVs in the donor inocula which did not colonize the
mice) indicating that the lower inoculum volumes used to inoculate the mice could not
have accounted for the low colonization numbers observed in these animals. Therefore,
the differential colonization patterns observed for the two animal models may be a result
of host adapted features present within these microbes and it would be of interest to
identify what factors help colonization. Future studies utilizing genome centric
approaches focused on colonized and non-colonized isolates may shed light into features
that help colonization. Such information would be critical to develop successful
probiotics for microbiome manipulation aimed at improving human health. An analysis
based on predicted metabolic functions also revealed a similar trend where the predicted
functional capacity of the HMA piglets was more similar to that of the human donors
with the exception of the infant donor, where HMA mice were functionally more similar
to the human donor (Supplementary Fig. 7). Out of all the donors, the two infant donors
had the lowest alpha-diversity (Fig. 1 and Supplementary Fig. 5). Thus, it is tempting to
speculate that the bacterial diversity of the inoculum may influence colonization.
However, the limited number of donors utilized in this study precludes us from making
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any robust conclusions in this regard. Future research with a wider range of donors will
lead to a better understanding of how the microbiota diversity of the donor impacts the
success of engraftment in animal models.
It is likely that host-related factors play a key role in favoring the establishment of
human gut bacterial communities in a porcine host compared to a murine host. The
domestic pig is widely used as an animal model in human infectious disease research
[35], nutritional studies [36], and the study of cardiovascular diseases [37] due to the
many anatomical, physiological, and immunological similarities [12, 38] that pigs share
with humans. The domestic pig is also considered the most human-like of all non-primate
animal models [39]. Of particular importance to the gut microbiota is the higher level of
morphological and functional similarities between the porcine gastrointestinal tract and
the human gut compared to widely used rodent models [40, 41]. Importantly, the porcine
immune system is considered to be much more similar to the human immune system
compared to that of mice [42, 43], and the immune system plays a key role in structuring
the microbiota during early development [44, 45, 46]. The size and volume of the
gastrointestinal tract available for colonization might also be an important factor that
differentiates the two animal models in terms of establishing human-like gut bacterial
communities, especially in terms of the number of available niches for colonization by a
complex microbiota. In humans, the gut epithelium is thought to play a role in selecting
for gut microbes by stimulating the growth of certain microbial groups while suppressing
others[47] . For example, host secretions such as fucosylated oligosaccharides are known
to actively recruit Bifidobacteria and certain Bacteroides spp. in the infant gut lumen[47].
Although much less is known about how host factors in animals play a role in selecting
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for certain gut microorganisms, it is likely that similar mechanisms are at play. It can be
speculated that, if more host related factors are shared between humans and pigs
compared to mice, then this would favor the establishment of a more donor-like
microbiota in the porcine gut compared to a murine gut. Thus, it is likely that anatomical,
physiological, and immunological similarities of the donor and recipient may influence
colonization of a more human-like microbiota in the recipient animal model.
For each donor, there were several core donor ASVs that failed to establish in
either animal model (Supplementary Data 4). One possibility is that, since we do not
know if the DNA came from viable cells or not, that we were only detecting DNA from
non-viable cells of these organisms. Another possibility is that some of these taxa might
be human-adapted strains which do not establish in other hosts; however, this conclusion
requires further experimental verification. These results underlie the importance of
characterizing the establishment of taxa of interest in HMA animal models in human-toanimal microbiota transplantation experiments, as the human taxa suspected to be the
cause of a human health outcome might not be able to colonize the animal model being
used. In fact, a recent study evaluating >1700 samples from human-to-GF mouse
transplant studies in the published literature reported that, on average, <50% of species
level taxa identified in the human donors are able to establish in GF mice[48].
Compared to the number of persistent colonizers that colonized each animal
model, only a small fraction of these ASVs established at relative abundances
comparable to levels observed in the respective donor’s consistently (Supplementary
Data 9). This observation is likely related to the different ecological environments found
in the guts of the two animal models compared to the human intestinal environment as
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well as dietary differences between the animal models and humans. Providing diets that
more closely resemble the diet of the human population under study to the HMA animal
model may potentially aid in the establishment of a more human-like microbiota. Our
analysis also revealed instances in which comparisons made at higher taxonomic levels
masked notable differences which existed at the underlying ASV level. For example, for
the Donor_3 core, the abundance of Lachnospiraceae was comparable between the
human donor, HMA mice, and HMA piglets (mean abundances of 22.15%, 18.74%, and
25.83%, respectively; Supplementary Data 7). However, only 15 out of 40 core
Lachnospiraceae ASVs colonized the HMA mice as opposed to the 31 out of 40
Lachnospiraceae ASVs which colonized the HMA piglets. Therefore, to accurately
monitor establishment of the microbiota in surrogate models, it is critical to look at lower
taxonomic levels to ensure colonization of representative species and their comparable
abundances.
We observed considerable variation in the number of core donor ASVs identified
in each donor and the success of their establishment in the two HMA animal models.
Even in donors of similar ages, such as the two children (Donor_2 and Donor_5), we
observed a marked difference in the number of core ASVs identified. This observation is
in agreement with the well-known interpersonal variation in human microbiota
composition[49]. We also noted considerable differences in colonization efficiency of
core ASVs in the HMA mice even when inoculated with donors of similar age. This was
most notable for the HMA mice inoculated with the two adult donors (Donor_3 and
Donor_6; Table 2.1 and Table 2.2). These results indicate that donor-to-donor variation
in colonization efficiency is an important factor to consider in human-to-animal
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microbiota transplant studies. Thus, individual characteristics of a particular donor - such
as genetics, dietary habits and lifestyle (which in turn affect the structure and composition
of their microbiota) - may greatly influence the colonization success of their microbiota
in HMA animal models.
We compared the transplantation results from our study with previous
transplantation experiments performed using HMA mice and HMA pigs. The successful
establishment of members of the phylum Bacteroidetes in both GF mice and piglets, as
well as the enrichment of members of the genus Bacteroides in GF mice is in agreement
with previous research[10, 50, 51, 52]. In contrast, previous studies have reported that
Bifidobacterium spp. tend to be very inefficient at colonizing GF mice[52, 53]. However,
in our study we noted that, across donors, almost all Bifidobacterium ASVs were able to
colonize the HMA mice although mostly at lower abundances compared to the donor.
These previous studies have used mice of different genetic backgrounds (e.g.,
C57BL/6[52]) compared to the C3H/HeN mice used in our study which might be a
reason for this observation. The low success of colonization of Faecalibacterium spp. in
the HMA mice of this study concurs with previous reports[52]. Concerning the
establishment of Firmicutes, a study comparing the establishment of a human donor (32year-old healthy adult) microbial community in different rat and mouse models noted
inefficient establishment of Firmicutes in the mouse models[50]. Specifically, it was
observed that eight abundant Clostridia phylotypes found in the human donor had
established in rats but were not detected in any of the mouse models, while a further six
abundant phylotypes belonging to Clostridia failed to colonize either the rat or mouse
models. In addition, only about 9 out of 48 Clostridia cluster IV members found in the
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human donor were detected in the mice. While the GF mouse strains used by these
authors (C57BL/6JZtm and NMRI/MaxZtm) were different from the C3H/HeN mice
used in our study, these results concur with our observation of poor establishment of
Firmicutes in the HMA mice across donors. Thus, it appears that the inefficient
colonization of GF mice with Firmicutes of human gut origin may be a common
limitation across mouse strains which merits further investigation.
The limited number of published studies relating to the transplantation of human
donor microbiotas into GF pigs hinders the ability to compare our results to the published
literature. This is especially so for comparing the colonization patterns for our more
mature donors as most of the studies related to HMA pigs involve transplantations from
infant donors[7, 8, 9, 11, 14, 15]. Even in one of the few studies which involved an adult
donor the results were reported only at the phylum level[16]. Therefore, there is a clear
need for more research to be conducted with HMA pigs using human donors of diverse
age groups and physiological conditions. For infants, a study using an HMA piglet model
reported that although a majority of OTU (operational taxonomic unit)-level taxa found
in the donor had colonized the piglets, their abundances had deviated from those of the
donor upon transplantation[8]. This corresponds to the results obtained for both infant
donors (Donor_1 and Donor_8) in our study where we observed that while a majority of
the core ASVs colonized the HMA piglets, their abundances had deviated considerably
from those observed in the donors (Supplementary Data 7 and 10). Finally, our
observation of Bifidobacterium Spp. successfully colonizing the HMA piglets is in line
with previous work[8, 10].

68
The results of our study point to judicious selection of HMA animal models for
future studies based on several model considerations. As an example, the murine model
might be a better option for studying a low diversity microbiota such as the human infant
microbiota while the porcine model may be a better option for studying humans with
more complex microbial community compositions. When considering an animal model to
study an aberrant microbiota implicated in a human disease condition, an HMA piglet or
mouse model could be selected based on the composition of the aberrant microbiota and
its probability of colonizing the animal model. For example, if the aberrant microbiota
has a high proportion of members of the family Lachnospiraceae, then an HMA piglet
model may be a more appropriate model as opposed to an HMA mouse model since our
results demonstrate that Lachnospiraceae members colonize better in the HMA piglets.
Although we selected human donors to represent major variations in the human
microbiome that may be driven by age, we only have a limited number of donors from
each age group which precludes us from extending our findings to age-related
colonization patterns. The lack of donor replication is mainly a result of the increased
cost and logistical difficulties related to maintaining large numbers of murine and porcine
animals under GF/gnotobiotic conditions. This is reflected by the fact that many studies
performed using HMA mice or piglets have used only a single human donor [8, 10, 11,
24, 50, 52] . Therefore, future studies with greater numbers of human donors representing
different age groups will shed more light into the generalizability of our findings to a
wider context. Our comparison of the HMA mice and HMA piglets also did not take into
account the differences in developmental stage between the mice and the piglets. For
example, although we sampled both species at the same time intervals post-inoculation, a
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5-week old mouse would be at a more advanced stage in its development life cycle
compared to a 5-week old piglet. What consequences this has on the ability of human gut
bacteria to colonize each animal model is an interesting question which merits further
research. Notwithstanding these limitations, our findings provide new insight into the
colonization dynamics of human gut bacteria in HMA murine and porcine models, which
would be useful for future studies utilizing these animal models.
In conclusion, this study provides evidence for the utility of both HMA mice and
HMA piglets as valuable animal models in human gut microbiota research depending on
the donor context. The results of our study also emphasize the necessity to characterize
the transplanted microbial communities at finer taxonomic levels (such as OTU or ASV
level) when evaluating the success of donor microbiota engraftment in HMA animals, as
comparisons done at higher taxonomic levels (e. g., Phylum, Family level) may lead to
misleading conclusions. Our findings also point to the importance of confirming the
establishment of targeted human taxa in the recipient animal models in human-to-animal
transplantation experiments as several core human taxa from our donors failed to
colonize either animal model.

Methods
Animals and husbandry practices
All animal-related intervention protocols and husbandry practices were approved
by the Institutional Animal Care and Use Committee (IACUC) at the University of
Nebraska-Lincoln (protocols 1215 and 1700 for the mice and 1400 for the piglets). Male
and female germ-free (GF) C3H/HeN mice were born and reared in flexible film isolators
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and maintained under gnotobiotic conditions at the University of Nebraska-Lincoln
(UNL) gnotobiotic mouse facility. GF status of experimental mice was confirmed prior to
study initiation as previously described [54]. At the beginning, there were 10 mice (5
male and 5 female) per isolator, with one isolator for each donor. However, 3 mice in the
isolator inoculated with Donor_1 inocula died during the study. All mice in a given
isolator were colonized with inocula from a single donor. Similarly, there were 10 mice
per isolator at the beginning of the second study (involving Donor_5 – Donor_8). One
mouse each from the isolators inoculated with Donor_5 and Donor_6 inocula died during
the study.
GF piglets were derived from two full-term (120-day) sows (Landrace x Duroc
cross-bred) artificially inseminated with the same semen lot. The germ-free piglets were
derived through hysterotomy via Cesarean section surgeries performed within the
confines of pre-sterilized, custom-built plastic surgery isolators attached to the skin of
anesthetized sows [55, 56]. The newly-born piglets were placed inside sterile ‘transfer
boxes’ while still inside the surgery bubble and transferred into sterile isolators with
positive pressure (Park Bioservices LLC, MA). The isolators were tested for sterility
using environmental swabs prior to introduction of the piglets. The swabs were cultured
on brain heart infusion (BHI) agar plates and incubated both aerobically and
anaerobically at 370 C. Fecal swabs from the piglets were collected prior to inoculation
with human donor inocula and were cultured similarly on BHI agar plates to test for
germ-free status. Similar to the mice, the piglets (male and female) were divided among 4
isolators (one isolator per donor). There were 4 piglets in the isolator inoculated with
Donor_1 and 3 piglets per isolator for the remaining 3 isolators. During the course of the
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experiment, one piglet from the isolator inoculated with Donor_1 died (fecal sample from
2 days post-inoculation was collected from this piglet prior to its death), resulting in a
final total of 12 piglets. A single isolator with 4 piglets was colonized with Donor_8
inocula in the second study. All 4 piglets survived the duration of this study.
The mice were kept on Teklad 2919 (irradiated) rodent diet (Envigo RMS, inc.,
IN) throughout the study after weaning while the piglets were initially provided with
commercially sterile human infant formula (Similac Pro-Advance®, Abbott Laboratories,
IL) for 4 wks and subsequently weaned on to the same Teklad 2919 rodent diet (This diet
met the nutritional requirements of the piglets; see Table 2.3 for diet composition). Sterile
water was provided to both species in the form of autoclaved water. A 14hr light/10hr
dark cycle was provided for both the piglets and mice. The HMA piglets were initially
maintained at 350 C for the first week after birth and then the temperature was reduced
gradually to reach 250 C which was subsequently maintained for the remainder of the
study. The HMA mice were maintained at 20 – 240 C throughout the study.
The gnotobiotic mouse facility and the gnotobiotic pig facility at UNL are both
housed in the same building (UNL Life Sciences Annex) in very close proximity to each
other.

Human donor fecal sample collection and inocula preparation
Human donors were recruited and consent was given as described on the IRB
protocol approved by the Institutional Review Board of the University of NebraskaLincoln (Approval number 20170116853EP). Fecal samples were obtained from four
human donors: Donor_1 (female, 20-week-old infant), Donor_2 (female, 5 years of age),
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Donor_3 (female, 25 years of age), and Donor_4 (female, 79 years of age). All donors
were free of antibiotic use during the previous 6 months, while Donor_4 was on nonantibiotic medication for a respiratory illness. The donors of the second study were as
follows: Donor_5 (male, 9 years of age), Donor_6 (male, 33 years of age), Donor_7
(female, 73 years of age), and Donor_8 (female, 6-month-old infant). From each donor,
fecal samples were obtained on five consecutive days. Upon receiving the samples to the
laboratory, samples were mixed with a solution of 50% glycerol and stored at -800 C.
Prior to inocula preparation, all 5 fecal samples from a donor were thawed at 4°C and
transferred into an anaerobic chamber. Within the anaerobic chamber, 0.5g from each
fecal sample was weighed and pooled to obtain a composite fecal sample of 2.5g. This
composite fecal sample was subsequently mixed with 50 mL of sterile Similac® infant
formula and thoroughly mixed to obtain the master pooled inoculum. Aliquots of this
pooled inoculum (referred to as ‘inoculum aliquots’) were subsequently used for
inoculating the GF mice as well as the GF piglets. Individual tubes with inoculum
aliquots were stored at -800 C until required to perform the inoculations. The tubes
contained sterile 20% glycerol to ensure the inoculum did not completely freeze.

Inoculation of germ-free mice and piglets
Each mouse was inoculated with 200uL of donor inoculum aliquots while the
piglets were inoculated with 4 mL of inoculum aliquots per piglet (this volume was
selected based on the body weight ratio between the mouse and the young piglet). The
mice were orally gavaged with the inoculum aliquots while for the piglets the inoculum
aliquots were added to the feed bowls to be taken up during feeding. Both the mice and
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the piglets were inoculated after weaning and adaptation to the solid diet. The GF mice
were weaned at 21 days of age and inoculated at 33 days of age. The GF piglets were
weaned at 28 days of age and inoculated at 31 days of age. All animals in a given
isolator were inoculated with the same donor. Following the first round of inoculations,
all animals were inoculated a second time in a similar manner two weeks later. The
remaining material from the inoculum aliquots were used for DNA extraction and
subsequent sequencing to characterize the fecal bacterial community of each donor that
went into each recipient GF animal.

Fecal sample collection and storage
From both animal models, fecal samples were collected at the following time
points post-inoculation (number of days after first round of inoculations): 2d, 7d, 14d,
21d, 28d, 35d, and 40d. Subsequently, all animals were humanely euthanized. Fecal
samples were collected using sterile fecal loops for the piglets. Fecal pellets from mice
were collected by allowing each mouse to defecate into a plastic cup placed inside the
isolator. All fecal samples were stored at -800 C until they were used for DNA
extractions.

Fecal DNA extraction, PCR amplification, and amplicon sequencing
DNA was extracted from all fecal samples using the OMEGA Mag-Bind® Soil
DNA 96 kit (Omega Bio-tek, Inc., GA) following the manufacturer’s protocol with the
following modification: after the initial bead-beating step, the samples were boiled for 10
mins at 900 C in a heated water-bath, followed by another round of bead-beating at 30 Hz
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for 10 mins. Samples were processed in batches of 96 and each batch contained mouse
fecal samples as well as piglet fecal samples in order to avoid any biases that may be
introduced due to possible variations during DNA extractions. Following DNA
extractions, PCR amplifications were performed using primers targeting the V4
hypervariable region of the 16S rRNA gene as previously described [57]. Each PCR
reaction consisted of 1X TerraTM PCR Direct Buffer (Takara Bio Inc., Mountain View,
CA), 0.625 units of TerraTM PCR Direct Polymerase (Takara Bio, Inc., Mountain View,
CA), 2.5 uM barcoded primers[57], 20-50 ng of template DNA, and 9 uL of nuclease-free
water for a total volume of 25 uL. PCR reactions were performed on an Applied
Biosystems Veriti 96-well Thermal Cycler (Thermo Fisher Scientific, Inc., Waltham,
MA) using the following program: Initial denaturation at 980 C for 3 min followed by 25
cycles of denaturing at 980 C for 30 sec, annealing at 550 C for 30 sec, and elongating at
680 C for 45 sec. This was followed by a final extension at 680 C for 4 mins. Agarose gel
electrophoresis using 2% (w/v) agarose (Green Bioresearch LLC, Baton Rouge, LA) was
used to visualize the resulting amplicons. Following amplicon normalization using the
SequalPrep Normalization Plate Kit (Invitrogen, Carlsbad, CA), equal volumes of
normalized amplicons were pooled together. Preparation of PCR plates, amplicon
normalization, and pooling were performed using an EpMotion M5073 robot (Eppendorf,
Hamburg, Germany). Subsequently, the quality of the pooled amplicons was assessed
using an Agilent BioAnalyzer 2100 High Sensitivity DNA chip (Agilent, Santa Clara,
CA) and quantified using a DeNovix dsDNA High Sensitivity Kit (DeNovix Inc.,
Wilmington, DE). Dual-index paired-end sequencing (2 x 250 bp) of pooled amplicons
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was performed on an Illumina® MiSeqTM platform (Illumina Inc., San Diego, CA) as
described previously [57] using V3 reagent kits.

Bioinformatic analysis
The bioinformatic data processing and analysis steps were performed in R [58] (version
3.6.0) using the phyloseq package [59](version 1.28.0). Briefly, denoising steps and
identification of amplicon sequence variants (ASVs) were performed following the
DADA2 (1.12.1) pipeline [60]. Potential contaminant ASVs originating from reagents
were identified and removed using the decontam package [61] (1.4.0) based on their
prevalence in negative controls. Following chimera removal, DNA extraction and PCR
negative controls were removed along with ASVs found only in those negative controls.
Taxonomic assignments were done using the DADA2-formatted training fasta file[62]
from the SILVA[63] Project’s version 138 release. ASVs classified as ‘Archaea’,
‘Eukaryota’, and ‘Cyanobacteria’ (with the exception of the non-photosynthetic class
Melainabacteria, as these are thought to be of gut origin [64]), as well as ASVs which
were only detected in a single sample were also filtered out. Any sample with less than
10,500 reads was also removed from the analysis. The final quality-filtered ASV table
consisted of 392 samples and 1135 ASVs accounting for 17,016,489 total reads at an
average read depth of 43,409 reads/sample (SD = 21,178) which was used in the
subsequent data analysis steps. Beta diversity analysis was done using unweighted
UniFrac and Bray-Curtis distance matrices and alpha diversity comparisons were
performed using the Shannon Index. All ASVs (i.e., core and non-core ASVs) were
considered for alpha diversity calculations as these estimates are sensitive to the
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presence/absence of rare taxa. Heatmaps and chord diagrams were generated using the R
packages ‘gplots’ [65] (3.0.4) and ‘circlize’ [66] (0.4.10), respectively. Metagenome
prediction based on 16S rRNA gene sequences was performed using PICRUSt2 [34] and
the associated tools HMMER (http://hmmer.org), EPA-NG [67], gappa [68], and castor
[69]. The Firmicutes phylogenetic tree (Fig. 6) was generated using the Interactive Tree
of Life (iTOL)[70] web interface.
In addition, the taxonomic assignments of ASVs identified as Faecalibacterium
prausnitzii (ASV_3233, ASV_3238, and ASV_3239), Bifidobacterium bifidum
(ASV_3778 and ASV_3779), and Ruminococcus bromii (ASV_3350) were verified with
the Basic Local Alignment Search Tool (BLAST)[71] against the nucleotide collection
(nr/nt) database using megablast (optimized for highly similar sequences).
For comparing the relative abundances of persistent colonizer ASVs in the HMA
animals with their abundances in the original donor inocula at each sampling time point,
DESeq2 [72] (1.24.0) was used as implemented through phyloseq. p-value adjustments
for multiple comparisons was performed using the Benjamini-Hochberg procedure[73].
Alpha diversity measures (Shannon index) as well as UniFrac and Bray-Curtis distances
(Fig. 3) were compared using the Wilcoxon rank-sum test[74]. Statistical significance in
all analyses was determined at p < 0.05.
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Fig.2.1. Box-whisker plots comparing the alpha diversity of the inoculum aliquots among
the different donors using the Shannon index. Statistical comparisons were performed using
the Wilcoxon rank-sum test. Boxes with different letters indicate statistically significant
differences (p < 0.05). The box represents the 25th and 75th percentiles as the interquartile range
(IQR) and the short black line represents the median. The whiskers represent the minimum and
maximum values. Outliers are shown as black dots. n=3 inoculum aliquots for Donor_1 and n=4
inoculum aliquots or Donor_2, Donor_3, and Donor_4.

green triangles, HMA mouse fecal samples; blue squares, HMA piglet fecal samples.

inoculation) and n= 37 mice (Donor_1=7, Donor_2 = 10, Donor_3 = 10, Donor_4 = 10). Red circles, human donor inocula;

Donor_1 (b) Donor_2 (c) Donor_3 (d) Donor_4. n = 13 (3 piglets/donor, with the exception n=4 for Donor_1, 2 days post

communities in each of the four donor inocula and the fecal samples from the corresponding HMA animal models. (a)

Fig. 2.2. Principal coordinate analysis (PCoA) plots using unweighted UniFrac and Bray-Curtis distances for the bacterial
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post inoculation) and n= 37 mice (Donor_1=7, Donor_2 = 10, Donor_3 = 10, Donor_4 = 10).

*** p < 1 x 10-5; **** p < 1 x 10-10; ns – not significant. n = 13 (3 piglets/donor, with the exception n=4 for Donor_1, 2 days

maximum values. Outliers are shown as black dots. Statistical comparisons were performed using the Wilcoxon rank-sum test.

as the interquartile range (IQR) and the short black line represents the median. The whiskers represent the minimum and

communities. (a) Unweighted UniFrac distances and (b) Bray-Curtis distances. The box represents the 25th and 75th percentiles

Fig. 2.3. Comparison of similarity of HMA animal fecal bacterial communities and corresponding human donor bacterial
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(Donor_1=7, Donor_2 = 10, Donor_3 = 10, Donor_4 = 10).

0.01; ns – not significant. n = 13 (3 piglets/donor, with the exception n=4 for Donor_1, 2 days post inoculation) and n= 37 mice

maximum values. Outliers are shown as black dots. Statistical comparisons are based on the Wilcoxon rank-sum test. * p < 0.05; ** p <

percentiles as the interquartile range (IQR) and the short black line represents the median. The whiskers represent the minimum and

samples at each sampling time point. (a) Donor_1 (b) Donor_2 (c) Donor_3 and (d) Donor_4. The box represents the 25th and 75th

Fig. 2.4. Box-whisker plots depicting the variation in alpha diversity between the donor inocula and the HMA animal fecal
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inoculation) and n= 37 mice (Donor_1=7, Donor_2 = 10, Donor_3 = 10, Donor_4 = 10).

donors, ASVM1 in HMA mice, and ASVP1 in HMA piglets. n = 13 (3 piglets/donor, with the exception n=4 for Donor_1, 2 days post

both HMA animal models are not shown. ASVs have been designated according to the following example: ASV_1 is ASVH1 in human

each end of a link are proportional to the abundance of that ASV in the respective host species. Core donor ASVs which failed to colonize

abundance of that ASV in the host species. Links indicate which core donor ASVs established in each animal model and the widths at

Donor_1 (b) Donor_2 (c) Donor_3 (d) Donor_4. Each sector represents an ASV and the size of the sector corresponds to the mean relative

Fig. 2.5. Chord diagram representing the colonization patterns of core donor ASVs in the two HMA animal models. (a)
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Fig. 2.6. Phylogenetic tree depicting the overall distribution of core donor ASVs
classified as Firmicutes among the two HMA animal models.
Red squares indicate the presence of core Firmicutes ASVs in the human donors while the green
squares and blue squares indicate which of those Firmicutes ASVs were able to colonize the
HMA mice and piglets, respectively. Green stars indicate persistent colonizers of HMA mice and
blue stars indicate persistent colonizers of HMA piglets. n = 13 (3 piglets/donor, with the
exception of n=4 for Donor_1, 2 days post inoculation) and n= 37 mice (Donor_1=7, Donor_2 =
10, Donor_3 = 10, Donor_4 = 10) - (72 kb, PDF).
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Table 2.1. Summary of the establishment of core donor ASVs in the two HMA animal
models for each donor.

Donor

Number of
core donor
ASVs

HMA
animal
model

Number of
colonizers

Number of
persistent
colonizers

Donor 1

26

Donor 2

76

Donor 3

140

Donor 4

134

Mice
Piglets
Mice
Piglets
Mice
Piglets
Mice
Piglets

21(80.8%)
20(76.9%)
37(48.7%)
65(85.5%)
66(47.1%)
106(75.7%)
55(41.0%)
92(68.6%)

16(61.5%)
15(57.7%)
21(27.6%)
43(56.6%)
31(22.1%)
69(49.3%)
28(20.9%)
38(28.3%)

Average
read depth
for fecal
samples
45,238
37,341
47,814
44,321
45,216
39,972
45,833
34,309
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Table 2.2. Summary of establishment of core donor ASVs in HMA animal models
transplanted with a second set of donors. NA – not applicable.

Donor
Donor_5

Number of
core donor
ASVs
107

Donor_6

117

Donor_7

151

Donor_8

20

HMA animal
model

Number of
colonizers

Mice
NA
Mice
NA
Mice
NA
Mice
Piglets

68(63%)
NA
85(73%)
NA
63(45%)
NA
16(80%)
18(90%)

Number of
persistent
colonizers
29(27%)
NA
43(37%)
NA
36(24%)
NA
13(65%)
11(61%)
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Table 2.3. Composition of Teklad 2919 (irradiated) rodent diet

Component

Amount

Macronutrients

Crude Potein
Fat (acid hydrolysis)
available Carbohydrate
Crude Fiber
Neutral Detergent Fiber
Ash
Energy Density
Calories from Protein
Calories from Fat
Calories from Carbohydrate

19%
9%
44.90%
2.60%
12.10%
5%
3.3 kcal/g
23%
22%
55%

Vitamins

Vitamin A
Vitamin D3
Vitamin E
Vitamin K3 (menadione)
Vitamin B1 (thiamin)
Vitamin B2 (riboflavin)
Niacin (nicotinic acid)
Vitamin B6 (pyridoxine)
Pantothenic Acid
Vitamin B12 (cyanocobalamin)
Biotin
Folate
Choline

15.0 IU/g
1.5 IU/g
110 IU/g
50 mg/kg
17 mg/kg
15 mg/kg
75 mg/kg
18 mg/kg
33 mg/kg
0.08 mg/kg
0.40 mg/kg
4 mg/kg
1200 mg/kg

Minerals

Calcium
Phosphorus
Non-phytate Phosphorus
Sodium
Potassium
Chloride
Magnesium
Zinc
Manganese

0.90%
0.70%
0.40%
0.10%
0.40%
0.40%
0.20%
60 mg/kg
80 mg/kg

86

Fatty Acids

Amino Acids

Copper
Iodine
Iron
Selenium

15 mg/kg
6 mg/kg
200 mg/kg
0.23 mg/kg

C 16:0 Palmitic

0.90%

C 18:0 Stearic

0.20%

C 18:1 ω9 Oleic

1.70%

C 18:2 ω6 Linoleic

3.90%

C 18:3 ω3 Linolenic
Total Saturated
Total Monounsaturated
Total Polyunsaturated

0.40%
1.20%
1.70%
4.40%

Aspartic Acid
Glutamic Acid
Alanine
Glycine
Threonine
Proline
Serine
Leucine
Isoleucine
Valine
Phenylalanine
Tyrosine
Methionine
Cystine
Lysine
Histidine
Arginine
Tryptophan

1.10%
3.50%
1.20%
0.70%
0.60%
1.80%
0.90%
2.30%
0.80%
0.90%
1.10%
0.50%
0.50%
0.30%
0.90%
0.40%
0.80%
0.20%
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Additional supplementary Materials
Supplementary Data 1 (.xlsx, 38 KB). Core ASV distribution for each donor in the two
HMA animal models including the respective relative abundances and taxonomic
classifications.
Supplementary Data 2 (.xlsx, 26 KB). Phylum, family, and genus level groupings of
colonizers and persistent colonizers in the two HMA animal models and their distribution
in the human donors.
Supplementary Data 3 (.xlsx, 28 KB). Mean relative abundances and taxonomic
classifications for the persistent colonizers identified for each animal model within each
donor.
Supplementary Data 4 (.xlsx, 15 KB). Taxonomic classifications for core ASVs from
each human donor that failed to colonize either of the two animal models.
Supplementary Data 5 (.xlsx, 10 KB). Taxonomic classifications for 27 common core
ASVs found across the 4 donors.
Supplementary Data 6 (.xlsx, 9 KB). Colonization success of the 27-common core
ASVs among the two HMA animal models.
Supplementary Data 7 (.xlsx, 37 KB). Phylum, family, and genus level taxonomy
assignments and relative abundances for the core ASVs from each donor that established
in each animal model.
Supplementary Data 8 (.xlsx, 117 KB). Relative abundance comparisons at each
sampling time point for the persistent colonizers of each animal model for each donor.
Supplementary Data 9 (.xlsx, 15 KB). Taxonomic classifications of persistent
colonizers with donor-like abundances for each animal model.
Supplementary Data 10 (.xlsx, 31 KB). Phylum, family, genus level taxonomy
assignments for core ASVs from donors of subsequent study which colonized the two
HMA animal models.
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CHAPTER 3

EVALUATION OF MICROBIOME STRUCTURE AND FUNCTION
IN INFANT MICROBIOTA-ASSOCIATED PIGLET MODELS

Abstract
Human microbiota-associated (HMA) piglets have been used to study the infant
microbiome. However, our knowledge on how closely the transplanted microbiota
resembles that of the human infant donor in terms of community structure and functional
potential is limited. To address this gap in knowledge and to investigate if maintaining
piglets on a milk-based diet similar to the donor would enhance colonization and lead to a
more donor-like microbiome, infant fecal microbiomes were transplanted into two groups
of germ-free (GF) piglets with replication. One group received milk as part of their diet
post-inoculation of the donor microbiome, while the other group was weaned onto a solid
diet before donor inoculation. The same experimental design was repeated in a second
study involving a second infant donor. In addition to the piglets, this study also involved
a group of GF mice (C3H/HeN) that were inoculated post-weaning. Both 16S rDNAbased community analysis and metagenome shotgun sequencing was performed on
samples collected. Results based on 16S rDNA sequencing as well as shotgun
metagenomics revealed that, a majority of taxa as well as KEGG orthology (KO) genes
from the infant donors were represented in the HMA piglets. However, the microbiome
community composition established in the pigs and mice were different from those in the
infant donors. Notably, regardless of whether milk was part of the diet post-inoculation,
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only about 19% to 37% of reads in the piglet fecal microbiotas originated from core
donor taxa. In contrast to the piglets, >80% of reads in the feces of mice originated from
core donor taxa; however, the functional microbiome profiles of both animal models
were still distinct from that of the donor. Finally, using a publicly available metagenomic
dataset, we show that a vast majority of the KOs shared across a diverse group of infants
can be represented in both the HMA piglets and mice. The outgrowth of rare members of
the infant donor community upon engraftment into GF piglets might be a previously
overlooked limitation of this animal model, which deserves further investigation in future
studies.

Key words: HMA piglet model, infant, microbiome

Introduction
The infant microbiome is believed to play an important role in the early
development of the human infant, and has been a major area of research interest in the
field of gut microbiome studies. The early life microbiota has been implicated in the
development and maturation of the infant immune system and gastrointestinal tract [1, 2,
3, 4] as well as brain and cognitive development [5, 6]. In addition, the intestinal
microbiota has also been linked to vaccine responses in infants [7, 8]. Moreover, the early
developmental trajectory of the infant microbiome is believed to have important health
implications later in life [9, 10].
Due to the many ethical and technical hurdles associated with directly performing
microbiota studies with human infants, the research community has developed human
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microbiota-associated (HMA) piglets (germ-free piglets colonized with infant fecal
microbial communities) [11, 12, 13, 14, 15] and HMA mice [16, 17] as surrogate models.
However, many of these studies do not report on the success of establishment of the
infant donor microbial communities in the recipient animals, thus making it difficult to
evaluate the neonatal HMA piglet and mouse models in terms of their capacity to harbor
and maintain a human infant microbiota. In addition, these studies have not characterized
and compared the functional capacities of the transplanted microbiomes in the animal
models with that of the donor infants in a comprehensive manner.
In this study, we use 16S rRNA gene-based community profiling as well as
shotgun metagenomics to evaluate the neonatal HMA piglet model in terms of its ability
to recapitulate the compositional and functional characteristics of human infant fecal
bacterial communities from two separate infant donors. For one of the donors, we also
compared the HMA piglet model with an HMA mouse model in terms of establishment
of the infant donor microbiota community and function. In addition, we also investigated
the effect of providing piglets with milk on the establishment of infant fecal microbial
communities in the HMA piglet model.

Materials and methods
Animal husbandry
Domestic piglets (Sus scrofa domesticus) were derived germ-free (GF) from two
full-term (120-day) sows (Landrace x Duroc cross-bred) artificially inseminated with the
same semen lot. The germ-free piglets were derived through hysterotomy via Cesarean
section surgeries performed within the confines of pre-sterilized, custom-built plastic
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surgery isolators attached to the skin of anesthetized sows [18, 19]. The newly-born
piglets were placed inside sterile ‘transfer boxes’ while still inside the surgery bubble and
transferred into sterile isolators with positive pressure (Park Bioservices LLC, MA). The
isolators were tested for sterility using environmental swabs prior to introduction of the
piglets as described previously [20]. Two trials were conducted. For the first trial, there
were 4 piglets housed in a single isolator. For the second trial, there were 4 isolators with
each one housing 3 piglets for a total of 12 piglets. Two of these isolators were inoculated
with Infant_1 donor inocula while the remaining 2 isolators were inoculated with
Infant_2 donor inocula. Within each donor, the 3 piglets in one isolator were inoculated
pre-weaning (early-inoculation) while the 3 piglets in the other isolator were inoculated
post-weaning (late-inoculation).
The germ-free C3H/HeN mice were derived and reared in a flexible film isolator
and maintained under gnotobiotic conditions at the University of Nebraska-Lincoln
(UNL) gnotobiotic mouse facility. GF status of experimental mice was confirmed prior to
study initiation as previously described [21]. There were 10 mice in the isolator at the
beginning of the study, but 3 mice died within the first 3 weeks. Thus, 7 animals
remained for the duration of the study.
The mice were kept on the Teklad 2919 (irradiated) diet (Envigo RMS, inc., IN)
throughout the study while all piglets (regardless of trial and whether they were
inoculated pre- or post-weaning) were initially provided with commercially sterile human
infant formula (Similac Pro-Advance®, Abbott Laboratories, IL). For the first trial, the 4
piglets were kept on milk for the first 3 weeks followed by a ‘transition period’ in which
they were provided with both milk and solid feed. By week 4 the piglets were weaned
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and only provided the solid diet. For trial 2, all piglets received infant formula (Similac
Pro-Advance®) at the beginning of the study. Subsequently, the piglets belonging to the
late-inoculation group were weaned on to the same Teklad 2919 rodent diet (This diet
met the nutritional requirements of the piglets; see Table 3.8 for dietary information). The
piglets in the early-inoculation group were also provided with the same solid diet from
week 4 onwards; however, they also continued to receive infant formula throughout the
duration of the study. Sterile water was provided to both species in the form of
autoclaved water. A 14hr light/10hr dark cycle was provided for both the piglets and
mice. Control of light/dark cycles as well as temperature control inside the facilities was
done as described previously [20].
All animal-related intervention protocols and husbandry practices were approved
by the Institutional Animal Care and Use Committee (IACUC) at the University of
Nebraska-Lincoln (protocols 1215 and 1700 for the mice and 1400 for the piglets).

Infant donor fecal sample collection and inocula preparation
Infant donors were recruited and consent was given by their parents as described
on the IRB protocol approved by the Institutional Review Board of the University of
Nebraska-Lincoln (Approval number 20170116853EP). Fecal samples were obtained
from two infants: INF_1 (female, 5-month-old infant), and INF_2 (female, 5-month-old
infant). INF_1 was on a formula diet while INF_2 was mainly on breast-milk
supplemented with infant formula and oatmeal. From each infant, fecal samples were
provided on five consecutive days. Upon receiving the samples to the laboratory, inocula
were prepared under anaerobic conditions as described previously [20]. Individual tubes
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with inoculum aliquots were stored at -800 C until required to perform the inoculations.
The tubes contained sterile 20% glycerol to ensure the inoculum did not completely
freeze.

Inoculation of germ-free mice and piglets
Each mouse was inoculated with 200uL of donor inoculum aliquots while the
piglets were inoculated with 4 mL of inoculum aliquots per piglet. The mice were orally
gavaged with the inoculum aliquots while for the piglets the inoculum aliquots were
bottle-fed (early-inoculation group) or added to the feed bowls to be taken up during
feeding (late-inoculation group). The GF mice were weaned at 21 days of age and
inoculated at 33 days of age. For both donors, The GF piglets of the early-inoculation
group were inoculated at 7 days of age while those piglets in the late-inoculation group
were weaned at 28 days of age and inoculated at 31 days of age. Following the first round
of inoculations, all animals were inoculated a second time after a two-week interval. As
described previously [20], the remaining material from the inoculum aliquots were used
for DNA extraction and subsequent sequencing to characterize the fecal bacterial
community of each donor that went into the recipient GF animals.

Fecal sample collection and storage
From all animals, fecal samples were collected at the following time points postinoculation (number of days after first round of inoculations): 2d, 7d, 14d, 21d, 28d, 35d,
and 40d. Subsequently, all animals were humanely euthanized at d41 post-inoculation.
The methods used to collect fecal samples from the mice and the piglets have been
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described previously [20]. All fecal samples were stored at -800 C until they were used
for DNA extractions.

Fecal DNA extraction, PCR amplification, high-throughput sequencing
For all collected fecal samples and donor aliquots, DNA extraction, PCR
amplification of the extracted DNA as well as amplicon sequencing targeting the V4
hypervariable region of the 16S rRNA gene on the Illumina® MiSeqTM platform
(Illumina Inc., San Diego, CA) were performed as described previously [20].
The same DNA used for 16S rRNA amplicon sequencing was also used for
shotgun metagenomic sequencing for the donor inocula (n=2 for INF1 and n=5 for INF2)
as well as the HMA animal fecal samples. For all animals regardless of particular
treatment, only DNA extracted from the following time points were considered: 2d, 7d,
21d, 35d, and 40d post-inoculation. Briefly, DNA from each sample was fragmented
using a sonicator (Bioruptor®, Diagenode S. A., Denville, NJ) with the power setting set
at ‘Low’ and consisting of 3 cycles of sonication for 30 seconds followed by 90 seconds
of rest (thus, each cycle lasted for 2 minutes). These conditions targeted sheared DNA
fragments of approx. 750 bp length. Following fragmentation of the DNA, library
preparation was performed using the NEBNext® UltraTM DNA Library Prep Kit (New
England Biolabs, Ipswich, MA). Size selection, adapter ligation, amplification and beadbased library purifications were performed according to the manufacturer’s instructions.
The quality of the prepared libraries was determined using an Agilent BioAnalyzer 2100
High Sensitivity DNA chip (Agilent, Santa Clara, CA) and quantified with a DeNovix
dsDNA High Sensitivity Kit (DeNovix Inc., Wilmington, DE). Individual libraries were
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then pooled at equal amounts followed by high-throughput sequencing (2X150 bp pairedend) on an Illumina® HiSeqTM 2500 instrument (Illumina Inc., San Diego, CA).

Additional shotgun metagenomic data from human infants
In order to expand the functional metagenomic information for human infants, we
downloaded shotgun metagenomic data from fecal samples collected from 32 infants
made available in a recent publication by Casaburi et al. [22]. The 32 infants were in the
same age category (4-6 months) as INF1 and INF2 from our study, and had consumed
either breast milk, infant formula, or a mixture of the two. The sequence data in the form
of fastq files were downloaded from the sequence read archive
(https://www.ncbi.nlm.nih.gov/sra) accessed using reference PRJNA633576.

16S rRNA gene-based community profiling
The profiling of the bacterial communities was performed in R version 4.1.1. [23]
using the phyloseq package (1.36.0) [24]. The initial quality filtering steps and
identification of amplicon sequence variants (ASVs) were done using the DADA2
pipeline (1.16) [25] as described previously [20]. Briefly, Potential contaminants
originating from reagents were identified and removed using the decontam package
(1.12.0) [26] followed by chimera removal and the filtering of any ASVs which were
only detected in negative controls. Assignment of taxonomy to the remaining ASVs was
performed using the DADA2-formatted fasta files from the SILVA Project’s version
138.1 release (March 2021). Non-bacterial ASVs were filtered out with the exception of
the Cyanobacterial class Melainabacteria due to their reported gut origin [27]. ASVs
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detected in only a single sample were also removed. Additionally, 7 samples with <
10,500 reads were also filtered out. The average read depth was 37,537 reads/sample. As
a final quality control step, we filtered out ASVs which had a relative abundance < 0.15%
in any sample and was detected in < 2 samples as recommended by Tom et al.
(Unpublished). This resulted in a final quality-filtered ASV table consisting of 184
samples and 298 ASVs. With the exception of alpha diversity, data analysis concentrated
on the establishment of ‘core’ donor ASVs (ASVs detected in all inoculum aliquots of a
given donor [20]) in the HMA animal models. Beta diversity analyses were performed
using Bray-Curtis and Unweighted UniFrac distances. Data analysis for trials 1 and 2
were performed separately.

Metagenomic analysis pipeline
The fastq files resulting from Illumina HiSeq sequencing had been demultiplexed
by the sequencing center. Quality control of the raw reads was performed as follows:
Sequencing adapters and other artifacts such as PhiX reads were removed using BBDuK
which is part of the BBMap suite (v38.06) of tools
(https://sourceforge.net/projects/bbmap/). Trimming reads based on quality was
subsequently performed using Sickle (1.33) [28], requiring a minimum quality score of
30 and a minimum read length of 50 following trimming. Reads passing quality filtering
were subsequently aligned against the genome of the relevant host (i. e., human, mouse,
or pig) using Bowtie2 (2.3) [29] and any sequences of host origin were removed. The
following reference genomes (downloaded from the UCSC genome browser) were used:
Human (GRCh38/hg38), mouse (GRCm39/mm39), and pig (SGSC
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Sscrofa11.1/susScr11). The remaining reads were used to perform de novo assembly
using MEGAHIT (1.2) [30]. This assembly was done separately within each host species.
The quality of each assembly was evaluated using QUAST (5.0) [31]. Each assembly was
filtered to retain only contigs of at least 2000 bp length, which were subsequently used to
predict open reading frames (ORFs) using the PROKKA pipeline (1.14) [32]. Using
bowtie2, reads from each of the host samples were then mapped back to the PROKKApredicted ORFs from the corresponding host assembly (e. g. reads from each of the
mouse samples would have been mapped back to the PROKKA ORFs predicted from the
mouse MEGAHIT assembly). The resulting SAM files were converted to BAM files
using SAMtools (1.9) [33] and duplicate reads were identified and removed using the
Picard tool (http://broadinstitute.github.io/picard/). A table containing the number of
reads mapping to each predicted ORF for each of the samples (a ‘features x samples
table’) was subsequently generated using a custom PERL script. For each host species,
the ORFs were annotated by uploading their amino acid sequences to Ghost KOALA
(https://www.kegg.jp/ghostkoala/) [34]. For functional analysis, only those ORFs which
had been assigned a KEGG Orthology (KO) number by GhostKOALA were considered.
Reads were normalized by multiplying relative abundances by 1,000,000 and expressed
as number of reads corresponding to feature per million reads. This normalized table was
subsequently used for beta diversity analysis using Binary Jaccard distances and BrayCurtis distances. Beta diversity among the samples was visualized using PCoA plots. One
donor sample (‘donor_1_01’) and one mouse sample (‘mouse_4_07’) were removed from
further analysis as they were deemed to be outliers based on their clustering on the PCoA
plots. The ‘KEGG mapper – Reconstruct’ tool

103
(https://www.genome.jp/kegg/mapper/reconstruct.html) was used to identify the
pathways to which KOs were assigned to.

Results
Establishment of infant (INF1) microbiota in GF piglets from trial 1
We first investigated how the donor microbiota of an infant (INF1) had
transplanted in GF piglets (n=4). A total of 21 core INF1 donor ASVs (ASVs found in all
INF1 inocula (n=4 replicates); see Materials and methods) were identified that accounted
for >96% of total INF1 donor reads, implying that these 21 core ASVs were the
predominant members of the INF1 donor fecal bacterial community. Nineteen out of the
21 core INF1 ASVs were detected in at least one of the HMA piglet fecal samples. Beta
diversity comparisons using principal coordinate analysis (Fig. 3.1) revealed distinct
clustering patterns with HMA piglet fecal samples collected at earlier time points on a
milk-based diet clustering closer to the donor inocula, and the fecal samples from the
later time points on a solid diet clustering further away from the donors. Furthermore,
alpha diversity analysis revealed that the fecal samples collected from later time points
had a significantly higher diversity (p < 0.05) compared to the donor inocula (Fig. 3.2).
The early fecal samples were collected while the piglets were receiving milk as part of
their diet while later samples were collected after the piglets had been weaned and on a
solid diet (See ‘Materials and methods’ for diet information). As such it was tempting to
speculate that diet provided to the HMA animals influenced colonization. To test this
hypothesis and to evaluate if maintaining the HMA piglets on a milk-based diet increased
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colonization of infant donor microbiota in the piglet model, we next investigated diet
effects on the infant HMA pig model.

Establishment of infant microbiome on milk and solid diets – Trial 2
The results from the first trial with INF1 indicated that the fecal microbiota of the
HMA piglets transplanted with INF1 inocula was most similar to the donor when the
piglets were on a milk-based diet. This led us to consider the impact of diet (specifically,
the influence of milk), on the establishment of an infant microbiota in GF piglets. To this
end, we performed a second experiment (trial 2) where GF piglets were divided into two
treatment groups with 3 animals per treatment group. One group of piglets received the
INF1 donor inoculum at 7 days of age while the piglets were still receiving milk (‘early
inoculation’ group) and the other group was inoculated after they had been weaned and
on a solid diet (‘late inoculation’ group). At 4 weeks of age, the piglets in the early
inoculation group were introduced to solid feed. However, these piglets continued to
receive milk as part of their diet. The late inoculation piglets remained on an exclusively
solid diet for the duration of the study (no exposure to milk following inoculation).
As described before, we concentrated on core ASVs to evaluate the establishment
of donor ASVs in the GF piglets fed the two different diets. A total of 18 core donor
ASVs (accounting for 82.7% of donor reads) were identified for INF1 inocula. Of these
18 core ASVs, 13 and 12 ASVs were found to be established in the early and late
inoculation piglets, respectively (Table 3.1). The PCoA plot using the Bray-Curtis
distances of the established microbiomes between donors and piglets displayed (Fig. 3.3)
separate clustering between donor inocula, early inoculation piglet fecal samples, and late
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inoculation piglet fecal samples. For the late inoculation piglets, the fecal samples
collected at 2 days post-inoculation and 7 days post-inoculation clustered separately and
closer to the donor (Fig. 3.3(b)). All the other fecal samples collected from these late
inoculation piglets clustered away and formed a separate cluster. Similar to the late
inoculation piglets on the solid diet, the early fecal samples collected from the early
inoculation piglets on milk (day 2 and day 7), clustered closer to the donor samples than
the later samples (Fig. 3.3(b)). Moreover, it appeared that with time the piglet fecal
samples were clustering further away from the donor inocula irrespective of diet.
To investigate possible donor-to-donor variation, we repeated this study using
inocula from a second infant donor (INF2). Once again, we had 3 GF piglets each for the
early inoculation and late inoculation groups, and the timing of inoculations and diets
provided were similar to the first donor. Additionally, as reported in one of our previous
publications [20], the INF2 late inoculation piglets were part of a larger study which also
involved inoculation of the same donor (INF2) into GF C3H/HeN mice. Thus, we
compared the establishment of INF2 fecal bacterial communities between milk-based
early inoculation and solid diet-based late inoculation in piglets, in addition to
colonization in mice receiving the same solid diet. Five donor inocula aliquots were
sequenced to represent the inocula bacterial communities. These 5 aliquots had been used
for inoculating the animals as follows: early inoculation piglets (n=2), late inoculation
piglets (n=1), and GF mice (n=2). A total of 25 core ASVs shared between the 5 donor
inocula, which accounted for 97.8% of total reads was used for subsequent analysis. Out
of these 25 core ASVs, 20, 19, and 21 were detected in the fecal samples of the early
inoculation piglets, late inoculation piglets, and HMA mice, respectively (Table 3.2).

106
Beta diversity comparisons using Bray-Curtis distances based on PCoA clustering (Fig.
3.4) revealed that the donor inocula clustered closer to the mouse fecal samples compared
to both groups of piglets. However, statistical analysis using PERMANOVA displayed
that the fecal samples from each of the animal models were significantly different (p <
0.05, PERMANOVA) from the donor inocula in terms of bacterial community
composition. Similar to INF1, for both piglets and mice, fecal samples collected at 2- and
7-days post-inoculation were most similar to the INF2 donor inocula (Fig. 3.5 and Fig.
3.6).
We subsequently evaluated the percentage of reads representing the core donor
ASVs within each of the animal models. For the early- and late-inoculation piglets
inoculated with INF2, only 36.5% and 28.4% of reads represented the core ASVs
identified. In contrast, 80.9% of the reads in the HMA mice represented the INF2 core
ASVs. This observation prompted us to inquire if the reads found in the pig model
represent non-core rare species in the human microbiome. To this end, we investigated
the non-core ‘rare’ASVs present in INF2 donor inocula. We identified 20 such ASVs in
the donor inocula which accounted for 2.2% of INF2 inocula reads. These 20 non-core
ASVs accounted for 17.9%, 15.1%, and 7.0% of reads in the early-inoculation piglets,
late-inoculation piglets, and mice, respectively. The taxonomy of these non-core ASVs
from INF2 are presented in Table 3A.1 in Appendix I. A single Bifidobacterium bifidum
ASV was among these non-core ASVs. However, a majority belonged to the Firmicutes
phylum. Thus only 54.4% and 43.5% of reads in the early- and late-inoculation piglets,
could be traced back to ASVs originating from the donor. In the HMA mice, 87.9% of
reads were traced backed to donor ASVs. A similar analysis was performed for INF1
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donor which displayed early-inoculation piglets to share 36.6% of the reads with INF1
core ASVs, while only 18.9% of the reads overlapped with late-inoculation piglets. A
further 14 ASVs were identified as ‘non-core’ ‘rare’ ASVs (accounting for 17.3% of
donor reads) in the INF1 donor inocula. The taxonomy of these non-core ASVs from
INF1 are presented in Table A1.2 in Appendix I. Members of the phyla Bacteroidetes,
Proteobacteria, and Firmicutes were represented with a majority belonging to the
Firmicutes phylum. These non-core ASVs accounted for 7.1% and 5.4% of the reads in
the early and late inoculation piglets, respectively. Therefore, only 43.7% and 24.3% of
the reads from the early- and late-inoculation piglets originated from INF1 inocula.
The small proportion of reads attributed to the donor inocula for the piglet
samples indicated that a substantial number of reads were originating from taxa that were
not detected in the donor inocula (which we would refer to as ‘donor-undetected ASVs’).
The donor-undetected ASVs identified (along with their abundances) in the fecal samples
of the early- and late-inoculation piglets transplanted with INF1 donor microbiota are
provided in Appendix I Tables A1.3 and A1.4. Similarly, the donor-undetected ASVs
colonizing the piglets and mice inoculated with the INF2 donor are shown in Tables
3.A5-3.A7. Interestingly, ASV_3273, which was classified as an Akkermansia spp., was
identified as a dominant donor-undetected ASV in all groups of piglets (regardless of
whether they were inoculated with INF1 or INF2).

Functional comparison of INF1 inocula with the transplanted microbiotas of the
HMA piglets
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To identify the functional potential of the transplanted microbiomes in the early
(milk-based diet) and late inoculation (solid diet) piglets and compare their functional
potential to the INF1 donor inocula, we performed shotgun metagenome sequence
analysis of the fecal samples from donors and HMA piglets from 5 selected time points
(see Materials and methods section for details). The quality assessment results based on
‘Quast’ analysis for each metagenome assembly is presented in Table 3.3. Additionally,
we mapped reads from each sample back to the corresponding host assembly as a means
of evaluating the quality of each assembly. The results demonstrated that 79%-83% of
reads from the INF1 donor samples mapped back to the INF1 donor assembly. For the
early inoculation piglet samples, 67-82% reads mapped back to the early inoculation
piglet assembly, while 75-80% of reads mapped back to the late inoculation piglet
assembly.
The prevalence of KEGG-annotated KOs in the donor inocula and in the earlyand late-inoculation piglets revealed distinct functional potentials between donors and
HMA piglets (Fig. 3.7; PERMANOVA, p = 0.001). Interestingly, for both the early- and
late-inoculation groups, the samples based on annotated KOs were closer to the donor in
time points collected closer to inoculation time compared to later time points (Fig. 3.8).
Of the 4921 KOs identified in the INF1 donor, 4770 (96.9%) and 4825 (98%) KOs were
represented in the early- and late-inoculation piglets, respectively. Only 68 (1.4%) of
INF1 donor KOs were not represented in either group of piglets.

Functional comparison of transplanted microbiotas in HMA piglets and mice with
donor INF2
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We compared the functional potential of the transplanted microbiomes in HMA
piglets and mice to the donor INF2 microbiome to evaluate functional redundancy and
functional differences between the animal models and the donor microbiome. Thus, we
performed shotgun metagenome sequencing of the INF2 donor inocula as well as fecal
samples collected from the HMA piglets and mice. Assembly quality information is
presented in Table 3.3. Regarding reads mapping back to assemblies, 75-81%, 64-83%,
77-82%, and 77-84% of reads from the INF2 donor, early inoculation piglet, late
inoculation piglet, and mouse samples mapped back to their respective metagenome
assemblies.
Beta diversity results using binary Jaccard distances (Fig. 3.9 (a)) suggested that
(similar to our observations with donor INF1), the human donors and the animal models
had microbiomes with distinct functional profiles. This observation was confirmed by
PERMANOVA analysis which indicated that samples from the animal models were
significantly different (p < 0.05) from the donor inocula. However, as shown in Fig 3.9
(b), the Jaccard distances for the early-inoculation piglets and the mice were closer to the
donor inocula compared to the late-inoculation piglets. Furthermore, in contrast to our
previous observation in HMA piglets inoculated with INF1, we did not observe the early
time points clustering closer to the donor inocula (Fig. 3.10). The fecal samples of the
mice showed much less variation between samples than did the fecal samples from the
early- and late-inoculation piglets (Fig. 3.10).

Representation of INF2 KOs in the animal models
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We investigated the overlap of KOs between INF2 donor inocula and each of the
HMA animal models (Fig. 3.11). A total of 5064 (54.1%) of the KOs were common to
the donor and both HMA animal models. For the HMA piglets, a higher number of donor
KOs were represented in the early-inoculation piglets compared to the late-inoculation
piglets (5668 (81.7%) and 5536 (79.8%) KOs, respectively). The number of donor KOs
represented in the HMA mice was 5259 (75.8%). Our analysis also identified 1023
(14.8%) of the KOs present in INF2 to be absent in both HMA animal models. The KOs
identified represented a broad range of metabolic pathways and were common to many
metabolic processes. However, we identified many KOs associated with the
biodegradation and metabolism of xenobiotic compounds in INF2 which failed to
establish in the HMA animal models (Fig. 3.12, Table 3.4). Furthermore, many of these
KOs associated with metabolism of xenobiotic compounds were associated with the
degradation of aromatic compounds such as Benzoate (Table 3.5). Interestingly, as shown
in Table 3.6, the representation of KOs related to xenobiotic degradation was much lower
in both animal models compared to the INF2 donor.

Comparing metagenomic data from human infants to HMA animal models
Due to the wide inter-individual variation in the infant gut microbiome and to
ensure that the data generated from the donor infant microbiomes used in this study are
representative of published infant microbiome data, we compared and expanded our
metagenome dataset with published infant metagenomes. To this end we acquired and
analyzed metagenomic sequence data from 32 infants from a study which investigated the
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microbiomes of infants across the United States [22] (see Materials and methods for
further details). This dataset will be referred to as the ‘Casaburi et al. study’ from hereon.
The infants sampled in the Casaburi et al. study were either fed breast milk, infant
formula, or a mixed diet (breast milk and infant formula). As diet is a major contributor
of microbiome composition and function, we first investigated if the microbiome function
would be influenced by feeding breast milk, formula, or a mixture. Beta diversity analysis
using Bray-Curtis distances of KOs identified and PERMANOVA analysis revealed type
of diet to show a tendency toward statistical significance (p=0.061). Therefore, we split
the infant data of the Casaburi et al. study by diet consumed into 3 groups – breast milkfed, formula-fed, and mixed diet - for subsequent analysis. We defined ‘core KOs’ within
each group by using cutoff thresholds specifying that a KO needed to be present in a
majority of infant samples (5/7, 7/9, and 13/16 samples for breast milk-fed, formula-fed,
and mixed diet infants, respectively) to be considered as part of the “core”. Using these
criteria, we identified 5171, 5484, and 5185 “core KOs” for the breast milk-fed, formulafed, and mixed diet groups, respectively.
Beta diversity comparisons between each of the Casaburi et al. study groups and
INF1, INF2 donors as well as the HMA animal models were performed, and the results
are presented in Figs. 3.13-3.15. We observed that for all 3 diet groups, the Casaburi et al.
study donor samples clustered closer to the INF1 donor inocula than they did to the INF2
donor inocula. The HMA animal model samples clustered with the inocula samples of
their respective donors.
Finally, we identified the “core KOs” detected in all Casaburi et al. study donors
as well as our INF1 and INF2 donors and compared with the HMA animal models. We
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identified 2970 such KOs which we refer to as the ‘stable core infant KOs’ since they are
found in all the infant samples in our dataset. As a percentage of total reads assigned to
all KOs within each of the infant categories (i. e., INF1, INF2, breast milk-fed infants,
formula-fed infants, and mixed diet infants), these 2970 KOs accounted for > 86% of
reads in all groups. Fig.3.16 shows a beta diversity plot representing the stable core KOs
in the HMA animal models. Comparison with our HMA animal models revealed a vast
majority of these stable core KOs to be present in all animal models (2969, 2970, 2969,
2968, and 2966 for INF1 early-inoculation piglets, INF1 late-inoculation piglets, INF2
early-inoculation piglets, INF2 late-inoculation piglets, and HMA mice, respectively).

Discussion
The recognition of the importance of the early life microbiota in human health is a
great motivator to study the human infant microbiome. To gain insights which can be
translated into clinical practice, it is important to study the infant microbiome at both the
taxonomic and functional levels. Due to the technical challenges as well as the sensitive
nature associated with directly studying the microbiome in human infants, GF animal
models which are transplanted with a human infant microbiota have the potential to
become valuable assets at the disposal of the microbiome research community.
In this study, we focused on evaluating the HMA piglet model in relation to its
ability to be colonized by human infant microbiomes. Our analysis was performed both at
the taxonomic level (16S rRNA gene sequencing) as well as the functional level
(metagenomic sequencing). We also looked into the influence of having milk as part of
the diet on the establishment of the infant microbiota in the GF piglets. We observed that
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a majority of the core taxa found in both INF1 and INF2 were able to colonize both
groups of piglets (early- and late-inoculation groups). Importantly from the perspective of
an infant microbiota, all the core Bifidobacterium ASVs identified in INF1 and the single
core Bifidobacterium ASV identified in INF2 colonized in the piglets, albeit at lower
relative abundances compared to the donor (Tables 3.1 and 3.2). Interestingly, all these
Bifidobacterium ASVs were at a higher relative abundance in the early-inoculation
piglets compared to the late-inoculation piglets, suggesting that milk may be needed for
increased colonization of the Bifidobacterium spp. While a majority of the core taxa
found in both INF1 and INF2 were able to colonize the early- and late-inoculation piglets
(Tables 3.1-3.2), they contributed only a minor percentage of reads (~19%-37%)
originating from the piglet fecal samples. In contrast, >80% of reads in mice inoculated
with INF2 originated from the core ASVs, indicating that the mice harbored a
transplanted microbiota which was more representative of the INF2 donor than both the
early- and late-inoculation piglets.
As shown in Tables A1.3-A1.7 in Appendix I, a substantial proportion of reads in
the piglet fecal samples originated from taxa that were not detected in the donor inocula
(‘donor-undetected ASVs’). Additionally, we observed an increase in the percentage of
reads contributed by donor-undetected ASVs with time (Tables A1.8(a) and A1.8(b) of
Appendix I). This trend was also observed for the mouse fecal samples (although to a
lesser extent than the piglet samples), suggesting that with time the established
microbiota can be influenced by host factors. This explains our observation of the fecal
samples collected from earlier time points from our animal models clustering closer to
the infant donor inocula compared to the fecal samples from later time points in the

114
PCoA plots (Figs 3.3 and 3.5). The possibility exists that the isolators were contaminated
with environmental bacteria (which may not have grown on the BHI agar plates we used
for sterility tests) and that these organisms had subsequently colonized the GF piglets.
However, the fact that the most abundant of these donor-undetected ASVs were
Akkermansia spp., Bifidobacterium spp., and Alistipes spp., which are all well-known
human gut-dwelling bacteria, including the infant gut [35], supports the hypothesis that
these microbes are rare or low abundant populations in the donor that expanded when
transplanted into the piglet model. Interestingly, a previous study involving HMA piglets
inoculated with the fecal microbiota of either Amish infants or non-Amish infants
reported an expansion of the phylum Verrucomicrobia – the phylum to which
Akkermansia belongs to – in the fecal microbiota of the piglets compared to the donors
[36]. A genome-wide association study (GWAS) also found a significant association
between the relative abundance of Akkermansia spp. with polymorphisms in 5
chromosomal regions of the porcine genome [37]. Therefore, it is possible that
Akkermansia spp. might actually have been positively selected for once engrafted into the
piglets. In addition, ASV_3273 (Akkermansia spp.) was also detected in the mice,
although at <1.0% abundance. Since the mice and piglets were housed in two separate
facilities with very limited cross traffic, this makes it further unlikely that this organism
was a contaminant. Thus, it is likely that these taxa were rare members of the donor
microbiota that were present at levels below the detection limit of sequencing in the
donor inocula, which upon colonizing the piglets, encountered more favorable conditions
and increased in abundance. To further investigate this possibility, we mapped short reads
from the INF1 and INF2 donors to reference genomes (downloaded from
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https://www.ncbi.nlm.nih.gov/datasets/genomes/) of some of the donor-undetected ASVs
using Bowtie2 and evaluated the resulting alignments using SAMtools ‘coverage’
command. The results presented in Table 3.9 show more than 1X coverage for a majority
of these reference genomes in the donor samples. Especially interesting is the high
coverage and breadth of coverage observed for B. intestinalis and P. distasonis. These
results demonstrate that the taxa identified are present in the donor samples and were
preferentially colonized in the animal models. A more sensitive targeted detection
method, such as real-time PCR, may be able to detect these taxa in the donor inocula.
This hypothesis was also put forward in a previous study [38] where the authors observed
that 20% of the microbial community established in GF C57BL/6 mice, which had been
inoculated with fecal matter from an adult donor, originated from phylotypes that were
not detected in the donor inocula.
In contrast to the piglets, who on average had about 40-50% of reads originating
from donor-undetected ASVs, the mice had only about 13% of reads originating from
such ASVs. This observation cannot be explained by dietary differences, since both the
late-inoculation piglets and the mice received the same solid diet following inoculation. It
can be speculated that the conditions of the porcine gastrointestinal tract may have been
more conducive for the outgrowth of a wider variety of infant donor bacteria compared to
the murine gastrointestinal tract. The larger volume of the porcine GI tract compared to
the murine GI tract might have in turn provided a greater number of open niches for the
donor microbiota to colonize and expand. Although we consistently observed the
expansion of donor-undetected ASVs for piglets inoculated with both donors, considering
the great diversity, stochasticity, and dynamic nature of the infant microbiome [39], it
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would be interesting to see if this observation can be replicated with GF piglets
transplanted with other infant microbiotas as well.
Our metagenome analyses at the level of KOs revealed that, while most of the
donor KOs were found in both animal models (Fig. 3.11), the overall functional
potentials were considerably different between the donor samples and the samples from
each of the animal models based on PCoA and PERMANOVA results (Fig. 3.10). At the
level of KEGG metabolic pathways, we did not observe notable differences between
INF2 donor and the animal models, with the exception of KOs involved in the
biodegradation of xenobiotic compounds (Fig. 3.12, Table 3.5). Rarefaction curves
(Appendix I Fig.A1.1-A1.4) indicated that the sequencing depths were adequate to
identify functional genes within each animal model. Thus, the KOs which were detected
in the donor inocula but not detected in the animal models might suggest that these KOs
may have originated from ASVs that failed to colonize the animal models. On the other
hand, for the piglets inoculated with INF1 and the piglets inoculated with INF2, we
observed a higher number of KOs than those detected in the donor inocula. These KOs
may have been contributed by the donor-undetected taxa which had expanded in these
animals.
The inclusion of the infant metagenome data from the study by Casaburi et al.
enabled us to compare the functional potential of INF1 and INF2 donors from our study
with the functional potentials of a wide range of infant microbiomes. Overall, it appeared
that INF1 was functionally more similar to the infants from the Casaburi et al. study
compared to INF2 (Figs 3.13-3.15). The higher representation of KOs relating to
xenobiotic biodegradation in INF2 appeared to differentiate this donor from INF1 as well

117
as the infants from the Casaburi et al. study (Table 3.7). Upon accessing the dietary
record for INF2, we observed that this infant had been provided oatmeal 24 hrs prior to
the collection of one of the fecal samples. As far as we are aware, the other infants were
on a completely milk-based diet. Thus, the presence of the oatmeal in the diet of INF2
might have contributed to a change in the structural and functional characteristics of the
INF2 microbiota, thus differentiating it from the other infant donors. The 2970 ‘stable
core KOs’ we identified across all the infants in our data analysis, we reasoned, would be
representative of the functional microbiome of 3 to 6-month-old infants on a primarily
milk-based diet. We observed that almost all of these KOs were represented in the piglets
(both early- and late-inoculation) as well as the mice.
An important caveat in our analysis of the metagenome data is the fact that we
only considered ORFs which had been assigned a KO number based on the KEGG
databases. Only about 60% of ORFs from each of the donors/animal models were
assigned a KO number in this manner. Thus, our analysis does not cover the full
spectrum of the functional potential of either the donor or animal metagenomes. A future
analysis using a different strategy that does not depend solely on KEGG database
annotations might be expected to yield interesting results.
Contrary to our expectations, keeping the piglets on a milk-based diet did not
appear to provide an advantage in establishing a microbiota more similar to the infant
donor at both the taxonomic and functional levels. However, we did observe that
members of the genus Bifidobacterium, which are considered important members of the
infant gut microbiome [40], were more abundant in the early-inoculation piglets
compared to the late-inoculation piglets (Tables 3.1 and 3.2). In addition, there was less
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variation in the presence of stable core KOs in the fecal samples from the earlyinoculation piglets compared to the late-inoculation piglets as well as the mice (Fig.
3.16). Our infant donors were on a diet consisting of mostly breast milk supplemented
with infant formula, while the early inoculation piglets were fed only infant formula.
Human breast milk has a different nutrient profile than formula milk, especially the
presence of a high concentration of human milk oligosaccharides (HMOs), that can shape
the infant gut microbial community [41]. The lack of breast milk in the diet provided to
the piglets may have contributed to the structure of the transplanted microbiota in the
early-inoculation piglets not resembling that of the donor more closely. Additionally, the
piglets in both treatment groups did not receive colostrum while the donors and mice
received colostrum, which may also affect microbiome establishment as colostrum is
known to provide important immunoglobins to the neonate. An interesting experiment
would be to transplant the microbiota of a breast milk-fed infant to GF piglets and
provide those piglets with colostrum and breast milk (ideally from the same mother) as
their diet. It is also likely that the ecological drivers inside the porcine gastrointestinal
tract which caused the diversification of the infant microbiota had a stronger effect on
structuring the transplanted microbiota than the dietary substrates.
In conclusion, the results of our study indicate that while a majority of infant
donor taxa and KO functional groups can be represented in GF piglets transplanted with
an infant microbiota (regardless of whether milk was part of the diet), there is a shift in
bacterial composition favoring taxa that likely had very low abundances in the donor.
This may in turn contribute to a different functional profile compared to that of the donor
microbiome. Our results also suggest that C3H/HeN GF mice transplanted with an infant

119
microbiota would harbor a microbial community that is taxonomically more
representative of the donor, although functionally distinct. Thus, further research needs to
be carried out to develop strategies to improve these animal models as surrogates for
studying the human infant gut microbiome.

(b)

1 based on Bray-Curtis distances (a) samples colored by diet (b) samples colored by time point.

Fig. 3.1. Principal coordinate analysis plots showing clustering of INF1 donor inocula and HMA piglet fecal samples from trial

(a)
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Fig. 3.2. Box-whisker plots comparing alpha diversity between the INF1 donor inocula
and the HMA piglet fecal samples from trial 1 based on the Shannon index. Boxes with
different letters indicate statistically significant differences (p < 0.05). The box represents
the 25th and 75th percentiles as the interquartile range (IQR) and the short black line
represents the median. The whiskers represent the minimum and maximum values.
Outliers are shown as black dots.

(b)

2 based on Bray-Curtis distances. (a) points colored by host species (b) points colored by time point.

Fig. 3.3. Principal coordinate analysis plots showing clustering of INF1 donor inocula and HMA piglet fecal samples from trial

(a)
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Fig. 3.4. Principal coordinate analysis plot showing clustering of INF2 donor inocula
along with HMA mouse and HMA piglet fecal samples from trial 2 based on Bray-Curtis
distances.

124

Fig. 3.5. Principal coordinate analysis plot showing clustering of INF2 donor inocula
along with HMA mouse and HMA piglet fecal samples from trial 2 based on Bray-Curtis
distances. Samples have been colored based on time point of sample collection.

(c)

(c)

(b)

Statistical comparisons were performed using the Wilcoxon rank-sum test. Outliers shown as black dots.

inoculation piglets (c) HMA mice. Boxes with different letters indicate statistically significant differences (p < 0.05).

Fig. 3.6. Comparison of Bray-Curtis distances to INF2 donor inocula based on time point. (a) early inoculation piglets (b) late

(a)
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Fig. 3.7. Principal coordinate analysis plot showing clustering of INF1 donor inocula
along with early and late inoculation HMA piglet fecal samples from trial 2 based on
Binary-Jaccard distances. Analysis performed on the presence of open reading frames
(ORFs) with assigned KO numbers in each sample.
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Fig. 3.8. Same PCoA plot as in Fig. 3.7 colored by sampling time point to depict the
clustering trajectory of samples with time.

(b)

a

b

inocula and fecal samples from the animal models.

frames (ORFs) with assigned KO numbers in each sample. (b) Box-whisker plots comparing Jaccard distances between donor

piglet fecal samples from trial 2 based on Binary-Jaccard distances. Analysis performed on the presence of open reading

Fig. 3.9. (a) Principal coordinate analysis plot showing clustering of INF2 donor inocula along with HMA mouse and HMA

(a)

a
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Fig. 3.10. Same PCoA plot as in Fig. 3.9(a) colored by sampling time point.
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Fig. 3.11. Venn diagram summarizing the representation of KOs identified in the INF2
donor inocula in the HMA animal models.
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Fig. 3.12. Pie chart representing (as percentages) the major KEGG metabolic pathways to
which the INF2 donor KOs which had failed to establish in the animal models belonged
to.
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Fig. 3.13. Principal coordinate analysis plot showing clustering of breast milk-fed infant
samples from Casaburi et al. study in relation to INF1 and INF2 donor inocula as well as
the samples from the HMA mice and HMA piglets based on Binary-Jaccard distances.
For the breast milk-fed infants, only the core KOs have been considered.

133

Fig. 3.14. Principal coordinate analysis plot showing clustering of formula-fed infant
samples from Casaburi et al. study in relation to INF1 and INF2 donor inocula as well as
the samples from the HMA mice and HMA piglets based on Binary-Jaccard distances.
For the formula-fed infants, only the core KOs have been considered.
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Fig. 3.15. Principal coordinate analysis plot showing clustering of mixed diet infant
samples (fed both breast milk and infant formula) from Casaburi et al. study in relation to
INF1 and INF2 donor inocula as well as the samples from the HMA mice and HMA
piglets based on Binary-Jaccard distances. For the mixed diet infants, only the core KOs
have been considered.
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Fig. 3.16. Principal coordinate analysis plot showing clustering of all infant samples
along with all HMA mouse and HMA piglet fecal samples from both trials 1 and 2 based
on Binary-Jaccard distances. Analysis was performed only considering the
presence/absence of the 2970 ‘stable core infant KOs’ in these samples.

Mean
abund.(%)

23.32
17.09
12.59
8.89
7.03
3.91
2.35
1.87
1.31
1.18
1.0
0.83
0.45

ASV_ID

ASV_1354

ASV_196

ASV_1761

ASV_198

ASV_3661

ASV_1349

ASV_3609

ASV_189

ASV_1881

ASV_1158

ASV_1739

ASV_2508

ASV_1745

0.27

0.32

0.32

0.42

0.39

0.57

0.78

1.97

2.74

3.5

5.07

10.68

12.15

Std.
dev.
(%)

Donor INF1

groups of GF piglets.

2.17

4.05

11.17

8.04

2.92

Std. dev.
(%)

4.07

1.79

6.07

1.15

5.11

Mean
abund.(%)

1.47

3.59

11.13

2.40

2.80

Std. dev.
(%)

Late inoculation piglets

0.01

0.35

3.04

0.5

2.13

0.5

0.07

0.97

3.38

1.6

1.62

1.05

0.55

0.44

0.13

0.51

0.27

undetected Undetected

0.23

0.18

0.18

0.70

0.26

Undetected undetected undetected Undetected

Undetected undetected undetected Undetected

3.64

3.04

13.05

5.18

3.68

Mean
abund.(%)

Early inoculation piglets

Enterobacteriaceae

Enterococcus spp.

Klebsiella spp.

Alistipes putredinis

Erysipelotrichaceae

Bifidobacterium bifidum

Veillonella spp.

Phascolarctobacterium
faecium
Bacteroides plebeius

Bifidobacterium spp.

Escherichia-Shigella

Bifidobacterium spp.

Bacteroides uniformis

Taxonomy

Table 3.1. Taxonomic and relative abundance information for the INF1 donor core ASVs and their establishment in the two
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0.37
0.33
0.15
0.13
0.06

ASV_2565

ASV_295

ASV_3708

ASV_454

ASV_1013

0.04

0.11

0.04

0.11

0.12

undetected

undetected

undetected

0.12

<0.01

0.09

0.18
0.10

0.16

undetected Undetected

undetected undetected Undetected

undetected undetected Undetected

undetected

0.12

0.01

Prevotellaceae

Haemophilus spp.

Clostridium sensu stricto 1

Eggerthella lenta

Streptococcus spp.
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8.39
6.14
4.30
4.18
3.78
1.91
1.56
1.26

0.85
0.74
0.61

ASV_1739

ASV_1356

ASV_2271

ASV_2266

ASV_1741

ASV_2205

ASV_1419

ASV_2561

ASV_2565

ASV_300

ASV_2206

ASV_1421

ASV_189

ASV_2270

ASV_3364

ASV_ID

0.11

0.26

0.18

0.30

0.19

0.10

0.59

0.58

0.79

0.64

0.98

0.26

0.48

0.03

Undet.

0.84

0.68

0.52

0.53

0.57

12.85

5.88

0.27

0.53

0.06

Undet.

0.57

0.50

0.63

0.70

0.80

6.08

6.55

0.53

0.06

Undet.

Undet.

0.47

1.16

1.39

0.55

0.61

6.23

5.65

0.56

0.06

Undet.

Undet.

0.62

0.90

1.98

1.1

1.23

4.95

4.60

1.98

0.49

Undet.

Undet.

2.58

3.54

0.33

0.26

0.28

16.14

1.691

1.04

0.29

Undet.

Undet.

1.76

1.78

0.49

1.07

1.15

8.82

3.66

Lachnoclostridium
spp.

Eggerthella lenta

Streptococcus spp.

Streptococcus spp.

Lachnoclostridium
spp.
Bacteroides vulgatus

[Ruminococcus]
gnavus group
[Ruminococcus]
gnavus group
Citrobacter spp.

Bacteroides uniformis

Klebsiella spp.

Early inoculation
Late inoculation
Mice
piglets
piglets
Taxonomy
Mean
Std.
Mean
Std.
Mean
Std.
Mean
Std.
abund.(%) dev.(%) abund.(%) dev.(%) abund.(%) dev.(%) abund.(%) dev.(%)
29.56
4.48
0.87
1.29
1.61
2.38
14.24
0.46
Erysipelatoclostridium
ramosum
12.13
1.68
2.01
2.32
1.98
3.34
15.65
7.58
[Ruminococcus]
gnavus group
10.49
8.68
2.52
1.93
0.85
1.16
0.80
0.73
Bifidobacterium
bifidum
9.29
0.93
5.08
3.07
3.18
3.62
15.98
10.59
Bacteroides vulgatus

Donor INF2

groups of GF piglets and GF mice.

Table 3.2. Taxonomic and relative abundance information for the INF2 donor core ASVs and their establishment in the two
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0.48
0.46
0.38
0.33
0.23
0.23
0.14
0.13
0.08
0.07

ASV_2269

ASV_2208

ASV_2207

ASV_3087

ASV_2268

ASV_2566

ASV_240

ASV_3760

ASV_1822

ASV_3604

0.02

0.04

0.06

0.04

0.05

0.04

0.01

0.12

0.16

0.08

1.52

0.10

<0.01

Undet.

Undet.

Undet.

1.67

0.18

0.20

Undet.

1.47

0.11

0.01

Undet.

Undet.

Undet.

0.83

0.23

0.25

Undet.

1.69

0.16

0.22

Undet.

Undet.

Undet.

1.55

0.39

0.40

Undet.

1.28

0.12

0.52

Undet.

Undet.

Undet.

0.95

0.44

0.47

Undet.

0.22

0.24

1.19

Undet.

Undet.

0.23

Undet.

1.53

1.61

0.34

0.32

0.10

1.96

Undet.

Undet.

0.23

Undet.

0.79

0.86

0.28

Veillonella spp.

Clostridium
butyricum
Ruminococcaceae

Actinomyces spp.

[Ruminococcus]
gnavus group
Lachnoclostridium
spp.
Lachnoclostridium
spp.
Flavonifractor
plautii
[Ruminococcus]
gnavus group
Streptococcus spp.
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7588
4511
2181
1079
675983

5254
1625
944
434
195
631656
35021

N50 (bp)

35151

30966

10330

INFI
donor

Total number of contigs
Number of contigs (>=
1000 bp)
Number of contigs (>=
5000 bp)
Number of contigs (>=
10000 bp)
Number of contigs (>=
25000 bp)
Number of contigs (>=
50000 bp)
Length of largest contig
(bp)

Parameter

Early
inoculatio
n
pigletsINF1
60931

performed using ‘Quast’.

32678

789321

1228

2504

5552

9960

39806

Late
inoculatio
n
pigletsINF1
69058

9897

694304

339

705

1894

4173

22591

54925

INF2
donor

45635

862046

792

1400

2840

4928

17890

Early
inoculatio
n
pigletsINF2
35616

22035

731712

935

1824

4031

6928

32877

Late
inoculatio
n
pigletsINF2
105904

70668

749460

515

843

1441

2312

10217

28908

Mice-INF2

Table 3.3. Quality information for metagenome assemblies produced using ‘MEGAHIT’. Quality assessments were
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Early piglets
83 (16.9%)
65 (13.2%)
38 (7.7%)
13 (2.6%)
55 (11.2%)
13 (2.6%)
15 (3%)
43 (8.8%)
24 (4.9%)
19 (3.9%)
123 (25.0%)

HMA mice
125 (19.0%)
76 (11.6%)
60 (9.1%)
18 (2.7%)
93 (14.1%)
15 (2.3%)
31 (4.7%)
56 (8.5%)
29 (4.4%)
24 (3.7%)
130 (19.8%)

Carbohydrate metabolism

Energy metabolism

Lipid metabolism

Nucleotide metabolism

Amino acid metabolism

Metabolism of other amino acids

Glycan biosynthesis and metabolism

Metabolism of cofactors and
vitamins
Metabolism of terpenoids and
polyketides
Biosynthesis of other secondary
metabolites
Xenobiotics biodegradation and
metabolism

Metabolic pathway

Animal model

130 (23.9%)

24 (4.4%)

21 (3.9%)

46 (8.4%)

20 (3.7%)

13 (2.4%)

75 (13.8%)

12 (2.2%)

36 (6.6%)

72 (13.2%)

96 (17.6%)

Late piglets

Table 3.4. INF2 KOs not represented in each animal model assigned to different metabolic pathways by KEGG Mapper.
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Table 3.5. The number of donor KOs not establishing in the animal models involved in
the degradation of various xenobiotic compounds

Xenobiotic compound degraded

Number of KOs

Benzoate degradation

29

Aminobenzoate degradation

17

Fluorobenzoate degradation

1

Chloroalkane and chloroalkene degradation

4

Chlorocyclohexane and chlorobenzene degradation

12

Toluene degradation

7

Xylene degradation

5

Nitrotoluene degradation

1

Ethylbenzene degradation

1

Styrene degradation

3

Atrazine degradation

2

Caprolactam degradation

1

Bisphenol degradation

2

Dioxin degradation

3

Naphthalene degradation

4

Polycyclic aromatic hydrocarbon degradation

7

Furfural degradation

6
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Steroid degradation

6
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Table 3.6. Number of KOs from each host assigned to different metabolic pathways by
KEGG Mapper. The percentages within parentheses reflect the proportion of KOs
assigned to a given pathway based on the total number of KOs assigned to all pathways
for a given host.

Number of KOs
Metabolic pathway

INF2 donor

Earlyinoculation
piglets

Lateinoculation
piglets

HMA
Mice

Carbohydrate metabolism

904 (26.7%)

838 (28.4%)

849 (28.9%)

Energy metabolism

373(11.0%)

322 (10.9%)

313 (10.6%)

Lipid metabolism

193 (5.6%)

144 (4.9%)

153 (5.2%)

Nucleotide metabolism

190 (5.6%)

177 (6.0%)

175 (6.0%)

765
(28.6%)
291
(10.9%)
124
(4.6%)
160 (6.0%)

Amino acid metabolism

554 (16.3%)

524 (17.8%)

498 (16.9%)

Metabolism of other amino
acids
Glycan biosynthesis and
metabolism
Metabolism of cofactors and
vitamins
Metabolism of terpenoids and
polyketides
Biosynthesis of other
secondary metabolites
Xenobiotics biodegradation
and metabolism

144 (4.3%)

135 (4.6%)

130 (4.4%)

190 (5.6%)

178 (6.0%)

196 (6.7%)

329 (9.7%)

291 (9.9%)

285 (9.7%)

96 (2.8%)

78 (2.6%)

78 (2.7%)

269
(10.1%)
67 (2.5%)

109 (3.2%)

94 (3.2%)

90 (3.1%)

78 (2.92%)

305 (9.0%)

169 (5.7%)

172 (5.7%)

159 (5.9%)

472
(17.7%)
127
(4.75%)
159 (6.0%)

144 (4.3%)
190 (5.6%)
329 (9.7%)
96 (2.8%)
109 (3.2%)
305 (9.0%)

273 (10.8%)
123 (4.9%)
159 (6.3%)
429 (17%)
107 (4.2%)
154 (6.1%)
262 (10.4%)
67 (2.7%)
73 (2.90%)
150 (5.9%)

Energy metabolism

Lipid metabolism

Nucleotide metabolism

Amino acid metabolism

Metabolism of other amino
acids
Glycan biosynthesis and
metabolism
Metabolism of cofactors
and vitamins
Metabolism of terpenoids
and polyketides
Biosynthesis of other
secondary metabolites
Xenobiotics
biodegradation and
metabolism

554 (16.3%)

190 (5.6%)

193 (5.6%)

373(11.0%)

904 (26.7%)

728 (28.8%)

Carbohydrate metabolism

INF2 donor

INF1 donor

Metabolic pathway

KOs have been considered for Casaburi et al. study infants.

153 (5.7%)

79 (3.0%)

61 (2.3%)

267 (10.0%)

153 (5.7%)

114 (4.3%)

461 (17.3%)

169 (6.3%)

149 (5.6%)

279 (10.5%)

Casaburi et al.
study
breast milk-fed
infants
777 (29.2%)

158 (5.7%)

63 (2.3%)

66 (2.4%)

273 (9.8%)

164 (5.9%)

130 (4.7%)

481 (17.3%)

171 (6.2%)

158 (5.7%)

307 (11.0%)

Casaburi et al.
study
formula-fed
infants
807 (29%)

157 (5.8%)

80 (3.0%)

63 (2.3%)

268 (9.9%)

142 (5.3%)

124 (4.6%)

474 (17.6%)

172 (6.4%)

133 (4.9%)

297 (11.0%)

Casaburi et al.
study
Mixed diet-fed
infants
789 (29.2%)

Table 3.7. Number of KOs from each infant group assigned to different metabolic pathways by KEGG Mapper. Only core
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Table 3.8. Composition of Teklad 2919 (irradiated) rodent diet

Component

amount

Macronutrients

Crude Potein
Fat (acid hydrolysis)
available Carbohydrate
Crude Fiber
Neutral Detergent Fiber
Ash
Energy Density
Calories from Protein
Calories from Fat
Calories from Carbohydrate

19%
9%
44.90%
2.60%
12.10%
5%
3.3 kcal/g
23%
22%
55%

Vitamins

Vitamin A
Vitamin D3
Vitamin E
Vitamin K3 (menadione)
Vitamin B1 (thiamin)
Vitamin B2 (riboflavin)
Niacin (nicotinic acid)
Vitamin B6 (pyridoxine)
Pantothenic Acid
Vitamin B12 (cyanocobalamin)
Biotin
Folate
Choline

15.0 IU/g
1.5 IU/g
110 IU/g
50 mg/kg
17 mg/kg
15 mg/kg
75 mg/kg
18 mg/kg
33 mg/kg
0.08 mg/kg
0.40 mg/kg
4 mg/kg
1200 mg/kg

Minerals

Calcium
Phosphorus
Non-phytate Phosphorus
Sodium
Potassium
Chloride
Magnesium
Zinc
Manganese

0.90%
0.70%
0.40%
0.10%
0.40%
0.40%
0.20%
60 mg/kg
80 mg/kg
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Fatty Acids

Amino Acids

Copper
Iodine
Iron
Selenium

15 mg/kg
6 mg/kg
200 mg/kg
0.23 mg/kg

C 16:0 Palmitic

0.90%

C 18:0 Stearic

0.20%

C 18:1 ω9 Oleic

1.70%

C 18:2 ω6 Linoleic

3.90%

C 18:3 ω3 Linolenic
Total Saturated
Total Monounsaturated
Total Polyunsaturated

0.40%
1.20%
1.70%
4.40%

Aspartic Acid
Glutamic Acid
Alanine
Glycine
Threonine
Proline
Serine
Leucine
Isoleucine
Valine
Phenylalanine
Tyrosine
Methionine
Cystine
Lysine
Histidine
Arginine
Tryptophan

1.10%
3.50%
1.20%
0.70%
0.60%
1.80%
0.90%
2.30%
0.80%
0.90%
1.10%
0.50%
0.50%
0.30%
0.90%
0.40%
0.80%
0.20%

1

LIB4_02

LIB4_01

LIB1_01

LIB1_06

Sample_id
LIB1_03

Organism
Akkermansia muciniphila
Akkermansia glyciniphila
Turicibacter sanguinis
Parabacteroides distasonis
Roseburia intestinalis
Akkermansia muciniphila
Akkermansia glyciniphila
Turicibacter sanguinis
Parabacteroides distasonis
Roseburia intestinalis
Akkermansia muciniphila
Akkermansia glyciniphila
Bacteroides intestinalis
Collinsella aerofaciens
Clostridioides difficile
Akkermansia muciniphila
Akkermansia glyciniphila
Bacteroides intestinalis
Collinsella aerofaciens
Clostridioides difficile
Akkermansia muciniphila

Coverage
2.43
0.21
0.92
9.83
3.97
4.25
0.29
0.96
11.79
4.67
1.68
0.17
9.96
3.19
0.72
0.98
0.21
21.46
2.51
1.02
1.36

1

Breadth of coverage
1.27%
0.15%
0.61%
8.25%
2.54%
2.25%
0.18%
0.60%
9.33%
2.97%
1.04%
0.12%
7.40%
2.22%
0.28%
0.55%
0.16%
17.70%
1.99%
0.54%
0.65%

Refers to the percentage of reference genome bases covered by short reads at 1X sequencing depth.

INF2

Donor
INF1

Table 3.9. Coverage results for short read alignments to reference genomes of select non-donor ASVs.
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LIB4_04

LIB4_03

Akkermansia glyciniphila
Bacteroides intestinalis
Collinsella aerofaciens
Clostridioides difficile
Akkermansia muciniphila
Akkermansia glyciniphila
Bacteroides intestinalis
Collinsella aerofaciens
Clostridioides difficile
Akkermansia muciniphila
Akkermansia glyciniphila
Bacteroides intestinalis
Collinsella aerofaciens
Clostridioides difficile

0.18
36.64
2.81
1.53
0.97
0.17
34.51
2.54
1.12
2.42
0.23
30.5
3.07
1.89

0.14%
30.13%
2.10%
0.77%
0.50%
0.13%
29.75%
1.95%
0.58%
1.30%
0.17%
21.44%
2.30%
1.00%
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CHAPTER 4

HUMAN MICROBIOTA-ASSOCIATED (HMA) PIGLETS AS
MODELS TO STUDY HOST-MICROBIOTA INTERACTIONS IN
OBESITY

Abstract
The high prevalence of obesity in the United States has resulted in much research
being undertaken to gain a better understanding of its causes as well as the discovery of
potential intervention strategies. Several studies have implicated the gut microbiota as an
environmental factor that affects obesity. However, few studies have attempted to
understand the potential mechanisms through which the gut microbiome can influence an
obese phenotype. One of the reasons for the lack of such insight might be the difficulty in
performing the necessary mechanistic studies directly in humans. In this study, we
investigated the potential for using human microbiota-associated (HMA) piglets as an
animal model to study host-microbiota interactions in obesity. Germ-free piglets were
inoculated with fecal bacterial communities from obese and normal weight donors, and
subsequently fed a low-fat/low-sugar or high-fat/high-sugar diet. The microbiotas
establishing in these animals were subsequently monitored. Results indicated that a
majority of the bacteria found in donor feces were able to colonize the piglets. In
addition, the microbiotas establishing in the piglets inoculated with obese donors were
distinct from the microbiotas establishing in the piglets inoculated with the normal weight
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donors. We also introduce cecum-cannulated HMA piglets as a model to study
mechanistic aspects of host-microbiota interactions in obesity.

Key words: HMA pigs, obesity, microbiome

Introduction
The last few decades have seen a significant increase in the prevalence of obesity
throughout the world. According to the WHO, worldwide obesity nearly tripled since
1975 [1]. While obesity is mostly associated with high-income countries, overweight and
obesity are now on the rise in low- and middle-income countries as well, particularly in
urban settings [1]. The prevalence of obesity in the United States of America is among
the highest in the world. In 2017-2018, the age-adjusted prevalence of obesity among US
adults was 42.4% [2]. Of particular concern is the rise in childhood obesity, which places
children and adolescents at high risk for poor health. The negative health outcomes of
obesity combined with its important social and economic consequences has led to a lot of
effort being expended to try and reverse the obesity epidemic in the US.
Several factors play a role in the development of obesity. A number of
environmental factors have emerged over the past several decades that have favored a
positive energy balance and weight gain. These factors include increasing per capita food
supplies and consumption (especially of high-calorie foods) that are often served and
consumed in large portions, decreased time spent in occupational physical activities, and
replacement of leisure-time physical activities with sedentary activities such as watching
television, use of medications with weight gain as a side effect, and inadequate sleep [3].
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Other environmental factors influencing obesity include toxins, viruses, and smoking [4].
Several intrauterine factors have also shown to influence postnatal and lifetime weight
gain and fatness, including maternal diabetes, maternal smoking, and intrauterine under
nutrition [4]. A complex system of interactions between genes and environmental factors
regulate energy balance, linked physiological processes, and weight [3]. Short- and longterm energy balance is controlled through a coordinated network of central mechanisms
and peripheral signals which arise from cells within adipose tissue, stomach, pancreas,
and other organs as well as the microbiome [5].
The initial studies reporting the potential involvement of the gut microbiome in
obesity [6, 7, 8, 9] spurred the interest in host-microbiome interactions and their effects
on host health. While some of the early reported associations between the microbiome
and obesity, such as the Firmicutes/Bacteroidetes ratio as a biomarker for obesity, have
been difficult to replicate [10, 11, 12, 13], it still remains an important area of research to
improve human health.
Human microbiota-associated (HMA) animal models are a valuable research tool
to better understand the host-microbiome interactions which can potentially contribute to
obesity. Though under-utilized in the field of microbiome research as an HMA animal
model, the domestic pig (Sus scrofa domesticus) shares many anatomical, physiological,
and immunological similarities with humans [14] and has been used as a surrogate model
for humans in other research areas such as studying infectious diseases [15], nutritional
studies [16], and the study of cardiovascular diseases [17]. To explore the potential of
using the porcine model to study gut microbiota-host interactions in obesity, we set out to
establish an HMA piglet model by inoculating GF piglets with human donor microbiota
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from obese or normal weight phenotypes based on their Body Mass Index (BMI). In
order to go beyond taxonomic descriptions and attempt to identify possible mechanisms
through which the gut microbiome might influence obesity, we complemented 16S
rDNA-based community profiling with RNA-Seq experiments in an attempt to correlate
ASVs with differentially expressed genes from cecal epithelial tissues of the porcine
hosts. Finally, we also describe the development of a cecum-cannulated piglet model
which can be used for studying cecal microbiota-host interactions through the collection
of cecal content samples while the animals are still alive.

Methods
Animals and animal husbandry
Twenty-one germ free (GF) piglets were derived from two sows (Sus scrofa
domesticus) using hysterectomy via Cesarean section surgeries performed within the
confines of pre-sterilized, custom-built plastic surgery isolators attached to the skins of
these animals as described previously [18]. The newly-born piglets were transferred to
boxes (which can be sealed air-tight) while still inside the surgery bubble and transferred
into sterile isolators with positive pressure (Park Bioservices LLC, MA). Prior to
introduction of the GF piglets, the isolators were tested for sterility as described
previously [18]. Piglets were housed at a density of 3-4 piglets/isolator and each isolator
was divided into 3 sections using divider panels. Each section housed 1-2 piglets. The
diets of the piglets consisted of sterile infant formula (Similac Pro-Advance®, Abbott
Laboratories, IL) for the first 2 weeks. At the beginning of the 3rd week, the animals
received a ‘transition diet’ in which they were provided with milk and either a high-
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fat/high-sugar (HF) or low-fat/low-sugar (LF) porcine diet (Both of these diets had been
sterilized through gamma irradiation), before being weaned at 4 weeks of age after which
they only received the HF or LF solid diets (see Appendix II for diet compositions). A
schematic representing the study design is presented in Fig. 4.1.

Donors
The human donors for this study consisted of 3 obese donors (BMI >= 30) and 5
normal weight donors (BMI 18.5-24.9). Donors ‘Normal_2014’ and ‘Obese_2014’ each
provided a single fecal sample; the remaining donors provided fecal samples on a daily
basis for 5 days for a total of 5 fecal samples per donor. On each day that a donor
provided a fecal sample, they also answered a questionnaire where information was given
on the food they had eaten within the past 24 hours. In addition to the human donors, we
had also collected fecal samples from a sow donor to be used for inoculating the control
group of piglets. For the sow, the fecal sample was collected only at a single time point.

Inocula preparation and inoculation of piglets
At the time the piglets were first inoculated, we had received only the day 1 fecal
sample from each donor. Each fecal sample was mixed with 50 mL of sterile infant
formula as described previously [18] inside an anaerobic chamber. A second inoculation
was performed 2 weeks following the first inoculation when all fecal samples were
received from each individual donor (with the exception of donors ‘Normal_2014’ and
‘Obese_2014’ who provided only a single fecal sample each throughout the study). The
individual fecal samples obtained from each donor were used to prepare a composite
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inoculum that was then mixed with sterile infant formula as described previously [18].
The dendrogram depicted in Appendix III shows that the inocula used for the first and
second inoculations clustered together for each donor. The inocula were prepared in the
mornings of inoculation and transferred in 5 mL volumes into sterile 15 mL conical tubes
and kept on ice until used for inoculations. Each piglet was inoculated by syringe feeding
2 mL of the inoculum (for the first inoculation) or by adding 2 mL of inoculum to the
feeding bowl which was then consumed by the piglet (second inoculation).

Cecal cannulation of selected piglets
At 7-8 weeks of age, cecal cannula were surgically inserted into 6 piglets which
included 3 piglets inoculated with an obese donor and on an HF diet (piglets B6P2, B4P1,
and B4P4) and 3 piglets inoculated with a normal weight donor and on an LF diet (B7P2,
B5P2, and B5P4). Surgeries were performed inside a pre-sterilized surgery bubble.
Sterilized transfer sleeves attached to the isolators where the piglets were housed
permitted the transfer of piglets from their isolators to the surgery bubble without the
animals being exposed to the outside environment (See image A4 in Appendix IV). One
of the piglets (B5P4) died 2d following surgery, so no data is reported for that animal. A
cecal sample had been collected from each piglet at the time of surgery prior to the
insertion of the cannulae. Following cannulation, cecal content samples were collected
through the cannulae of these piglets at the following time points (post-cannulation):
B4P1 – 13d and 16d; B4P4 – 8d, 13d, 16d; B5P2 – 8d, 11d, 13d; B6P2 - 8d, 11d, 13d,
19d; B7P2 – 8d, 11d, 14d.
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Fecal and cecal sample collections
Fecal samples were collected from each animal at weekly time points (the first
week following the first round of inoculations was considered week 1) for the duration of
the study, which was 60 days for the non-cannulated piglets and 72 days for the
cannulated piglets. Fecal loops (VetOne, Boise, ID) which had been sterilized by
autoclaving were used for collecting the fecal samples from the piglets. Cecal contents
from all the piglets were collected at euthanization. In addition, cecal contents were also
sampled through the cannulae using sterile fecal loops from the cannulated piglets. Cecal
epithelial tissue samples from all piglets were collected at euthanization and frozen in
liquid Nitrogen. The collected fecal/cecal content samples and cecal tissues were stored
at -800 C until they were subjected to DNA/RNA extractions.

DNA extractions, PCR amplifications, and high-throughput amplicon sequencing
DNA was extracted from all fecal and cecal content samples using the OMEGA
Mag-Bind® Soil DNA 96 kit (Omega Bio-tek, Inc., GA) following the manufacturer’s
protocol with an added bead-beating step consisting of boiling the samples at 900 C for 10
mins after the initial bead-beating, followed by another round of bead-beating at 30 Hz
for 10 mins. DNA extractions from porcine cecal epithelial tissues was performed using
the Qiagen DNeasy® Blood and Tissue Kit (QIAGEN Sciences, Germantown, MD)
following the instructions for the spin-column protocol for total DNA extractions from
animal tissues. Following DNA extractions, PCR amplifications were performed using
primers targeting the V4 hypervariable region of the 16S rRNA gene as previously
described [18]. The resulting PCR amplicons were visualized using Agarose gel
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electrophoresis performed using 2% (w/v) agarose gels (Green BioResearch LLC, Baton
Rouge, LA). The SequalPrep Normalization Plate Kit (Invitrogen, Carlsbad, CA) was
used to normalize the PCR amplicons, following which equal volumes of normalized
amplicons were pooled together. Preparation of PCR plates, amplicon normalization, and
pooling were performed using an EpMotion M5073 robot (Eppendorf, Hamburg,
Germany). The quality of the pooled amplicon library was assessed using an Agilent
BioAnalyzer 2100 High Sensitivity DNA chip (Agilent, Santa Clara, CA) and quantified
using a DeNovix dsDNA High Sensitivity Kit (DeNovix Inc., Wilmington, DE). Dualindex paired-end sequencing (2 x 250 bp) of pooled amplicons was subsequently
performed on an Illumina® MiSeqTM platform (Illumina Inc., San Diego, CA) as
described previously [19] using V3 reagent kits for fecal and cecal content samples, while
the pooled amplicon library originating from cecal tissues was sequenced using V2 and
V2 Nano reagent kits.

RNA extractions, depletion of rRNA, and RNA-Seq
A TRIzol-based RNA isolation protocol was used for extracting RNA from cecal
epithelial tissues. Briefly, 0.5g of frozen tissue was measured and transferred to a
sterilized mortar containing liquid nitrogen and ground using a pre-sterilized pestle until
the tissue became a powder. Subsequently, 5 mL of TRIzol reagent (Thermo Fisher
Scientific, Waltham, MA) was added and the tissue was homogenized with the TRIzol.
The homogenized tissue in TRIzol was left at room temperature for 5 mins. Afterwards,
the contents were transferred to pre-sterilized polypropylene tubes (which were treated
with RNAse AWAYTM (Thermo Fisher Scientific, Waltham, MA) prior to use) and 2 mL
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of Chloroform was added. Each tube was then vortexed for 15 seconds and incubated at
room temperature for 3 mins. The samples were then centrifuged at 10,000 rpm for 30
mins in a refrigerated centrifuge maintained at 40 C. Following centrifugation, the upper
aqueous layer (3-5 mL) was transferred to a new sterile centrifuge tube and 3 mL of
isopropyl alcohol was added and the tube gently swirled. The samples were then stored at
-800 C for 30 mins and centrifuged at 10,000 rpm for 10 mins at 40 C. The supernatant
was discarded and the RNA pellet was washed with 5 mL of freshly made 75% ethanol.
The samples were once again centrifuged at 10,000 rpm for 5 mins at 40 C. Following
centrifugation, residual ethanol was removed by pipetting and the pellets were air-dried
for 5 mins. Finally, the air-dried RNA pellets were dissolved in 200 uL of 1xTE buffer
and stored at -800 C. The quality of the extracted total RNA was determined using the
Agilent Bioanalyzer 2100 instrument with Agilent RNA 6000 Pico reagents and chips
(Agilent, Santa Clara, CA). Total RNA concentrations were measured using the DeNovix
RNA assay (DeNovix Inc., Wilmington, DE).
For the total RNA extracted from the cecal epithelial tissue samples, the
NEBNext® Poly(A) mRNA Magnetic Isolation Module (New England Biolabs, Ipswich,
MA) was used to isolate the Eukaryotic host mRNA following manufacturer’s
instructions. The purified mRNAs were run on the Bioanalyzer using RNA 6000 Pico
reagents to assess the success of the Poly(A) magnetic mRNA isolation procedure. First
and second strand cDNA synthesis was performed for the mRNA using the ProtoScript®
II First Strand cDNA Synthesis Kit (New England Biolabs, Ipswich, MA) and the
NEBNext® UltraTM II Non-Directional RNA Second Strand Synthesis Module (New
England Biolabs, Ipswich, MA), respectively, following the manufacturer’s instructions.
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When following the protocol for first strand cDNA synthesis, the provided d(T)23VN (50
uM) primers were used for the Eukaryotic mRNA isolated from the porcine cecal
epithelial tissues.
The cDNA prepared was then used for RNA-Seq library preparation using the
NEBNext® UltraTM DNA Library Prep Kit (New England Biolabs, Ipswich, MA). The
cDNA was fragmented using a sonicator (Bioruptor®, Diagenode S. A., Denville, NJ)
with the power setting set at ‘Low’ and consisting of 3 cycles of sonication for 30
seconds followed by 90 seconds of rest. These conditions targeted sheared DNA
fragments of approx. 750 bp length. Size selection, adapter ligation, amplification (x18
PCR cycles) and bead-based library purifications were performed according to the
manufacturer’s instructions. The quality of the prepared cDNA libraries was determined
using an Agilent BioAnalyzer 2100 High Sensitivity DNA chip (Agilent, Santa Clara,
CA) and quantified with a DeNovix dsDNA High Sensitivity Kit (DeNovix Inc.,
Wilmington, DE). Individual libraries were then pooled at equal amounts followed by
high-throughput sequencing on an Illumina® HiSeqTM 2500 instrument (Illumina Inc.,
San Diego, CA) as a 2x150bp paired-end sequencing run.

16S rRNA sequence analysis
The 16S rRNA gene-based profiling of the bacterial communities of fecal and
cecal content/tissue samples was performed in R version 4.1.1. [20] using the phyloseq
package (1.36.0) [21]. The DADA2 pipeline (1.16) [22] was used to perform the initial
quality filtering steps and identification of amplicon sequence variants (ASVs).
Following chimera removal, assignment of taxonomy to the remaining ASVs was
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performed using the DADA2-formatted fasta files from the SILVA Project’s version
138.1 release (March 2021). Non-bacterial ASVs were filtered out with the exception of
the Cyanobacterial class Melainabacteria due to their reported gut origin [23]. A single
sample with < 9,000 reads was also filtered out. Finally, we filtered out ASVs that had a
relative abundance of less than 0.15% in a given sample as well as ASVs detected in less
than 2 samples. This resulted in a final quality-filtered ASV table consisting of 195
samples and 691 ASVs. The average read depth was 44,505 reads/sample. Alpha
diversity comparisons were performed using the Shannon index. Beta diversity analyses
were performed using Bray-Curtis and Unweighted UniFrac distances after normalizing
reads to relative abundances. When performing beta diversity comparisons, only fecal
samples collected after the piglets were on a solid diet (i. e., weeks 3-7) were considered.
Fecal samples collected after cannulation were also excluded from the analysis. In
addition to cecal/fecal samples collected at euthanization from all piglets, 4 cecal/fecal
pairs collected from cannulated piglets while they were still alive were included for the
alpha/beta diversity comparisons between cecal content and fecal samples.
Additionally, DESeq2 (1.32.0) [24] was used to perform differential abundance
analysis. Such comparisons were performed for Obese versus Normal weight donors, ObHMA versus Norm-HMA piglets and HF versus LF groups within Ob-HMA and NormHMA piglets. Differential abundance analysis was also performed for the comparison
between cecal tissue and cecal content bacterial communities. ASVs with an adjusted pvalue < 0.05 were considered significantly differentially abundant in all instances.

Analysis of porcine cecal tissue RNA-seq data
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Adapter sequences and low-quality reads were removed using BBDuk
(https://sourceforge.net/projects/bbmap/) and Sickle (1.33) [25], and rRNA reads were
removed using SortMeRNA (4.3.2) [26]. The remaining reads were aligned to the porcine
genome (downloaded from ENSEMBL:
ftp.ensembl.org/pub/release104/fasta/sus_scrofa/dna/Sus_scrofa.Sscrofa11.1.dna.toplevel
.fa.gz ) using the STAR aligner (2.7) [27] to identify host reads. The resulting alignments
were evaluated to identify percent of reads aligning to exons/introns, 5’ or 3’ bias, rRNA
genes etc. using qualimap 2 [28]. Following quality checking, SAMtools [29] was used to
filter the alignment BAM files to obtain paired-reads with unique mapping to the porcine
genome. Transcript abundances for each sample were subsequently quantified using
Salmon (1.4) [30]. For use in salmon quantification, the porcine genome and
transcriptome (downloaded from ENSEMBL: http://ftp.ensembl.org/pub/release104/gtf/sus_scrofa/Sus_scrofa.Sscrofa11.1.104.gtf.gz) were concatenated and
subsequently indexed as described in the Salmon documentation (https://combinelab.github.io/alevin-tutorial/2019/selective-alignment/). Differentially expressed genes
were identified using the DESeq2 package. Genes with an absolute log2 fold change of 2
and an adjusted p-value of < 0.05 were considered as significantly differentially
abundant. Annotation of genes based on Ensembl gene identifiers was performed using
the ‘bioMart’ package in R(2.48.3) [31].

Statistical analysis to remove genes which may have been identified as differentially
expressed between Obese and Normal phenotypes as a result of confounding effects
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For differential gene expression (DEG) comparisons, we were interested mainly
on (1) HF vs LF diet within either obese or normal weight phenotype, and (2) DEGs
between the obese and normal weight phenotypes. Due to the other factors in our study
design which may have an influence on gene expression (such as donor-to-donor
variation and cannulation), we followed a conservative approach with the objective of
identifying only those genes most likely to have been differentially expressed as a result
of our conditions of interest. For effect of diet on gene expression, we analyzed the data
separately for the obese (Ob-HMA piglets) and normal weight (Norm-HMA piglets).
When performing DEG analysis via DESeq2, the following formula was used for the
statistical design:

Design = Specific donor + Cannulation + Diet

For identifying DEGs as a result of HF vs LF diets, we filtered out any genes that
were identified as DEGs in any of the other two factors (DEGs which were result of
donor-to-donor variation and DEGs which were due to cannulation). In identifying
differentially expressed genes between the obese and normal weight phenotypes, we
performed DEG analysis between all the Ob-HMA and Norm-HMA piglets and filtered
out any gene which had previously been identified as a DEG in any of the other factors
(DEGs which were a result of donor-to-donor variation, DEGs which were due to
cannulation, and DEGs which were a result of HF vs LF diets).
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Associations between differentially expressed genes in cecal epithelial tissues and
cecal tissue bacterial community
We performed correlation analysis between the significantly differentially
abundant genes identified for the Ob-HMA and Norm-HMA piglet comparison and the
cecal epithelial tissue microbiota from the corresponding samples (these cecal tissue
samples were collected at euthanization). For the correlation analysis, only ASVs which
were present in at least 3 of these samples were considered. This resulted in 223 ASVs
being retained which were subsequently used in the correlation analysis with the
differentially expressed genes. Prior to analysis, ASV abundances were normalized using
the centered log ratio (clr) transformation. For the differentially expressed genes, counts
were normalized using variance stabilizing transformation. Pearson correlation analysis
was implemented with the ‘corr.test’ function of the ‘psych’ R package (2.2.3). A total of
51,076 correlations were performed and multiple comparison correction was done using
the ‘qvalue’ package (2.24.0) in R to identify significant associations. Gene-ASV
correlations were considered significant if -0.5 > R > 0.5 and qvalue < 0.01.

Statistical analysis
Alpha diversity comparisons were performed using the Wilcoxon test
implemented in R. For comparing the fecal bacterial community structures (beta
diversity) of the HMA piglets inoculated with obese and normal weight donors,
PERMANOVA [32] analysis was performed in the R package ‘vegan’ (2.5.7) using the
‘adonis’ function. The following statistical model was used:
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Dm = Donor_phenotype + Specific_donor + Diet + Week + Donor_phenotype: Diet,
permutations = 999

For beta diversity comparisons within a donor phenotype, the following formula was
used:

Dm = Spec_donor + Diet + Week + Spec_donor: Diet, permutations = 999

Dm – distance matrix; Donor_phenotype – Obese/Normal weight; Specific_donor –
donor used for inoculations

Statistical significance for all analyses was determined at p = 0.05.

Results
Characterizing the donor and HMA piglet bacterial communities
To compare establishment of donor fecal bacterial communities from obese (Ob)
and normal weight (Norm) human donors, 16S rDNA-based community analysis was
performed on HMA piglets and human donor samples. Alpha and beta diversity
comparisons (Figs 4.2 and 4.3, respectively) indicated that there were no statistically
significant differences (p > 0.05, Wilcoxon test for alpha diversity, PERMANOVA for
beta diversity) between the two donor phenotypes at the global bacterial community
level. We subsequently focused on the phyla Bacteroidetes and Firmicutes in the two
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phenotypes as these phyla have been implicated in the development of obesity [7, 33].
The Norm donors had a significantly higher relative abundance of Bacteroidetes
compared to the Ob donors, while there was no significant difference in the Firmicutes
abundances between the two phenotypes (Fig 4.4(a) and (b), respectively).
The transplanted bacterial communities of the HMA piglets were subsequently
characterized using alpha and beta diversity analyses. Similar to the donors, we did not
observe a significant difference in alpha diversity between HMA piglets inoculated with
an obese microbiota (Ob-HMA-piglets) and the piglets inoculated with a normal weight
microbiota (Norm-HMA-piglets) (Fig. 4.5). However, beta diversity analysis (Fig. 4.6)
revealed that fecal samples from Ob-HMA-piglets and the Norm-HMA-piglets were
significantly different in microbiota composition (p < 0.05, PERMANOVA; Appendix V,
1(a) and (b)). Considering relative abundances of the Bacteroidetes, the Norm-HMApiglets had a slightly higher mean abundance compared to the Ob-HMA-piglets (17.18%
(SD = 12.04%) and 13.17% (SD = 8.26%), respectively) but this was not statistically
significant (Fig. 4.7 (a)). Additionally, a slight increase in the mean abundance of
Firmicutes (Fig. 4.7 (b)) was observed in the Ob-HMA-piglets compared to the NormHMA-piglets (37.52% (SD = 22.39%) and 35.53% (SD = 19.20%)).
Since within each phenotype (obese or normal weight) the piglets received either
a high-fat or low-fat diet, as well as a milk diet prior to weaning, the impact of diet on the
microbiota was evaluated. For alpha diversity, no significant impact of diet was observed
for the piglets that were inoculated with a Norm donor (Fig. 4.8). For the piglets
inoculated with an Ob donor microbiota, a significant difference in the Shannon index
was observed between the milk diet and HF diet and a tendency was observed between
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the milk diet and the LF diet, with the solid diets (either LF or HF) having a higher
diversity (Fig. 4.9). Both LF and HF diets also had a significantly higher diversity than
the transition diet. No significant difference was observed in the fecal bacterial diversity
between the LF and HF diets for both the Norm-HMA-piglets and the Ob-HMA-piglets
(Fig. 4.10). In terms of beta diversity, a significant influence of diet was observed for the
Ob-HMA piglets but not for the Norm-HMA piglets (Appendix V, 2(a) and (b)).
The DESeq2 analysis for differentially abundant ASVs between the Ob versus
Norm donors resulted in the identification of 41 significantly differentially abundant
ASVs (Appendix VI (a)). Similarly, when we compared the Ob-HMA and Norm-HMA
piglet bacterial communities, 91 ASVs were identified as differentially abundant
(Appendix VI (b)). Thirteen of the 41 differentially abundant ASVs identified in the
obese versus normal weight donor comparison were also represented in the Ob-HMA
versus Norm-HMA piglet comparison. Interestingly, all 13 of these ASVs showed the
same ‘direction’ of log fold change in both the human donors and the HMA pigs (i. e., if
an ASV was significantly more abundant in the obese donors compared to the normal
weight donors, it was also more abundant in the Ob-HMA pigs compared to the normHMA pigs) (Table 4.1).
Within each phenotype, we also identified ASVs which were significantly
differentially abundant based on the diet consumed (HF vs LF, see Appendix VI(c) and
(d)). Fifty-eight differentially abundant ASVs were identified for HF versus LF
comparison for the Ob-HMA piglets, while 23 such ASVs were identified for the same
comparison for the Norm-HMA piglets.
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Establishment of donor taxa in the HMA piglets
Beta diversity analysis comparing the HMA piglets to the human donors as well
as the control piglets (i.e., GF piglets inoculated with porcine fecal matter) showed the
fecal samples from the HMA piglets clustering with the human donor samples, while the
control piglet samples clustered separately (Fig. 4.11). We subsequently evaluated the
colonization efficiency of the taxa in each one of our donors in the corresponding HMA
piglets. The results showed that ~79-85% of donor ASVs were present at some timepoint
in the feces of the HMA piglets for each of the donors (Table 4.2). However, for all
donors, there were marked differences in the number of donor ASVs detected at the
different dietary stages (Table 4.2). In general, a higher number of donor taxa were
detected when the piglets were on a solid diet (either HF or LF) compared to when the
HMA piglets were on milk. As shown in Table A7.1 of Appendix VII, the increase in the
number of donor ASVs detected as the diet transitioned from milk to solid appears to be a
result of the expansion of members belonging to the phylum Firmicutes.

Comparing bacterial communities of fecal, cecal content, and cecal tissue samples
We subsequently compared the bacterial community structures of the cecal
content and fecal samples that had been collected from each piglet at the time of
euthanization, as well as a further 8 cecal content/fecal sample pairs that we had collected
from 4 of the cannulated piglets while they were still alive. Alpha diversity comparisons
revealed no significant difference between the two types of samples (Fig. 4.12). Beta
diversity comparisons revealed a statistically significant difference between the two types
of samples, although the effect sizes were small (Fig. 4.13.; Appendix V 3(a) and (b)).
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We also compared the cecal tissue and cecal content bacterial communities from
samples collected at euthanization. The cecal tissue bacterial communities had a
significantly higher alpha diversity (p < 0.01, Wilcoxon test) than the cecal content
bacterial communities when compared using the Shannon index (Fig. 4.14). Beta
diversity analysis also showed significant differences in bacterial community structure
between the cecal tissue and cecal content samples (Fig. 4.15 and Appendix V 4(a) and
(b)), especially when taxa abundances were considered (Bray-Curtis distances).
Additionally, 49 differentially abundant ASVs were identified for the two types of
samples (Table 4.3). Finally, a comparison of the bacterial communities of the fecal and
cecal tissue samples revealed significant differences between the two communities (p <
0.001, R2 = 0.106 for unweighted UniFrac and p < 0.001, R2 = 0.154 for Bray-Curtis
distance matrices based on PERMANOVA).

Cecal content samples collected from cannulated piglets
Fig. 4.16 shows beta diversity results for the cecal content samples collected from
the cannulated piglets. With the exception for B4P1 and B4P4, we observed that the preand post-cannulation cecal content samples clustered together for each individual piglet.
PERMANOVA analysis results (Appendix V (5)) showed no significant difference (p >
0.05) in bacterial community structure for the pre-cannulation versus post-cannulation
cecal content samples.

Comparing cecal epithelial gene expression of Ob-HMA and Norm-HMA piglets

172
To investigate the potential influence of an obese versus normal weight
microbiota on the gene expression profile of cecal epithelial tissues of the HMA piglets,
we compared gene expression between Ob-HMA and Norm-HMA piglets. According to
our criteria of a p < 0.05 and an absolute log2 fold change in expression of 1 (which
corresponds to a linear fold change of 2 for upregulated genes or 0.5 for downregulated
genes) as well as removing DEGs which were a result of confounding factors (see
Materials and Methods), 3 genes were identified as significantly differentially expressed
between the two groups of piglets (Table 4.4 (a)). Of these, gene AADAC was
upregulated in the Ob-HMA piglets while the other two genes were upregulated in the
Norm-HMA piglets. Two genes were significantly differentially expressed between the
Ob-HMA piglets on an HF diet versus Ob-HMA piglets on an LF diet; both genes were
upregulated in the piglets on the LF diet (Table 4.2 (b)). For the Norm-HMA piglets, 4
genes were identified as DEGs between the LF and HF groups. Two of these genes
(PLIN1 and ADIPOQ) were upregulated in LF group while ENSSSCG00000039103 and
ENSSSCG00000005962 upregulated in the HF group. We did not identify any ASVs that
were significantly associated with DEGs in our correlation analysis according to our
criteria (i. e., -0.5 > R > 0.5 and qvalue < 0.01).

Discussion
Although studies involving HMA pigs have been published in the literature for
more than a decade, research exploring this animal model as recipients of microbial
communities associated with a specific human disease condition have not been reported.
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In this study, our objective was to evaluate the possibility of using HMA piglets as
models to study host-microbiota interactions in obesity under different dietary conditions.
At a global community level, our results demonstrated that the HMA piglets
harbored bacterial communities more similar to the human donors compared to fecal
bacterial communities present in conventional pigs (Fig. 4.11). When evaluating the
efficacy of transplantation of the different donor microbiotas into the GF piglets, the
results showed that ~79-85% of donor ASVs were detected at some timepoint in the feces
of the HMA piglets for all the donors (Table 4.2). However, we observed marked
differences in the number of ASVs detected from the HMA piglets as a function of the
diet that the piglets were consuming (Table 4.2). In general, a higher number of donor
ASVs were detected in the piglets post-weaning compared to pre-weaning, which
appeared to be driven by greater colonization of members of the phylum Firmicutes
(Table A7.1 in Appendix VII), which occurred with the dietary change (liquid to solid).
While the second round of inoculations for the piglets coincided with the transition to a
solid diet, we do not believe that the increase in detection of ASVs in the post-weaning
samples was a direct result of this second inoculation as the inocula used for the first and
second inoculations had similar microbiota compositions (Appendix III). However, the
new substrates that were introduced with the solid diet may have helped increase the
abundance of Firmicutes, thus leading to the increase in diversity. As such, we believe
the organisms would have been present at low abundance when fed the milk diet and
increased as a result of dietary change. This raises an interesting question as to when the
best time would be to inoculate GF piglets in these types of studies. While further
research would be required to answer this question, the results of our study indicate that
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(at least for adult donors) inoculating piglets post-weaning would result in a greater
colonization efficiency.
Considering community level characteristics of the obese/normal weight donor
microbiotas and the transplanted microbiotas in the HMA piglets, we observed the
microbiome characteristics of the donor to successfully replicate within the piglets. For
example, neither the human donors nor the HMA piglets showed significant differences
in alpha diversity between the normal weight and obese phenotypes (although in both
humans and piglets, the normal weight phenotype showed a numerically higher diversity
than the obese phenotype, Fig. 4.2 and Fig. 4.5). Similarly, in both humans and HMA
piglets, the obese phenotype showed a numerically higher abundance in the phylum
Firmicutes compared to the normal weight phenotype, although these differences did not
reach statistical significance (Figs. 4.4 (b) and 4.7(b)). However, in contrast, although
there was a significantly higher abundance of Bacteroidetes members in the normal
weight donors compared to the obese donors, we did not observe a significant difference
in Bacteroidetes abundances between the Norm-HMA-piglets and the Ob-HMA-piglets
(Figs. 4.4 (a) and 4.7 (a)). Also, while we did not observe a significant difference in beta
diversity between the obese and normal weight donors, we did observe a significant
difference in beta diversity between the Ob-HMA and Norm-HMA piglets. Many factors,
such as dietary differences between the human donors and the HMA piglets, as well as
differences in the gastrointestinal environments between the two species may have played
a role in bringing about these differences.
Differential abundance analysis between the obese vs normal weight donors as
well as Ob-HMA vs Norm-HMA piglets identified 13 differentially abundant ASVs
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which were common to both analyses. Of interest was the fact that the direction of the
log2 fold change was the same for all of these 13 ASVs between the human donors and
the piglets. Some of these differentially abundant ASVs have been implicated in human
obesity. For example, although more abundant in the obese phenotype in our study,
Parabacteroides distasonis has been reported to alleviate obesity and metabolic
dysfunctions through the production of succinate and secondary bile acids [34].
Barnesiella intestinihominis was observed in another study [35] to be decreased in the
obese microbiota. We observed 3 Barnsiella members (species level unknown) among
the 13 shared differentially abundant ASVs, with one of them (ASV_1980) more
abundant in the normal weight phenotype and the other two (ASV_1981 and ASV_1986)
more abundant in the obese phenotype. The higher abundance of Sutterella in our normal
weight donors and Norm-HMA piglets compared to their obese counterparts agrees with
a recent study [33] which observed reduced levels of Sutterella in obese and overweight
Italian adults compared to normal weight controls.
Considering the effect of an HF or LF diet on structuring the bacterial
communities, we observed a significant impact of diet on the Ob-HMA piglet microbiota
but not on the Norm-HMA piglet microbiota (Appendix V 2(a) and (b)). This was
supported by the differential abundance analysis results which identified 58 differentially
abundant ASVs between the HF versus LF groups for the Ob-HMA piglets, while only
23 such ASVs were identified for the Norm-HMA piglets (Appendix VI (c) and (d)).
Considering the marked difference in the sugar and fat content between the two diets
(Appendix II), it is interesting as to why the microbiota in the Norm-HMA piglets did not
respond differently. One possibility is the absence or low abundance of members in the
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community which can digest the substrates which were different in the two diets (for
example, lard). Another possibility is that, even if present, such organisms may have been
metabolically outcompeted by other members of the microbiota. A possible means of
testing this hypothesis is to use metagenomics or (preferably) metatranscriptomics to
identify the presence/expression of genes related to carbohydrate and fat metabolism in
the bacterial communities of the Norm-HMA piglets.
Beta diversity comparisons indicated that there were significant community level
differences between the cecal content and cecal tissue microbiota communities of the
piglets (Fig. 4.15). Differential abundance analysis identified 49 ASVs which were
significantly differentially abundant (Padj < 0.05) between the two types of samples
(Table 4.3). Twenty-four of these ASVs were more abundant in the cecal tissue samples
while the remaining 25 were more abundant in the cecal contents. Bacteroides spp. and
Sutterella spp. were more abundant in the cecal tissue samples. This observation agrees
with what has been observed in humans as these bacteria are known to be associated with
the colonic mucosa [36, 37]. Surprisingly, the well-known mucin degrader Akkermansia
muciniphila was more abundant in the cecal contents relative to the cecal tissues (Table
4.3). In a previous study using GF piglets to study the infant microbiota, the phylum
Verrucomicrobia (to which Akkermansia muciniphila belongs to) was more abundant in
the colonic mucosa compared to feces in one group of HMA piglets, while in the other
group this was the opposite [38]. We did not find any information regarding the
biogeography of Akkermansia spp. within the porcine gut in the current literature. More
research in this area might be needed to yield reasonable explanations for these
observations. It is also possible that the method used to extract cecal tissue DNA may
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also have contributed to the lower abundance of Akkermansia muciniphila observed in
the cecal tissue samples.
As shown in Appendix IX, the many DEGs which were a result of the various
treatments we had in our study design complicated our efforts to identify differentially
expressed genes between piglets inoculated with an ‘obese’ donor microbiota and piglets
inoculated with a ‘normal weight’ donor microbiota, as well as DEGs which were
affected by HF or LF diets within each of those phenotypes. After filtering out any DEGs
which may have been a result of confounding factors, we identified only 3 genes which
were significantly differentially abundant between the cecal epithelial tissues of the ObHMA piglets and the Norm-HMA piglets (Table 4.4(a)). Gene TRHDE, which codes for
the thyrotropin releasing hormone degrading enzyme (TRHDE), was expressed at a
higher level in the Norm-HMA piglets compared to the Ob-HMA piglets. In Yorkshire
pigs, the TRHDE gene has been considered a candidate gene which might affect feed
conversion ratio (FCR) [39]. Thyrotropin-releasing hormone (TRH), which is degraded
by TRHDE, has been linked to high levels of thyroid stimulating hormone (TSH) found
in obese and overweight children [40]. However, TRH did not have an effect on weight
gain in a study that compared lactating sows that were fed TRH in the diet versus control
sows [41]. Thus, it is difficult to speculate on the significance of the overexpression of
TRHDE in the Norm-HMA piglets compared to the Ob-HMA piglets. PCDH9 (encoding
protocadherin 9), which was overexpressed in the Ob-HMA piglets, has been associated
with BMI in European human populations in genome-wide association (GWAS) studies
[42]. We were unable to find any references relating PCDH9 with any growth-related
traits in pigs. The two DEGs with a known function identified in the comparison between

178
Norm-HMA piglets on an LF versus HF diet were PLIN1 and ADIPOQ, both of which
were overexpressed in the piglets on an LF diet (Table 4.4 (C)). PLIN1, which codes for
perilipin 1, has been identified as a highly expressed gene in porcine adipose tissue and
has been strongly implicated in porcine intramuscular fat (IMF) deposition and adipocyte
differentiation [43]. The ADIPOQ gene is also thought to influence fat deposition in pigs,
as interference with ADIPOQ expression has been shown to inhibit the differentiation of
porcine preadipocytes [44]. Considering that both PLIN1 and ADIPOQ are positively
involved in fat deposition, it is reasonable to have expected that both genes would have
been overexpressed in the HF group of Norm-HMA piglets instead of the LF group. A
possible explanation for our observation of overexpression of these two genes in the LF
group might be because of higher food intake by these piglets (compared to the NormHMA piglets on an HF diet) which would have resulted in a higher intake of fat. Since
we did not monitor feed intake during our study, this hypothesis cannot be verified at this
time.
At euthanization of the animals, we were able to collect fecal, cecal content, and
cecal epithelial tissue samples from all the animals. Thus, we had an opportunity to
compare the ASVs detected from each of these samples at this time point. Overall, we
identified 347 ASVs in the fecal samples, 366 ASVs in the cecal contents, and 386 ASVs
in the cecal tissue samples. The Venn diagram presented in Fig 4.17. shows that, while a
majority (55%) of ASVs were shared between the 3 types of samples, some ASVs were
only detected in one type of sample. Most notable was that 60 ASVs (12.8%) were only
detected in the cecal tissue samples (the taxonomy of these ASVs is provided in
Appendix VIII). Since the cecal tissue microbiota will be in closer contact with the host
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epithelium, they can be expected to have more of an influence on gene expression and
thus affect host-microbiota interactions. These differences between the luminal and
tissue-associated microbial communities raises an important question regarding the use of
only fecal samples from human donors as the transplant material for ‘humanizing’ GF
animal models. Human fecal samples can be expected to contain mainly luminal
microbes with lower representation of gut mucosa-associated microbes. Since mucosaassociated microbes may have a more important role to play in host-microbiota
interactions (especially immune interactions), the lower representation of these organisms
in feces might lead to incomplete recapitulation of human gut microbiome functions in
HMA animal models transplanted exclusively with human fecal microbes. We also
performed beta diversity comparisons between the donor inocula and the fecal, cecal
content, and cecal tissue bacterial communities. The motivation was to determine which
one (if any) of these bacterial communities was more similar to the donor inocula
communities. As shown in Fig. 4.18, for both the Ob-HMA and Norm-HMA piglets, the
fecal, cecal content, and cecal tissue communities clustered together, indicating that
neither community was more similar to the donor communities. This was further
confirmed by PERMANOVA analysis, where the pair-wise comparisons showed that all
three porcine sample types were significantly different (p < 0.05) from the human donor
samples.
Our attempt to cecum-cannulate HMA piglets demonstrated the feasibility of
performing such surgical procedures within the confines of an isolator as well as the
ability of these HMA piglets to recover and function following cannulation (only 1 out of
the 6 piglets died following cannulation due to complications encountered during the
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surgical procedure). It should also be possible to use similar techniques to insert cannulae
into other areas of the porcine gastrointestinal tract as well (e.g., the colon). The ability to
collect cecal samples from such animals while they are still alive make them attractive
models for studying host-microbiota interactions, as well as providing direct
opportunities to manipulate the microbiome through the cannula. Additionally, the cecum
cannulated porcine model provides opportunities unavailable in current HMA rodent
models to investigate microbiome compositional and functional changes at the site of
fermentation and also to perform gene expression investigations over time before and
after perturbation of the microbiomes. In this study, we did not identify major shifts in
cecal bacterial community structure following cannulation as the cecal samples collected
pre-cannulation clustered with the cecal samples collected post-cannulation within each
piglet (Fig. 4.16) and was supported by PERMANOVA results (p > 0.05 for pre- vs postcannulation samples comparison, Appendix V (5)). The exceptions to this were piglets
B4P1 and B4P4. These two piglets were housed in the same isolator and had grown large
enough to be able to get over the dividers separating the individual piglets within the
isolator. Thus, they were often seen together in the same compartment, and as a likely
result of this contact, also had their cannular caps removed at frequent intervals, thus
exposing their cecal microbiotas to outside elements (including air/oxygen). The notable
shifts in bacterial communities in the cecal samples collected from these piglets is likely a
result of these exposures. Thus, the potential for cannulae to be removed/compromised as
a result of physical contact between piglets is an important point to consider when
designing future experiments utilizing cannulated piglet models.
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In summary, our study points to the possibility of using HMA piglets as model
animals to study human obesity from a microbiome perspective. Notwithstanding the fact
that the study design complicated our ability to investigate the influence of an
obese/normal weight microbiome on host gene expression, we are confident that better
study designs and the use of larger numbers of animals in future experiments would
permit the study of such aspects of host-microbiota interactions. We are particularly
encouraged by the results for the cannulated HMA piglets and believe that further
improvements to this animal model can facilitate important discoveries related to hostmicrobiota interactions in obesity and other metabolic conditions.
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Fig. 4.2. Comparison of alpha diversity by donor phenotype. Statistical analysis
performed using the Wilcoxon test.

(b)

Fig. 4.3. Comparison of beta diversity with donor phenotype (a) Unweighted UniFrac distances and (b) Bray-Curtis distances.
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weight donors. Statistical analysis performed using the Wilcoxon test.

Fig. 4.4. Comparison of relative abundances of (a) Bacteroidetes and (b) Firmicutes phyla between the obese and normal
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Fig. 4.5. Comparison of alpha diversity of fecal samples of HMA piglets inoculated with
either obese or normal weight donor inocula. Statistical analysis performed using the
Wilcoxon test.

(b)

distances and (b) Bray-Curtis distances.

Fig. 4.6. Comparison of beta diversity of the fecal samples from Ob-HMA and Norm-HMA piglets. (a) Unweighted UniFrac

(a)
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(b)

HMA piglets. Statistical analysis performed using the Wilcoxon test.

Fig. 4.7. Comparison of relative abundances of (a) Bacteroidetes and (b) Firmicutes phyla between the Ob-HMA and Norm-

(a)
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(b)

transitioned to a LF diet (b) piglets that transitioned to a HF diet. Statistical analysis performed using the Wilcoxon test

Fig. 4.8. Alpha diversity comparisons based on diet for piglets inoculated with normal weight donors. (a) piglets that

(a)
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(b)

LF diet (b) piglets that transitioned to a HF diet. Statistical analysis performed using the Wilcoxon test.

Fig. 4.9. Alpha diversity comparisons based on diet for piglets inoculated with obese donors. (a) piglets that transitioned to a

(a)
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(b)

analysis performed using the Wilcoxon test.

Fig. 4.10. Alpha diversity comparisons between LF and HF diets for (a) Norm-HMA-piglets (b) Ob-HMA-piglets. Statistical
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Fig. 4.11. Principal coordinate analysis (PCoA) plot depicting the clustering of human
donor, HMA piglet, and control pig fecal samples based on Unweighted UniFrac
distances.
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Fig. 4.12. Alpha diversity comparisons between cecal content and fecal samples.
Statistical analysis performed using the Wilcoxon test.

(b)

piglets based on (a) Unweighted UniFrac distances (b) Bray-Curtis distances.

Fig. 4.13. Principal coordinate analysis (PCoA) plots depicting the clustering of cecal content and fecal samples of HMA

(a)
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Fig. 4.14. Alpha diversity comparisons between cecal tissue and cecal content samples.
Statistical analysis performed using the Wilcoxon test.

(b)

collected at euthanization from the HMA piglets based on (a) Unweighted UniFrac distances (b) Bray-Curtis distances.

Fig. 4.15. Principal coordinate analysis (PCoA) plots depicting the clustering of cecal tissue and cecal content samples

(a)
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Fig. 4.16. Principal coordinate analysis (PCoA) plots based on Bray-Curtis distances
depicting the clustering of cecal content samples collected from each of the 5 cecumcannulated piglets (Samples collected at euthanization have been excluded as these were
collected after the animals had died while the other samples were collected while they
were alive).
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Fig. 4.17. Venn diagram representing the number of ASVs detected in the fecal, cecal
content, and cecal tissue samples collected at euthanization from the 9 Norm-HMA and 7
Ob-HMA piglets.

communities with human donor communities (a) Normal weight phenotype (b) Obese phenotype.

Fig. 4.18. Principal coordinate analysis plots depicting the clustering of fecal, cecal content, and cecal tissue bacterial
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(a)

a negative value indicates higher abundance in the normal weight phenotype.

(b)

Norm-HMA piglets. Positive values in the ‘log2FoldChange’ column indicate higher abundance in the obese phenotype while

Table 4.1. Shared significantly differentially abundant ASVs (a) obese versus normal weight donors (b) Ob-HMA versus

200

85
84
101
84
100
86

Ob_001

Ob_002

Norm_2014

Norm_001

Norm_002

ASVs

donor

71 (82.5%)

84 (84%)

70 (83.3%)

84 (83.2%)

70 (83.3%)

67 (78.8%)

piglets

HMA

detected in

donor

ASVs in

number of

number of

Ob_2014

Donor

Total

Total

41

62

48

31

34

31

No. of ASVs

Milk

25

51

35

42

40

37

No. of ASVs

Milk + solid

55

74

56

75

62

45

No. of ASVs

Low fat diet

56

60

56

79

49

62

No. of ASVs

High fat diet

Establishment of donor ASVs in the HMA piglets based on diet

Table 4.2. Establishment of donor taxa in the HMA piglets. Number of donor ASVs detected at each dietary stage is reported.
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105
120

Norm_003

Norm_004
(84.2%)

101

89 (84.8%)
48

35
45

49
84

77
87

82
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Table 4.3. Significantly differentially abundant ASVs between cecal content and cecal
tissue samples. A positive ‘log2FoldChange’ indicates that an ASV was more abundant
in the cecal tissues, while a negative value indicates an ASV was more abundant in cecal
contents. ‘padj’ refers to a p-value which has been corrected for multiple comparisons
using the Benjamini-Hochberg method.

ASV_ID log2FoldChange
Padj
Taxonomy
ASV_2
-2.916155071
0.0419933 Akkermansia muciniphila
ASV_3
-1.883392723 0.03549891 Escherichia-Shigella spp.
ASV_6
-1.745480986 0.03549891 Clostridium sensu stricto 1 spp.
ASV_7
-2.848556926 0.00289456 Desulfovibrio fairfieldensis
ASV_9
-3.467935836
2.69E-08 HT002 spp.
ASV_10
-3.14626604
0.00109636 Collinsella aerofaciens
ASV_12
-4.692308804 0.03212848 Lactobacillus spp.
ASV_15
-2.057465829 0.00289456 Monoglobus pectinilyticus
ASV_19
3.467940112
0.01659901 Bacteroides spp.
ASV_30
3.391966137
0.00511297 Bacteroides spp.
ASV_36
3.449754821
0.00026953 Parabacteroides merdae
ASV_41
-3.314856307 0.01659901 Clostridium sensu stricto 1 butyricum
ASV_49
10.29059168
1.47E-09 Bacteroides spp.
ASV_50
3.657104253
0.02118107 Bacteroides spp.
ASV_54
4.144915123
0.02639534 [Ruminococcus] torques group spp.
ASV_56
4.935131791
7.00E-05 Bacteroides eggerthii
ASV_60
5.047933073
0.0007519 Bacteroides eggerthii
ASV_66
-24.88572535
1.71E-15 Escherichia-Shigella spp.
ASV_68
6.36148228
0.01741055 Prevotella_9 copri
ASV_69
3.835664191
0.03446321 Bacteroides spp.
ASV_71
-11.69027342
7.83E-07 Lactobacillaceae spp.
ASV_74
9.704679948
0.01162291 Barnesiella spp.
ASV_77
3.097116683
0.03549891 Bacteroides spp.
ASV_94
-3.064621298 0.01950472 Adlercreutzia equolifaciens
ASV_99
-5.741369674 0.04454568 Parabacteroides distasonis
ASV_108
5.201651812
5.61E-05 Oscillibacter spp.
ASV_120
18.18970035
2.35E-08 Bacteroides intestinalis
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ASV_129
ASV_131
ASV_142
ASV_157
ASV_162
ASV_200
ASV_212
ASV_216
ASV_232
ASV_238
ASV_254
ASV_282
ASV_284
ASV_323
ASV_349
ASV_536
ASV_537
ASV_549
ASV_606
ASV_637
ASV_718
ASV_810

-27.34902362
-7.030691566
-5.639414044
4.934966307
-7.76698415
-5.167933566
11.67463965
5.929554967
-4.561119649
-26.02820529
5.752987961
-7.765654408
4.648908001
4.878896513
4.095522342
6.934078042
-20.70449628
-20.72998909
-24.01167322
-21.55078218
7.025921459
24.42440937

1.01E-22
0.00537495
0.02869576
0.0026784
0.04948186
0.02869576
0.00122253
0.04273371
0.04948186
2.01E-16
0.04948186
0.01356141
0.02829202
0.02696009
0.04948186
0.03549891
1.21E-10
1.21E-10
3.94E-14
1.85E-11
0.01343303
3.70E-17

Limosilactobacillus spp.
Clostridium sensu stricto 6 bornimense
[Eubacterium] hallii group
Flavonifractor plautii
Clostridium sensu stricto 1 butyricum
Coriobacteriales spp.
Megamonas spp.
Ruminococcus bicirculans
Blautia spp.
Akkermansia spp.
UCG-003 spp.
Anaerotruncus colihominis
Lachnoclostridium edouardi
Sutterella spp.
Frisingicoccus spp.
CAG-56 spp.
Bacteroides spp.
Staphylococcus spp.
Christensenellaceae R-7 group
Clostridium sensu stricto 1 spp.
Coprococcus catus
Succinatimonas hippei

log2FoldChange
-1.246231441
3.682177791
-1.033384677

log2FoldChange
2.248382423
3.406559956

Ensemble_gene_id

ENSSSCG00000000515
ENSSSCG00000031367
ENSSSCG00000038842

Ensemble_gene_id

ENSSSCG00000003970

ENSSSCG00000038570

0.000407286

0.000487046

Padj

0.035429417
0.012455602
0.047197095

Padj

(b)

protein_coding

protein_coding

gene_biotype

(a)

protein_coding
protein_coding
protein_coding

gene_biotype

Obese phenotype (c) LF vs HF diet for Normal weight phenotype.

not assigned

GUCA2B

external_gene_name

TRHDE
AADAC
PCDH9

external_gene_name

not assigned

guanylate cyclase activator 2B

description

description
thyrotropin releasing hormone
degrading enzyme
arylacetamide deacetylase
protocadherin 9

Table 4.4. Differentially expressed genes and their descriptions (a) Obese vs Normal weight phenotype (b) LF vs HF diet for
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log2FoldChange
2.189009409
-2.328087204
2.353228072
-1.741485426

Ensemble_gene_id

ENSSSCG00000001844
ENSSSCG00000005962
ENSSSCG00000039103

ENSSSCG00000040980

0.041518897

0.041518897
0.004665871
0.034101216

Padj

(c)

not assigned

PLIN1
not assigned
ADIPOQ

external_gene_name

not assigned

perilipin 1
not assigned
adiponectin, C1Q and collagen domain containing

description

206

207
References
1.
2.
3.
4.
5.
6.
7.
8.
9.
10.
11.
12.
13.
14.
15.
16.
17.

Organization WH. Obesity and overweight 2021 [updated 06/09/2021; cited 2022
02/26/2022]. Available from: https://www.who.int/news-room/factsheets/detail/obesity-and-overweight.
Hales CM, Carroll, M. D., Fryar, C. D., Ogden, C. L. Prevalence of obesity and
severe obesity among adults: United States, 2017-2018. Hyattsville, MD: National
Center for Health Statistics; 2020.
Heymsfield SB, Wadden TA. Mechanisms, Pathophysiology, and Management of
Obesity. N Engl J Med. 2017;376:254-66.
Bray GA. Obesity: The Disease. Journal of Medicinal Chemistry. 2006;49:40017.
van der Klaauw AA, Farooqi IS. The hunger genes: pathways to obesity. Cell.
2015;161:119-32.
Bäckhed F, Ding H, Wang T, Hooper LV, Koh GY, Nagy A, et al. The gut
microbiota as an environmental factor that regulates fat storage. Proc Natl Acad
Sci U S A. 2004;101:15718-23.
Ley RE, Bäckhed F, Turnbaugh P, Lozupone CA, Knight RD, Gordon JI. Obesity
alters gut microbial ecology. Proc Natl Acad Sci U S A. 2005;102:11070-5.
Ley RE, Turnbaugh PJ, Klein S, Gordon JI. Human gut microbes associated with
obesity. Nature. 2006;444:1022-3.
Turnbaugh PJ, Ley RE, Mahowald MA, Magrini V, Mardis ER, Gordon JI. An
obesity-associated gut microbiome with increased capacity for energy harvest.
Nature. 2006;444:1027-31.
Duncan SH, Lobley GE, Holtrop G, Ince J, Johnstone AM, Louis P, et al. Human
colonic microbiota associated with diet, obesity and weight loss. Int J Obes
(Lond). 2008;32:1720-4.
Magne F, Gotteland M, Gauthier L, Zazueta A, Pesoa S, Navarrete P, et al. The
Firmicutes/Bacteroidetes Ratio: A Relevant Marker of Gut Dysbiosis in Obese
Patients? Nutrients. 2020;12.
Schwiertz A, Taras D, Schäfer K, Beijer S, Bos NA, Donus C, et al. Microbiota
and SCFA in lean and overweight healthy subjects. Obesity (Silver Spring).
2010;18:190-5.
Sze MA, Schloss PD. Looking for a Signal in the Noise: Revisiting Obesity and
the Microbiome. mBio. 2016;7.
Wang M, Donovan SM. Human microbiota-associated swine: current progress
and future opportunities. Ilar j. 2015;56:63-73.
Meurens F, Summerfield A, Nauwynck H, Saif L, Gerdts V. The pig: a model for
human infectious diseases. Trends Microbiol. 2012;20:50-7.
Roura E, Koopmans SJ, Lalles JP, Le Huerou-Luron I, de Jager N, Schuurman T,
et al. Critical review evaluating the pig as a model for human nutritional
physiology. Nutr Res Rev. 2016;29:60-90.
Suzuki Y, Yeung AC, Ikeno F. The representative porcine model for human
cardiovascular disease. J Biomed Biotechnol. 2011;2011:195483.

208
18.

Aluthge ND, Tom WA, Bartenslager AC, Burkey TE, Miller PS, Heath KD, et al.
Differential longitudinal establishment of human fecal bacterial communities in
germ-free porcine and murine models. Commun Biol. 2020;3:760.
19.
Kozich JJ, Westcott SL, Baxter NT, Highlander SK, Schloss PD. Development of
a dual-index sequencing strategy and curation pipeline for analyzing amplicon
sequence data on the MiSeq Illumina sequencing platform. Appl Environ
Microbiol. 2013;79:5112-20.
20.
Team RC. R: A language and environment for statistical computing. R
Foundation for Statistical Computing. Vienna, Austria2021.
21.
McMurdie PJ, Holmes S. phyloseq: an R package for reproducible interactive
analysis and graphics of microbiome census data. PLoS One. 2013;8:e61217.
22.
Callahan BJ, McMurdie PJ, Rosen MJ, Han AW, Johnson AJ, Holmes SP.
DADA2: High-resolution sample inference from Illumina amplicon data. Nat
Methods. 2016;13:581-3.
23.
Di Rienzi SC, Sharon I, Wrighton KC, Koren O, Hug LA, Thomas BC, et al. The
human gut and groundwater harbor non-photosynthetic bacteria belonging to a
new candidate phylum sibling to Cyanobacteria. Elife. 2013;2:e01102.
24.
Love MI, Huber W, Anders S. Moderated estimation of fold change and
dispersion for RNA-seq data with DESeq2. Genome Biol. 2014;15:550.
25.
Joshi NAFJN. Sickle: A sliding-window, adaptive, quality-based trimming tool
for FastQ files
(Version 1.33) [Software]. Available at https://github.com/najoshi/sickle. 2011.
26.
Kopylova E, Noé L, Touzet H. SortMeRNA: fast and accurate filtering of
ribosomal RNAs in metatranscriptomic data. Bioinformatics. 2012;28:3211-7.
27.
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR:
ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15-21.
28.
Okonechnikov K, Conesa A, García-Alcalde F. Qualimap 2: advanced multisample quality control for high-throughput sequencing data. Bioinformatics.
2016;32:292-4.
29.
Li H, Handsaker B, Wysoker A, Fennell T, Ruan J, Homer N, et al. The Sequence
Alignment/Map format and SAMtools. Bioinformatics. 2009;25:2078-9.
30.
Patro R, Duggal G, Love MI, Irizarry RA, Kingsford C. Salmon provides fast and
bias-aware quantification of transcript expression. Nat Methods. 2017;14:417-9.
31.
Durinck S, Spellman PT, Birney E, Huber W. Mapping identifiers for the
integration of genomic datasets with the R/Bioconductor package biomaRt. Nat
Protoc. 2009;4:1184-91.
32.
Anderson MJ. Permutational Multivariate Analysis of Variance (PERMANOVA).
Wiley StatsRef: Statistics Reference Online. p. 1-15.
33.
Palmas V, Pisanu S, Madau V, Casula E, Deledda A, Cusano R, et al. Gut
microbiota markers associated with obesity and overweight in Italian adults. Sci
Rep. 2021;11:5532.
34.
Wang K, Liao M, Zhou N, Bao L, Ma K, Zheng Z, et al. Parabacteroides
distasonis Alleviates Obesity and Metabolic Dysfunctions via Production of
Succinate and Secondary Bile Acids. Cell Rep. 2019;26:222-35.e5.
35.
Duan M, Wang Y, Zhang Q, Zou R, Guo M, Zheng H. Characteristics of gut
microbiota in people with obesity. PLoS One. 2021;16:e0255446.

209
36.
37.
38.

39.
40.
41.
42.
43.
44.

Hiippala K, Kainulainen V, Kalliomäki M, Arkkila P, Satokari R. Mucosal
Prevalence and Interactions with the Epithelium Indicate Commensalism of
Sutterella spp. Front Microbiol. 2016;7:1706.
Paone P, Cani PD. Mucus barrier, mucins and gut microbiota: the expected slimy
partners? Gut. 2020;69:2232-43.
Dhakal S, Wang L, Antony L, Rank J, Bernardo P, Ghimire S, et al. Amish
(Rural) vs. non-Amish (Urban) Infant Fecal Microbiotas Are Highly Diverse and
Their Transplantation Lead to Differences in Mucosal Immune Maturation in a
Humanized Germfree Piglet Model. Front Immunol. 2019;10:1509.
Miao Y, Mei Q, Fu C, Liao M, Liu Y, Xu X, et al. Genome-wide association and
transcriptome studies identify candidate genes and pathways for feed conversion
ratio in pigs. BMC Genomics. 2021;22:294.
Rijks J, Penders B, Dorenbos E, Straetemans S, Gerver WJ, Vreugdenhil A.
Pituitary response to thyrotropin releasing hormone in children with overweight
and obesity. Sci Rep. 2016;6:31032.
Cabell SB, Esbenshade KL. Effect of feeding thyrotropin-releasing hormone to
lactating sows. J Anim Sci. 1990;68:4292-302.
Albuquerque D, Nóbrega C, Manco L, Padez C. The contribution of genetics and
environment to obesity. Br Med Bull. 2017;123:159-73.
Li B, Weng Q, Dong C, Zhang Z, Li R, Liu J, et al. A Key Gene, PLIN1, Can
Affect Porcine Intramuscular Fat Content Based on Transcriptome Analysis.
Genes (Basel). 2018;9.
Gao Y, Li F, Zhang Y, Dai L, Jiang H, Liu H, et al. Silencing of ADIPOQ
efficiently suppresses preadipocyte differentiation in porcine. Cell Physiol
Biochem. 2013;31:452-61.

210

CHAPTER 5

SUMMARY AND FUTURE OUTLOOK

Despite the potential advantages of using human microbiota-associated (HMA)
pigs as model animals for investigating the human microbiome, relatively few studies
have used this animal model. As such, a knowledge gap exists in the applicability of the
HMA piglet model for human microbiome studies and how it compares to the widely
used HMA mouse models. The work presented in the previous chapters aimed to address
some of these knowledge gaps.
Studies in the microbiome literature which highlight some of the drawbacks of
using HMA mouse models have suggested that pigs might be a more relevant HMA
animal model for human microbiome investigations compared to HMA rodent models [1,
2]. Our first study compared the HMA C3H/HeN mouse model to the HMA piglet model
investigating colonization and persistence of colonization of human fecal bacteria from
donors representing different age groups in these two animal models. The results revealed
that the child, adult, and senior donor microbiotas colonized the HMA piglets more
successfully compared to the HMA mice. Notably, members of the phylum Firmicutes
colonized the HMA piglets more efficiently than the HMA mice. For the infant donor,
both models were comparable in terms of the number of taxa that had colonized;
however, relative abundances were more similar to the donor microbiota in the HMA
mice compared to that of the HMA piglets.
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In the current literature, several studies have used the HMA piglet as a model to
study the human infant microbiota [3, 4, 5, 6]. However, these studies fail to clearly
describe the transplantation efficiency of the infant microbiota in detail (especially at
lower taxonomic levels such as OTU/ASV level). Here, we characterized the transplanted
donor fecal microbiotas in piglets which were inoculated with fecal matter from two
separate infant donors. We observed an expansion of certain taxa that were rare species in
the donor inocula and this feature appears to have consequences at the functional level
within the microbiome as metagenomic analysis revealed distinct functional clustering of
the donor inocula and the fecal samples from HMA piglets. This phenomenon of
expansion of rare taxa present within the human infant microbiota when transplanted into
GF piglets is an important consideration that researchers have to consider when trying to
extrapolate results from HMA porcine models to human infants.
Based on our knowledge, the use of HMA piglets as recipients of microbiotas
from humans with a specific disease phenotype is yet to be reported [7]. Thus, in the
study described in chapter 4, we transplanted the fecal microbiota from obese and
normal-weight donors into GF piglets in order to investigate the possibility of
recapitulating the microbial characteristics of obesity in these animals. Results indicated
that a majority of the bacteria found in donor feces were able to colonize the piglets and
that, once established, the ‘normal weight’ and ‘obese’ piglets maintained distinct
microbiota structures. We also introduced cecum-cannulated HMA piglets as a model to
study mechanistic aspects of host-microbiota interactions in obesity.
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Although the HMA piglet model has great potential as a research tool to study the
human intestinal microbiota, there are a few challenges that need to be overcome in order
to encourage its broad adoption in the microbiome field. The larger size of piglets
(relative to commonly used rodent models) prohibits long-term studies (such as studies
involving microbiota and chronic diseases) involving HMA piglets as these animals
become too large to be housed inside isolators (The longest time for which we have been
able to keep piglets in isolators has been for 72 days). Another drawback of the larger
size of piglets is that it limits the number of animals that can be housed in an isolator at
any given time, which can potentially diminish the statistical power of studies conducted
using HMA piglets. The use of mini pigs as HMA animals may provide additional
opportunities in this regard as these animals are considerably smaller than the domestic
pig.
Another challenge for the popularization of HMA porcine models is the high costs
related to the derivation and maintenance of these animals. Compared to a single
gnotobiotic mouse which is estimated to cost around $500, a litter of gnotobiotic pigs is
estimated to cost around $25,000 [8]. This is reflected by the fact that, compared to germfree/gnotobiotic mouse facilities, there are a much smaller number of gnotobiotic pig
facilities. Another issue is that, compared to the wide availability of rodents due to the
multiple vendors that exist to provide them, no such resources are available for pigs at the
current moment.
Another aspect worth considering is the provision of colostrum to germ-free (GF)
piglets. The immune naivety of GF piglets as a result of not having exposure to colostrum
may be a risk factor for the survival of these piglets in their first few days of life. The
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challenge for us has been finding a suitable method to sterilize colostrum without
damaging the immunoglobulins. Due to its high viscosity filtration cannot be used for this
purpose. An interesting idea which we are yet to test is sterilization via Gamma
irradiation.
In spite of these challenges, the advantages (ability to provide milk from birth
onwards, opportunity to perform cannulations, many similarities with humans, etc.)
offered by the HMA porcine model provide exciting new opportunities to gain a deeper
understanding into the host-microbiota interactions which play a role in influencing
human health and well-being as well as to develop and evaluate novel microbiotatargeted therapeutics such as pre- and probiotics.
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APPENDIX I

Table A1.1. Taxonomy of non-core ASVs detected in donor INF2

ASV_ID
ASV 190
ASV_454
ASV_480
ASV_495
ASV_1740
ASV_1744
ASV_1761
ASV_2449
ASV_2470
ASV_2506
ASV_2508
ASV_3357
ASV_3360
ASV_3365
ASV_3448
ASV_3515
ASV_3605
ASV_3606
ASV_3609
ASV_3757

Taxonomy
Bifidobacterium bifidum
Haemophilus spp.
Pseudomonas spp.
Stenotrophomonas spp.
Enterobacteriaceae spp.
Klebsiella spp.
Escherichia-Shigella spp.
Turicibacter sanguinis
Staphylococcus spp.
Enterococcus spp.
Enterococcus spp.
Erysipelatoclostridium spp.
Erysipelatoclostridium spp.
Erysipelatoclostridium spp.
Intestinibacter bartlettii
Terrisporobacter mayombei
Veillonella spp.
Veillonella spp.
Veillonella spp.
Clostridium sensu stricto 1 neonatale
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Table A1.2. Taxonomy of non-core ASVs detected in donor INF1

ASV_ID
ASV_480
ASV_1016
ASV_1381
ASV_1759
ASV_1762
ASV_2215
ASV_2270
ASV_2378
ASV_2380
ASV_2504
ASV_2506
ASV_3494
ASV_3602
ASV_3747

Taxonomy
Pseudomonas spp.
Prevotella_9 spp.
Bacteroides spp.
Escherichia-Shigella
Escherichia-Shigella
Anaerocolumna spp.
[Ruminococcus] gnavus group
Limosilactobacillus spp.
Lacticaseibacillus spp.
Enterococcus spp.
Enterococcus spp.
Romboutsia spp.
Veillonella spp.
Clostridium sensu stricto 1 paraputrificum
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Table A1.3. Donor-undetected ASVs detected in the fecal samples from the early
inoculation piglets inoculated with INF1. Only ASVs with > 1.0% relative abundance are
shown.

ASV_ID

Std. Dev.
(%)

Taxonomy

ASV_167

Mean
abund.
(%)
7.38

7.07

Alistipes spp.

ASV_3273

5.63

7.27

Akkermansia spp.

ASV_2533

5.05

6.02

Lactococcus spp.

ASV_1388

4.92

3.97

Bacteroides spp.

ASV_3868

4.24

6.30

Roseburia intestinalis

ASV_1304

2.64

3.67

Parabacteroides merdae

ASV_2449

2.54

2.56

Turicibacter sanguinis

ASV_3267

2.20

4.68

Akkermansia muciniphila

ASV_52

2.00

1.67

Hungatella spp.

ASV_3565

1.76

0.84

Veillonella

ASV_2450

1.48

2.77

Turicibacter sanguinis

ASV_2776

1.26

1.40

Blautia spp.

ASV_1393

1.16

1.49

Bacteroides spp.
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Table A1.4. Donor-undetected ASVs detected in the fecal samples from the late
inoculation piglets inoculated with INF1. Only ASVs with > 1.0% relative abundance are
shown.

ASV_ID

Std. Dev.
(%)

Taxonomy

ASV_3273

Mean
abund.
(%)
12.05

7.23

Akkermansia spp.

ASV_1388

8.62

4.2

Bacteroides spp.

ASV_3868

5.97

3.83

Roseburia intestinalis

ASV_2776

3.90

2.95

Blautia spp.

ASV_1167

3.18

4.09

Alistipes spp.

ASV_3208

2.65

1.85

Ruminococcus bicirculans

ASV_2449

2.54

1.70

Turicibacter sanguinis

ASV_2533

2.49

2.66

Lactococcus spp.

ASV_1844

2.44

1.76

Ruminococcus bromii

ASV_1331

2.41

1.37

Parabacteroides distasonis

ASV_800

2.41

2.24

Parasutterella excrementihominis

ASV_3515

2.24

1.47

Terrisporobacter mayombei

ASV_1421

1.96

1.82

Bacteroides vulgatus

ASV_1387

1.82

2.06

Bacteroides spp.
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ASV_1385

1.73

3.04

Bacteroides spp.

ASV_3565

1.73

2.92

Veillionella spp.

ASV_3059

1.27

0.84

UCG-002 (Oscillospiraceae)

ASV_2205

1.17

0.65

Lachnoclostridium spp.

ASV_3704

1.10

1.01

Clostridium sensu stricto 1

ASV_2541

1.03

1.21

Lactococcus spp.
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Table A1.5. Donor-undetected ASVs detected in the fecal samples from the early
inoculation piglets inoculated with INF2. Only ASVs with > 1.0% relative abundance are
shown.

ASV_ID

Std. Dev.
(%)

Taxonomy

ASV_3273

Mean
abund.
(%)
11.87

10.43

Akkermansia spp.

ASV_196

9.68

11.36

Bifidobacterium spp.

ASV_1372

3.68

3.60

Bacteroides intestinalis

ASV_1373

3.65

3.65

Bacteroides intestinalis

ASV_1158

3.13

4.15

Alistipes putredinis

ASV_346

1.72

2.13

Collinsella aerofaciens

ASV_198

1.42

2.7

Bifidobacterium spp.

ASV_3704

1.34

1.77

Clostridium sensu stricto 1
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Table A1.6. Donor-undetected ASVs detected in the fecal samples from the late
inoculation piglets inoculated with INF2. Only ASVs with > 1.0% relative abundance are
shown.

ASV_ID

Std. Dev.
(%)

Taxonomy

ASV_3273

Mean
abund.
(%)
12.49

8.63

Akkermansia spp.

ASV_196

6.46

10.76

Bifidobacterium spp.

ASV_1167

3.64

3.91

Alistipes spp.

ASV_1373

3.63

3.71

Bacteroides intestinalis

ASV_1372

3.62

3.60

Bacteroides intestinalis

ASV_148

3.13

5.15

Subdoligranulum spp.

ASV_1393

2.99

2.27

Bacteroides spp.

ASV_198

1.91

3.26

Bifidobacterium spp.

ASV_800

1.37

1.41

Parasutterella excrementihominis

ASV_3279

1.13

1.28

Akkermansia spp.

ASV_161

1.03

1.31

UBA1819 (Ruminococcaceae)
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Table A1.7. Donor-undetected ASVs detected in the fecal samples from the mice
inoculated with INF2. Only ASVs with > 1.0% relative abundance are shown.

ASV_ID

Std. Dev.
(%)

Taxonomy

ASV_1881

Mean
abund.
(%)
5.43

3.29

Erysipelotrichaceae

ASV_3446

3.66

2.31

Clostridioides difficile

ASV_1745

1.95

2.76

Enterobacteriaceae spp.
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Fig A1.1. Rarefaction curve for donor inocula from INF2.
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Fig A1.2. Rarefaction curve for fecal samples from early inoculation piglets inoculated
with INF2.
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Fig A1.3. Rarefaction curve for fecal samples from late inoculation piglets inoculated
with INF2.
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Fig A1.4. Rarefaction curve for fecal samples from mice inoculated with INF2.

76.6 (52.6)

34.4 (37.0)

inoculation

inoculation

13.4 (16.8)

7d post-

2d post-

Late-inoculation piglets 38.5 (38.2)

piglets

Early-inoculation

Animal model

deviations.

(a)

83.7 (40.5)

68.2 (63.9)

inoculation

14d post-

82.2 (31.3)

56.9 (49.5)

inoculation

21d post-

inoculation

35d post-

81.4 (32.5) 82.3 (29.8)

76.4 (46.3) 74.5 (58.8)

inoculation

28d post-

79.0 (28.4)

76.4 (61.0)

inoculation

40d post-

time points. (a) animals inoculated with INF1 (b) animals inoculated with INF2. Values inside parentheses are standard

Table A1.8. The percentage of reads accounted for by donor-undetected ASVs in fecal samples collected at different sampling
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Mice

piglets

Late-inoculation

piglets

Early-inoculation

Animal model

5.3 (7.5)

30.3 (53.4)

8.9 (4.7)

46.4 (49.4)

29.4 (36.8)

inoculation

inoculation

13.2 (11.6)

7d post-

2d post-

12.0 (5.8)

49.2 (26.3)

54.0 (48.6)

inoculation

14d postinoculation

35d post-

56.8 (43.9) 55.0 (38.3)

inoculation

28d post-

(b)

12.9 (5.3)

19.3 (7.0)

23.1 (6.6)

67.9 (60.1) 66.7 (43.7) 74.3 (71.9)

48 (40.9)

inoculation

21d post-

14.2 (9.0)

60.8 (44.2)

50.4 (32.3)

inoculation

40d post-
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APPENDIX II

Diet composition

Ingredient
Casein
Whey protein isolate
Maltodextrin
Lactose monohydrate
Sucrose
Lard
Soybean oil
Cellulose
Vitamin Mix, Teklad (40060)
Thiamin HCl
Mineral Mix, AIN-93G-MX (94046)
Calcium phosphate, dibasic
Calcium carbonate
Potassium citrate, monohydrate
Sodium chloride
Magnesium oxide
Ferric citrate
Zinc sulfate, heptahydrate
Cupric sulfate
Sodium selenite (0.0445% in sucrose)
Potassium iodate
TBHQ, antioxidant
DL-Methionine

Low-fat, low-sugar
(LF) diet (g/kg)
214

High-fat, high sugar
(HF) diet (g/kg)
214

100
80
50
20
20
50
6
0.01
35
4.5
4.5
2.8
2.6
0.5
0.5
0.38
0.01
0.5
0.005
0.004
2.5

96.191
80
300
180
20
50
6
0.01
35
4.5
4.5
2.8
2.6
0.5
0.5
0.38
0.01
0.5
0.005
0.004
2.5
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APPENDIX III

Dendrogram based on unweighted UniFrac distances showing clustering of inocula used
for inoculating the GF piglets. The samples starting with ‘Comp_’ denotes the mixture of
all fecal samples collected from a given donor and used for the second inoculation.
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APPENDIX IV

Image A4. Set up used for connecting housing isolators to surgery bubble used for cecum
cannulation surgeries. The surgery bubble (center) is connected to the two isolators via
sterilized transfer sleeves which permit the transfer of piglets from the isolators to the
surgery bubble without exposure to the outside environment.
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APPENDIX V

PERMANOVA outputs

(1) Comparing beta diversity of HMA piglet fecal samples using PERMANOVA. (a)
Unweighted UniFrac distances and (b) Bray-Curtis distances.
Model: Dist. matrix ~ Donor_phenotype + Spec_donor + Diet + Week + Donor_phenotype: Diet,
permutations = 999

(a)

(b)
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(2) Comparing beta diversity of HMA piglet fecal samples within the Obese and Normal
weight phenotypes using PERMANOVA. (a) Norm-HMA piglets (b) Ob-HMA
piglets. Unweighted UniFrac distance matrices have been used.
Model: Dist. matrix ~ Spec_donor + Diet + Week + Spec_donor: Diet, permutations = 999

(a)

(b)
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(3) Comparing beta diversity of HMA piglet cecal content versus fecal samples using
PERMANOVA. (a) Unweighted UniFrac distances and (b) Bray-Curtis distances.
Model: Dist. matrix ~ Sample type + Donor_phenotype + Spec_donor + Diet + Week, permutations=999

Factor

Df

Sample type
Donor_phenotype
Specific donor
Diet
Week
Residuals
Total

1
1
6
1
1
29
39

Sums of
sqs
0.2092
0.4702
1.2976
0.1518
0.1168
2.2346
4.4803

Means
sqs
0.20923
0.47025
0.21627
0.15182
0.11683
0.07706

F Model

R2

p-value

2.7153
6.1027
2.8067
1.9702
1.5162

0.04670
0.10496
0.28962
0.03389
0.02608
0.49876
1.00000

0.001
0.001
0.001
0.013
0.076

F Model

R2

p-value

4.3521
5.5418
2.7551
2.6199
1.1356

0.07354
0.09364
0.27933
0.04427
0.01919
0.49003
1.00000

0.001
0.001
0.001
0.005
0.333

(a)

Factor

Df

Sample type
Donor_phenotype
Specific donor
Diet
Week
Residuals
Total

1
1
6
1
1
29
39

Sums of
sqs
0.8055
1.0257
3.0595
0.4849
0.2102
5.3673
10.9530

Means
sqs
0.80549
1.02567
0.50992
0.48488
0.21018
0.18508
(b)
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(4) Comparing beta diversity of HMA piglet cecal tissue versus cecal content samples
using PERMANOVA. (a) Unweighted UniFrac distances and (b) Bray-Curtis
distances.
Model: Dist. matrix ~ Sample type + Donor_phenotype + Spec_donor + Diet, permutations = 999

Factor

Df

Sample type
Donor phenotype
Specific donor
Diet
Residuals
Total

1
1
6
1
22
31

Sums of
sqs
0.3780
0.4377
0.0788
0.1198
1.8443
3.8585

Means
sqs
0.37804
0.43767
0.17979
0.11980
0.08383

F Model

R2

p-value

4.5096
5.2209
2.1447
1.4291

0.09798
0.11343
0.27958
0.03105
0.47797
1.00000

0.001
0.001
0.001
0.123

F Model

R2

p-value

7.5725
4.2089
1.8819
1.3361

0.16317
0.09069
0.24331
0.02879
0.47404
1.00000

0.001
0.001
0.001
0.146

(a)

Factor

Df

Sample type
Donor_phenotype
Specific donor
Diet
Residuals
Total

1
1
6
1
22
31

Sums of
sqs
1.5128
0.8409
2.2558
0.2669
4.3951
9.2715

Means
sqs
1.51282
0.84085
0.37597
0.26692
0.19978
(b)
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(5) Comparison of beta diversity (Bray-Curtis distance matrix) of cecal samples
collected from cannulated piglets pre- and post-cannulation.
Model: Dist. matrix ~ Description + Pig_ID + Week, permutations = 999. ‘Description’ refers to whether
the cecal sample was pre- or post-cannulation.
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APPENDIX VI

DESeq2 Results

(a) Significantly differentially abundant ASVs between obese donors and normal
weight donors. A positive value in ‘log2FoldChange’ indicates ASV was more
abundant in obese donors and a negative value indicates ASV was more abundant
in normal weight donors.

ASV_ID

log2FoldChange

padj

Taxonomy

ASV_112

-7.330669897

0.033225434

ASV_130
ASV_175

-22.77903543
22.04407292

1.56E-12
4.00E-12

[Eubacterium] ruminantium group
Akkermansia spp.

ASV_218

-22.19867476

4.32E-12

Phascolarctobacterium succinatutens

ASV_480
ASV_492

8.760923112
22.01771422

0.014918858
4.06E-12

ASV_549

-23.04238317

9.22E-13

ASV_1022
ASV_1030

24.32405292
8.422951732

3.74E-14
0.02440113

ASV_1050

21.89644206

4.49E-12

ASV_1069
ASV_1223

-23.11170601
-8.039132497

8.34E-13
0.027944525

[Eubacterium] siraeum group
NK4A214 group

ASV_1290

-8.188851963

0.022930371

UCG-002 spp.

ASV_1366
ASV_1369

22.18558631
22.29330534

2.96E-12
2.38E-12

[Eubacterium] hallii group
[Eubacterium] hallii group

ASV_1385

22.67536448

1.09E-12

Streptococcus spp.

ASV_1407
ASV_1433

-24.38306397
24.79170363

5.09E-14
1.65E-14

Catenibacterium mitsuokai
Holdemanella spp.

ASV_1662

24.20414532

4.22E-14

Dialister spp.

ASV_1665
ASV_1690

23.48790371
-25.16745121

1.99E-13
1.65E-14

Dialister spp.
Butyricimonas paravirosa

ASV_1695

-21.96384697

6.30E-12

Butyricimonas virosa

Lachnoclostridium spp.

Roseburia intestinalis
Roseburia spp.
Eisenbergiella massiliensis
Ruminococcus spp.
Incertae Sedis spp.
[Eubacterium] coprostanoligenes group
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ASV_1698

-22.00927122

6.07E-12

Butyricimonas virosa

ASV_1699

-21.24026152

3.17E-11

Butyricimonas spp.

ASV_1730
ASV_1731

21.9907827
-8.396031697

4.15E-12
0.002169704

Bacteroides eggerthii
Bacteroides spp.

ASV_1746

-8.903696374

0.000671881

Bacteroides spp.

ASV_1768
ASV_1785

24.01670994
23.01068615

5.43E-14
5.74E-13

Bacteroides vulgatus
Parabacteroides distasonis

ASV_1878

-23.3212364

5.74E-13

Alloprevotella spp.

ASV_1879
ASV_1980

-22.73448895
-21.24283927

1.64E-12
3.17E-11

Alloprevotella spp.
Barnesiella spp.

ASV_1981

21.60327398

7.94E-12

Barnesiella spp.

ASV_1986

24.30519352

3.74E-14

Barnesiella spp.

ASV_2132

-21.99363299

6.07E-12

Senegalimassilia spp.

ASV_2139

-7.079308366

0.01235517

ASV_2144

21.89193806

4.49E-12

Collinsella spp.

ASV_2145

21.96845662

4.20E-12

Collinsella spp.

ASV_2300

24.89047894

1.65E-14

Desulfovibrio spp.

ASV_2318

-23.18253252

2.74E-14

Mannheimia spp.

ASV_2324

-7.754850507

0.040785051

Coriobacteriales Incertae Sedis spp.

Sutterella spp.

(b) Significantly differentially abundant ASVs between Ob-HMA and Norm-HMA
piglets. A positive value in ‘log2FoldChange’ indicates ASV was more abundant
in Ob-HMA piglets and a negative value indicates ASV was more abundant in
Norm-HMA piglets.

ASV_ID

log2FoldChange

Padj

Taxonomy

ASV_10

-2.766665953

0.015110496

Lachnoclostridium spp.

ASV_21

-25.52153966

5.88E-72

Lachnoclostridium spp.

ASV_42

-5.120752515

0.043398

Lachnospiraceae spp.

ASV_178

2.385510823

0.003968093

Akkermansia muciniphila

ASV_180

2.61404235

0.048396922

Akkermansia spp.
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ASV_182

-3.455365184

0.00171507

Akkermansia spp.

ASV_184

-2.974661726

0.000885487

Akkermansia muciniphila

ASV_185
ASV_186

-3.487965478
-3.43799968

0.008308664
0.01098143

Akkermansia spp.
Akkermansia spp.

ASV_218

-8.797275886

4.74E-41

ASV_221
ASV_246

4.41035918
6.773673412

3.61E-09
0.001075872

ASV_257

-6.324636897

1.07E-05

ASV_262
ASV_273

24.72801215
-2.880261563

7.02E-60
0.010463021

Lacticaseibacillus spp.
Lactobacillus spp.

ASV_399

1.7069913

0.014548811

Alistipes shahii

ASV_401

-25.17764321

4.25E-51

Alistipes spp.

ASV_407

-3.879215883

7.96E-09

Alistipes obesi

ASV_442

25.52271208

1.57E-35

Escherichia-Shigella spp.

ASV_490

-8.464654018

8.75E-09

Roseburia spp.

ASV_548

25.51550404

8.01E-52

Eisenbergiella spp.

ASV_558

2.72213003

0.041960774

ASV_664

25.70898312

2.30E-62

Eubacterium spp.

ASV_728

-25.63999575

1.46E-79

Clostridium sensu stricto 6 spp.

ASV_730

-3.749190636

0.003886598

Clostridium sensu stricto 6 bornimense

ASV_742

5.969234296

0.014548811

Clostridium sensu stricto 1 spp.

ASV_762

-25.18431471

1.92E-56

Clostridium sensu stricto 1 disporicum

ASV_809

24.94085739

6.17E-36

Christensenellaceae R-7 group

ASV_830

25.53089816

9.37E-57

Christensenellaceae R-7 group

ASV_895

4.28956716

0.005548736

Ruminococcaceae spp.

ASV_912

-2.798510101

0.001401722

Harryflintia acetispora

ASV_919
ASV_920

5.601141712
-4.325677779

0.00652712
0.01098143

Negativibacillus spp.
Negativibacillus spp.

ASV_962

-27.36919564

8.01E-104

Subdoligranulum variabile

ASV_979
ASV_1007

-5.134763008
2.199051591

0.000885487
0.023961053

Fournierella spp.
DTU089 spp.

ASV_1080

-5.543714145

0.009046962

Ruminococcaceae spp.

ASV_1207
ASV_1223

-5.778139655
-25.30910277

0.002827835
4.12E-66

NK4A214 group
NK4A214 group

ASV_1245

-24.43234927

1.20E-40

UCG-005 spp.

ASV_1274
ASV_1282

-27.92539765
-25.90172848

1.42E-141
5.37E-91

UCG-002 spp.
Oscillospira spp.

ASV_1289

-5.398153813

0.000140843

UCG-002 spp.

ASV_1290
ASV_1295

-25.15812655
-6.746320007

4.25E-51
7.26E-07

UCG-002 spp.
UCG-003 spp.

Phascolarctobacterium succinatutens
Phascolarctobacterium faecium
Lactobacillus spp.
Pediococcus spp.

Ruminococcaceae spp.
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ASV_1309

1.795500329

0.002478768

Oscillibacter spp.

ASV_1369

23.72199687

4.53E-67

ASV_1393
ASV_1403

3.366547125
-4.016082083

1.13E-06
0.01383027

ASV_1433

24.73022172

2.15E-50

ASV_1455
ASV_1504

-5.26063715
-25.71682242

0.007219335
6.75E-51

Holdemania massiliensis
Intestinibacter spp.

ASV_1507

2.602991223

0.00969999

Intestinibacter bartlettii

ASV_1519
ASV_1525

-25.09209903
-2.995071066

4.47E-43
0.003886598

Terrisporobacter spp.
Romboutsia spp.

ASV_1567

-5.678497593

0.012319873

[Eubacterium] nodatum group

ASV_1581

25.75554835

5.60E-85

Weissella spp.

ASV_1603

24.80070544

3.03E-46

Turicibacter spp.

ASV_1690

-26.54295489

1.48E-153

Butyricimonas paravirosa

ASV_1713

-3.457381546

0.00431666

Alistipes spp.

ASV_1732

-24.18762743

8.92E-39

Bacteroides spp.

ASV_1740

-26.65775775

5.14E-80

Bacteroides spp.

ASV_1749

3.350975972

0.001376314

Bacteroides spp.

ASV_1752

-1.488158714

0.003657333

Bacteroides spp.

ASV_1769

-1.990318177

0.028270075

Bacteroides vulgatus

ASV_1785

8.723845824

3.69E-20

Parabacteroides distasonis

ASV_1787

-23.3548941

6.30E-76

Parabacteroides distasonis

ASV_1800

-24.84358947

4.70E-59

Parabacteroides faecis

ASV_1808

-5.427507559

0.018262172

Prevotella_9 spp.

ASV_1878

-24.84872891

1.25E-67

Alloprevotella spp.

ASV_1887

-6.099909622

7.86E-05

Paraprevotella spp.

ASV_1889
ASV_1979

-5.250585295
-28.4233908

0.000790818
1.26E-85

Paraprevotella spp.
Barnesiella spp.

ASV_1980

-4.509765333

6.20E-05

Barnesiella spp.

ASV_1981
ASV_1986

25.61272
28.22616969

6.29E-44
1.76E-217

Barnesiella spp.
Barnesiella spp.

ASV_1991

-22.96326451

3.26E-43

Bacteroidales spp.

ASV_1992
ASV_2116

-23.77883151
2.858144733

2.04E-66
0.018396345

Bacteroidales spp.
Gordonibacter urolithinfaciens

ASV_2128

-5.634212666

0.005604894

Slackia faecicanis

ASV_2130
ASV_2132

5.350556342
-5.845511439

0.010425799
0.002395059

Slackia isoflavoniconvertens
Senegalimassilia spp.

ASV_2133

5.554899418

0.000427069

Senegalimassilia anaerobia

ASV_2164
ASV_2279

-3.670841068
2.757819346

0.000476424
0.003663796

Coriobacteriales spp.
Bifidobacterium spp.

[Eubacterium] hallii
Streptococcus spp.
Coprobacillus cateniformis
Holdemanella spp.
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ASV_2324

-4.802397822

0.002827835

Sutterella spp.

ASV_2330

-4.18443167

0.006275465

Oxalobacter formigenes

ASV_2334
ASV_2371

4.681131015
-5.18788886

0.003999505
0.03923175

Parasutterella excrementihominis
Dorea formicigenerans

ASV_2379

7.32663481

1.27E-09

Lachnoclostridium spp.

ASV_2440

-24.86475781

9.11E-64

[Ruminococcus] gauvreauii

(c) Significantly differentially abundant ASVs based on HF versus LF diets for the
Ob-HMA piglets. A positive value in ‘log2FoldChange’ indicates ASV was more
abundant in piglets fed an HF diet and a negative value indicates ASV was more
abundant in piglets fed an LF diet.

ASV_ID

log2FoldChange

padj

Taxonomy

ASV_11

-25.69467515

2.40E-16

ASV_124
ASV_175
ASV_176
ASV_177

5.54225498
9.739912312
9.541601307
8.20936998

0.02398594
7.80E-10
2.43E-10
0.02879394

Anaerostipes hadrus
Akkermansia spp.
Akkermansia spp.
Akkermansia spp.

ASV_178
ASV_179

4.235178517
6.522460168

2.20E-07
0.01108783

Akkermansia muciniphila
Akkermansia spp.

ASV_180
ASV_181
ASV_246
ASV_257
ASV_273
ASV_431
ASV_442
ASV_548
ASV_558
ASV_663
ASV_687

8.890834011
9.831458982
9.410368878
-24.68955852
4.317048078
17.97064214
18.52192243
17.88919796
4.319398537
-24.22573419
-23.00222111

7.47E-12
1.66E-08
0.00586202
4.09E-19
0.0097627
2.56E-09
4.70E-16
9.22E-11
0.02101345
1.71E-18
8.94E-14

Akkermansia spp.
Akkermansia spp.
Lactobacillus spp.
Pediococcus spp.
Lactobacillus spp.
Klebsiella spp.
Escherichia-Shigella spp.
Eisenbergiella spp.
Ruminococcaceae spp.
Eubacterium spp.
Clostridia spp.

ASV_730

-23.59124402

2.15E-16

Lachnoclostridium spp

Clostridium sensu stricto 6 bornimense
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ASV_792
ASV_807
ASV_820

-21.80379638
2.378230441
-27.15819345

4.48E-12
0.04440244
3.61E-33

Christensenellaceae R-7 group
Christensenellaceae R-7 group
Christensenellaceae R-7 group

ASV_830
ASV_1050

6.086233385
-25.14511952

0.00028138
1.45E-22

Christensenellaceae R-7 group
[Eubacterium] coprostanoligenes group

ASV_1080
ASV_1089
ASV_1099
ASV_1199
ASV_1242
ASV_1367

-23.30189792
7.532357305
29.47372451
-22.59242263
-24.82253173
8.282430181

1.15E-13
1.35E-05
4.36E-21
8.94E-14
3.55E-25
0.00141216

Ruminococcaceae spp.
Ruminococcus bicirculans
[Eubacterium] coprostanoligenes group
Colidextribacter spp.
UCG-005 spp.
[Eubacterium] hallii group spp.

ASV_1435
ASV_1531
ASV_1560
ASV_1581

-25.97529014
3.033464288
4.45906314
4.398218709

3.94E-43
0.04440244
0.02357817
0.02357817

Faecalicoccus pleomorphus
Romboutsia sedimentorum
Family XIII AD3011 group spp.
Weissella spp.

ASV_1586
ASV_1598
ASV_1602

-23.4840966
2.787351536
3.966776961

2.59E-15
0.04614804
0.01211386

Enterococcus spp.
Turicibacter sanguinis
Turicibacter sanguinis

ASV_1663
ASV_1696
ASV_1697
ASV_1713

26.56253277
-21.96963609
-23.37220683
-23.49464376

2.95E-17
3.11E-12
9.92E-14
9.07E-19

Dialister invisus
Butyricimonas spp.
Butyricimonas spp.
Alistipes spp.

ASV_1729

6.236850258

1.23E-05

Bacteroides eggerthii

ASV_1733
ASV_1741
ASV_1753
ASV_1769
ASV_1889
ASV_1980
ASV_1981
ASV_1982
ASV_1983
ASV_1986
ASV_2133
ASV_2164
ASV_2375

-27.30174195
-26.48161773
-24.34337736
-7.23149071
-22.68809176
-24.94737563
-26.44272209
-24.67478141
-23.50887913
7.678654674
7.849011806
-23.38798459
-23.3389644

7.72E-67
1.42E-46
1.95E-16
5.46E-08
5.34E-13
1.73E-26
3.66E-48
1.92E-20
3.39E-16
4.87E-12
5.62E-07
9.91E-14
9.07E-19

Bacteroides intestinalis
Bacteroides massiliensis
Bacteroides finegoldii
Bacteroides vulgatus
Paraprevotella spp.
Barnesiella spp.
Barnesiella spp.
Barnesiella spp.
Barnesiella spp.
Barnesiella spp.
Senegalimassilia anaerobia
Coriobacteriales spp.
Coprococcus spp.

ASV_2416
ASV_2419

2.657178048
6.549138039

0.02197468
0.04440244

Blautia caecimuris
Blautia glucerasea

ASV_2437

5.65356132

0.00559388

Blautia massiliensis
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(d) Significantly differentially abundant ASVs based on HF versus LF diets for the
Norm-HMA piglets. A positive value in ‘log2FoldChange’ indicates ASV was
more abundant in piglets fed an HF diet and a negative value indicates ASV was
more abundant in piglets fed an LF diet.

ASV_ID

log2FoldChange

padj

Taxonomy

ASV_175

19.00177656

4.89E-09

Akkermansia spp.

ASV_180

18.84486882

5.39E-09

Akkermansia spp.

ASV_181

18.85625493

5.39E-09

Akkermansia spp.

ASV_264

-9.840689177

0.00767217

Lacticaseibacillus spp.

ASV_273

4.511292294

0.00215856

Lactobacillus spp.

ASV_444

-9.141201372

0.02235497

Escherichia-Shigella spp.

ASV_492

-12.08467813

0.00078236

Roseburia spp.

ASV_745

-23.83053204

7.30E-14

ASV_762

4.666114279

0.02176995

ASV_818

-29.90832354

1.40E-21

Christensenellaceae R-7 group

ASV_820

-3.880314149

0.00262594

Christensenellaceae R-7 group

ASV_961

-4.834658135

0.01351788

Subdoligranulum spp.

ASV_1051

-27.04267494

6.40E-18

[Eubacterium] coprostanoligenes group

ASV_1099

-10.99637952

0.00300413

[Eubacterium] coprostanoligenes group

ASV_1393

-7.72680456

3.84E-10

Streptococcus spp.

ASV_1521

18.61822412

8.41E-09

Romboutsia ilealis

ASV_1524

-23.57491947

1.11E-13

Romboutsia spp.

ASV_1786
ASV_1788

-9.238746491
-5.151157927

0.00028632
4.92E-05

Parabacteroides distasonis
Parabacteroides distasonis

ASV_1979

-4.446579477

0.00486865

Barnesiella spp.

ASV_2274
ASV_2300

-9.921407015
-23.14759832

0.00300413
2.82E-13

Bifidobacterium spp.
Desulfovibrio spp.

ASV_2424

18.08289112

2.42E-08

Sarcina spp.
Clostridium sensu stricto 1 disporicum

Blautia spp.

No. of
ASVs in
donor
7
14
1
54
5
4

Phylum

Actinobacteriota

Bacteroidota

Desulfobacterota

Firmicutes

Proteobacteria

Verrucomicrobiota

Norm_25_004.

4

4

40

1

12

Total
no. of
ASVs
detected in
HMA
piglets
6

(a)

4

0

12

1

9

No. of
ASVs
detected in
piglets
while on
milk diets
5

4

0

16

1

10

6

No. of ASVs
detected in
piglets while
on transition
diet

2

2

25

1

10

5

No. of ASVs
detected in
piglets while
on low fat
diet

4

4

37

1

11

5

No. of ASVs
detected in
piglets while
on high fat
diet

Ob_2014 (b) Ob_30_001 (c) Ob_30_002 (d) Norm_2014 (e) Norm_25_001 (f) Norm_25_002 (g) Norm_25_003 (h)

Table A7.1. Number of donor ASVs detected in the HMA piglets at different dietary stages categorized by phylum. (a)
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No. of
ASVs in
donor
4
7
67
2
4

Phylum

Actinobacteriota

Bacteroidota

Firmicutes

Proteobacteria

Verrucomicrobiota

4

2

54

7

Total
no. of
ASVs
detected in
HMA
piglets
3

(b)

4

1

21

6

No. of
ASVs
detected in
piglets
while on
milk diets
2

4

1

25

7

3

4

2

46

7

3

No. of ASVs No. of ASVs
detected in
detected in
piglets while piglets while
on transition
on low fat
diet
diet

2

1

37

6

3

No. of ASVs
detected in
piglets while
on high fat
diet

245

12
1
73
4
1

Bacteroidota

Desulfobacterota

Firmicutes

Proteobacteria

Verrucomicrobiota

Actinobacteriota

Phylum

1

4

59

1

12

(c)

1

3

13

0

11

Total
No. of
No. of ASVs no. of ASVs
ASVs
in donor
detected in
detected in
HMA
piglets while
piglets
on milk
diets
10
7
3

0

1

26

0

10

5

No. of ASVs
detected in
piglets while
on transition
diet

1

4

52

1

12

5

No. of ASVs
detected in
piglets while
on low fat
diet

1

3

58

1

11

5

No. of ASVs
detected in
piglets while
on high fat
diet
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No. of
ASVs in
donor
9
13
56
1
5

Phylum

Actinobacteriota

Bacteroidota

Firmicutes

Fusobacteria

Proteobacteria

4

1

46

12

Total
no. of
ASVs
detected in
HMA
piglets
7

(d)

4

1

27

11

No. of
ASVs
detected in
piglets
while on
milk diets
5

3

1

18

8

5

No. of ASVs
detected in
piglets while
on transition
diet

4

1

36

12

3

No. of ASVs
detected in
piglets while
on low fat
diet

4

0

34

12

6

No. of ASVs
detected in
piglets while
on high fat
diet
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No. of
ASVs in
donor
5
17
67
6
5

Phylum

Actinobacteriota

Bacteroidota

Firmicutes

Proteobacteria

Verrucomicrobiota

5

5

53

16

5

Total
no. of ASVs
detected in
HMA
piglets

(e)

5

5

32

16

No. of
ASVs
detected in
piglets
while on
milk diets
4

5

4

23

16

3

No. of ASVs
detected in
piglets while
on transition
diet

5

4

44

16

5

No. of ASVs
detected in
piglets while
on low fat
diet

5

1

35

15

4

No. of ASVs
detected in
piglets while
on high fat
diet
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No. of
ASVs in
donor
7
16
1
58
4

Phylum

Actinobacteriota

Bacteroidota

Desulfobacterota

Firmicutes

Proteobacteria

2

46

1

16

6

Total
no. of ASVs
detected in
HMA
piglets

(f)

1

23

1

12

No. of
ASVs
detected in
piglets
while on
milk diets
4

1

9

0

11

4

No. of ASVs
detected in
piglets while
on transition
diet

2

35

1

15

2

No. of ASVs
detected in
piglets while
on low fat
diet

2

35

1

13

5

No. of ASVs
detected in
piglets while
on high fat
diet

249

No. of
ASVs in
donor
8
22
1
68
1
4
1

Phylum

Actinobacteriota

Bacteroidota

Desulfobacterota

Firmicutes

Fusobacteria

Proteobacteria

Verrucomicrobiota

1

2

1

55

1

22

7

Total
no. of ASVs
detected in
HMA
piglets

(g)

1

1

1

17

1

13

No. of
ASVs
detected in
piglets
while on
milk diets
1

0

1

0

20

1

21

6

No. of ASVs
detected in
piglets while
on transition
diet

1

2

1

47

1

20

5

No. of ASVs
detected in
piglets while
on low fat
diet

1

2

1

51

1

20

6

No. of ASVs
detected in
piglets while
on high fat
diet
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No. of
ASVs in
donor
10
31
2
69
6
2

Phylum

Actinobacteriota

Bacteroidota

Desulfobacterota

Firmicutes

Proteobacteria

Verrucomicrobiota

2

3

56

2

30

8

Total
no. of ASVs
detected in
HMA
piglets

(h)

2

2

17

2

22

No. of
ASVs
detected in
piglets
while on
milk diets
3

1

2

15

1

24

2

No. of ASVs
detected in
piglets while
on transition
diet

2

2

44

2

29

5

No. of ASVs
detected in
piglets while
on low fat
diet

2

1

47

2

28

7

No. of ASVs
detected in
piglets while
on high fat
diet

251

252

APPENDIX VIII

Taxonomy of ASVs only detected in cecal tissue samples at euthanization

ASV_ID
ASV_40
ASV_93
ASV_121
ASV_122
ASV_127
ASV_148
ASV_187
ASV_201
ASV_210
ASV_226
ASV_228
ASV_236
ASV_245
ASV_246
ASV_258
ASV_280
ASV_292
ASV_294
ASV_311
ASV_352
ASV_357
ASV_358
ASV_359
ASV_366
ASV_371
ASV_381
ASV_382
ASV_395
ASV_412
ASV_430
ASV_436
ASV_440

Taxonomy
Pirellulaceae;CPla-4 termite group
Oscillospiraceae;UCG-002
Treponema spp.
Verrucomicrobiota;Kiritimatiellae;WCHB1-41
Prevotellaceae UCG-001
Treponema spp.
Prevotellaceae NK3B31 group
Christensenellaceae
Bacilli;RF39
Muribaculaceae
Bacteroides spp.
Phascolarctobacterium
Christensenellaceae
Christensenellaceae R-7 group
Bacteroidales RF16 group
Prevotellaceae UCG-003
Treponema spp.
Agathobacter spp.
Muribaculaceae
Prevotella spp.
Christensenellaceae
Bacteroidales
Prevotellaceae NK3B31 group
Anaerovoracaceae;Family XIII AD3011 group
Bacteroidales;F082
Alloprevotella spp.
Christensenellaceae
Ruminococcus spp.
Lachnospiraceae;[Eubacterium] eligens group
Bacteroidales RF16 group
Alloprevotella spp.
Rikenellaceae RC9 gut group
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ASV_444
ASV_474
ASV_491
ASV_498
ASV_511
ASV_513
ASV_518
ASV_555
ASV_562
ASV_581
ASV_582
ASV_635
ASV_661
ASV_668
ASV_747

Oscillospirales;[Eubacterium] coprostanoligenes group
Fibrobacter intestinalis
Oscillospira spp.
Lachnospira spp.
Rikenellaceae RC9 gut group
Bacteroides finegoldii
Oscillospiraceae;UCG-005
Sutterella wadsworthensis
Alloprevotella spp.
Parabacteroides spp.
Faecalibacterium spp.
Clostridia vadinBB60 group
Oscillospiraceae;UCG-005
Bacteroides spp.
Lachnoclostridium
Lachnospirales;Defluviitaleaceae;Defluviitaleaceae UCGASV_761 011
ASV_779 Oscillospirales;UCG-010
ASV_781 Ruminococcus flavefaciens
ASV_801 Oscillospiraceae;UCG-005
ASV_810 Succinivibrionaceae;Succinatimonas hippei
ASV_825 Clostridium sensu stricto 1;paraputrificum
ASV_833 Parabacteroides spp.
ASV_850 Sphaerochaeta
ASV_883 Prevotellaceae NK3B31 group
ASV_990 Cetobacterium spp.
ASV_1033 Rhodospirillales
ASV_1098 Pseudomonas spp.
ASV_1378 Lachnospiraceae
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APPENDIX IX

Number of differentially expressed genes as a result of donor-to-donor variation and
cecum cannulation within the Norm-HMA and Ob-HMA piglets.

Norm-HMA pigs

Comparison

Number of
DEGS

Norm_25_002_vs_Norm_25_001

0

Norm_25_003_vs_Norm_25_001

4

Norm_25_004_vs_Norm_25_001

1

Lean_2014_vs_ Norm_25_001

313

Cannulated_vs_uncannulated

306

Ob_30_002_vs_Ob_30_001

143

Ob_2014_vs_Ob_30_001

17

Cannulated_vs_uncannulated

15

Ob-HMA pigs

